Cayman公司成立于1980年，在过去20多年的发展过程中，始终保持着为科研工作者提供高质、优价研究产品的宗旨。该公司目前可以提供2,138 多种生化和免疫试剂，涉及肿瘤、氧化氮、神经学、凋亡、氧化性损伤、内分泌学等研究领域。非常有特色的检测试剂盒包括类花生酸类物质、游离的生物标志、环核苷、激素及氧化氮等。此外，还提供多种高质量试剂，如类花生酸类物质、氧化氮试剂及许多相关脂质、脂肪酸、酶和抗体等。Cayman非常愿意接受各地客户的要求，合成复杂和不稳定分子。
品牌商名称：Cayman Chemical
：(734) 971-3335
地址：1180 East Ellsworth Road Ann Arbor, Michigan 48108 USA
公司：http://www.caymanchem。。ｃｏｍ/
世界*实验材料供应商Cayman正式授权上海起发为其中国代理，Cayman在一直是行业的*,一直为广大科研客户提供zui为的产品和服务,上海起发一直秉承为中国科研客户带来的产品，的服务， 签约Cayman就是为了给广大科研客户带来更加完善的产品和服务,您的满意将是我们zui大的收获
Cayman中国代理，Cayman上海代理，Cayman北京代理，Cayman广东代理，Cayman江苏代理 Cayman湖北代理, Cayman天津, Cayman黑龙江代理, Cayman内蒙古代理, Cayman吉林代理, Cayman福建代理, Cayman江苏代理, Cayman浙江代理, Cayman四川代理,
部分报价3
| 品牌 | 目录号 | 产品 | 规格 | 2015目录价 |
| Cayman2015 | 10719 | JWH 073 6-hydroxyindole metabolite-d7 | 500 μg | 4102 |
| Cayman2015 | 10720 | JWH 073 7-hydroxyindole metabolite-d7 | 1 mg | 5572 |
| Cayman2015 | 10720 | JWH 073 7-hydroxyindole metabolite-d7 | 100 μg | 1330 |
| Cayman2015 | 10720 | JWH 073 7-hydroxyindole metabolite-d7 | 500 μg | 4102 |
| Cayman2015 | 10721 | JWH 201 | 10 mg | 1484 |
| Cayman2015 | 10721 | JWH 201 | 25 mg | 3528 |
| Cayman2015 | 10721 | JWH 201 | 5 mg | 784 |
| Cayman2015 | 10722 | JWH 302 | 10 mg | 1484 |
| Cayman2015 | 10722 | JWH 302 | 25 mg | 3528 |
| Cayman2015 | 10722 | JWH 302 | 5 mg | 784 |
| Cayman2015 | 10724 | C-20 Ceramide | 1 mg | 140 |
| Cayman2015 | 10724 | C-20 Ceramide | 10 mg | 1120 |
| Cayman2015 | 10724 | C-20 Ceramide | 25 mg | 2450 |
| Cayman2015 | 10724 | C-20 Ceramide | 5 mg | 630 |
| Cayman2015 | 10727 | 3,5-dimethyl PIT-1 | 1 mg | 280 |
| Cayman2015 | 10727 | 3,5-dimethyl PIT-1 | 10 mg | 2240 |
| Cayman2015 | 10727 | 3,5-dimethyl PIT-1 | 25 mg | 4900 |
| Cayman2015 | 10727 | 3,5-dimethyl PIT-1 | 5 mg | 1260 |
| Cayman2015 | 10728 | PIT-1 | 10 mg | 406 |
| Cayman2015 | 10728 | PIT-1 | 100 mg | 2940 |
| Cayman2015 | 10728 | PIT-1 | 5 mg | 210 |
| Cayman2015 | 10728 | PIT-1 | 50 mg | 1680 |
| Cayman2015 | 10729 | 5-methoxy DALT | 1 mg | 490 |
| Cayman2015 | 10729 | 5-methoxy DALT | 10 mg | 2576 |
| Cayman2015 | 10729 | 5-methoxy DALT | 5 mg | 1456 |
| Cayman2015 | 10730 | 3-Fluoromethcathinone (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 10730 | 3-Fluoromethcathinone (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 10730 | 3-Fluoromethcathinone (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 10734 | UNC0638 | 1 mg | 532 |
| Cayman2015 | 10734 | UNC0638 | 10 mg | 2352 |
| Cayman2015 | 10734 | UNC0638 | 5 mg | 1512 |
| Cayman2015 | 10734 | UNC0638 | 50 mg | 10920 |
| Cayman2015 | 10735 | Phthalazinone pyrazole | 1 mg | 532 |
| Cayman2015 | 10735 | Phthalazinone pyrazole | 10 mg | 3192 |
| Cayman2015 | 10735 | Phthalazinone pyrazole | 5 mg | 2128 |
| Cayman2015 | 10736 | (±)-WIN 55,212 (mesylate) | 10 mg | 798 |
| Cayman2015 | 10736 | (±)-WIN 55,212 (mesylate) | 25 mg | 1890 |
| Cayman2015 | 10736 | (±)-WIN 55,212 (mesylate) | 5 mg | 420 |
| Cayman2015 | 10736 | (±)-WIN 55,212 (mesylate) | 50 mg | 3360 |
| Cayman2015 | 10739 | Isoliquiritigenin | 1 mg | 420 |
| Cayman2015 | 10739 | Isoliquiritigenin | 10 mg | 3360 |
| Cayman2015 | 10739 | Isoliquiritigenin | 5 mg | 1890 |
| Cayman2015 | 10739 | Isoliquiritigenin | 50 mg | 14700 |
| Cayman2015 | 10742 | 5(Z),8(Z),11(Z)-Eicosatrienoic Acid-d6 | 1 mg | 6272 |
| Cayman2015 | 10742 | 5(Z),8(Z),11(Z)-Eicosatrienoic Acid-d6 | 100 μg | 784 |
| Cayman2015 | 10742 | 5(Z),8(Z),11(Z)-Eicosatrienoic Acid-d6 | 500 μg | 3528 |
| Cayman2015 | 10743 | CAY10650 | 1 mg | 728 |
| Cayman2015 | 10743 | CAY10650 | 10 mg | 5824 |
| Cayman2015 | 10743 | CAY10650 | 5 mg | 3276 |
| Cayman2015 | 10743 | CAY10650 | 50 mg | 25480 |
| Cayman2015 | 10744 | JWH 200 4-hydroxyindole metabolite | 1 mg | 1330 |
| Cayman2015 | 10744 | JWH 200 4-hydroxyindole metabolite | 10 mg | 4900 |
| Cayman2015 | 10744 | JWH 200 4-hydroxyindole metabolite | 5 mg | 3150 |
| Cayman2015 | 10745 | JWH 200 5-hydroxyindole metabolite | 1 mg | 1330 |
| Cayman2015 | 10745 | JWH 200 5-hydroxyindole metabolite | 10 mg | 4900 |
| Cayman2015 | 10745 | JWH 200 5-hydroxyindole metabolite | 5 mg | 3150 |
| Cayman2015 | 10746 | JWH 200 6-hydroxyindole metabolite | 1 mg | 1330 |
| Cayman2015 | 10746 | JWH 200 6-hydroxyindole metabolite | 10 mg | 4900 |
| Cayman2015 | 10746 | JWH 200 6-hydroxyindole metabolite | 5 mg | 3150 |
| Cayman2015 | 10747 | JWH 200 7-hydroxyindole metabolite | 1 mg | 1330 |
| Cayman2015 | 10747 | JWH 200 7-hydroxyindole metabolite | 10 mg | 4900 |
| Cayman2015 | 10747 | JWH 200 7-hydroxyindole metabolite | 5 mg | 3150 |
| Cayman2015 | 10748 | Pifithrin-μ | 10 mg | 868 |
| Cayman2015 | 10748 | Pifithrin-μ | 25 mg | 2044 |
| Cayman2015 | 10748 | Pifithrin-μ | 5 mg | 546 |
| Cayman2015 | 10748 | Pifithrin-μ | 50 mg | 3822 |
| Cayman2015 | 10749 | Methylhexanamine (hydrochloride) | 10 mg | 770 |
| Cayman2015 | 10749 | Methylhexanamine (hydrochloride) | 5 mg | 406 |
| Cayman2015 | 10749 | Methylhexanamine (hydrochloride) | 50 mg | 3248 |
| Cayman2015 | 10750 | PRMT4 (human recombinant) | 100 μg | 3332 |
| Cayman2015 | 10750 | PRMT4 (human recombinant) | 25 μg | 924 |
| Cayman2015 | 10750 | PRMT4 (human recombinant) | 50 μg | 1750 |
| Cayman2015 | 10752 | PRMT6 (human recombinant) | 100 μg | 3332 |
| Cayman2015 | 10752 | PRMT6 (human recombinant) | 25 μg | 924 |
| Cayman2015 | 10752 | PRMT6 (human recombinant) | 50 μg | 1750 |
| Cayman2015 | 10755 | G9a-like protein (human recombinant) | 100 μg | 8568 |
| Cayman2015 | 10755 | G9a-like protein (human recombinant) | 25 μg | 2380 |
| Cayman2015 | 10755 | G9a-like protein (human recombinant) | 50 μg | 4522 |
| Cayman2015 | 10756 | MLL1/WAR complex (human recombinant) | 100 μg | 8190 |
| Cayman2015 | 10757 | NSD1 (human recombinant) | 100 μg | 9016 |
| Cayman2015 | 10757 | NSD1 (human recombinant) | 25 μg | 2506 |
| Cayman2015 | 10757 | NSD1 (human recombinant) | 50 μg | 4760 |
| Cayman2015 | 10758 | NSD2 (human recombinant) | 100 μg | 9016 |
| Cayman2015 | 10758 | NSD2 (human recombinant) | 25 μg | 2506 |
| Cayman2015 | 10758 | NSD2 (human recombinant) | 50 μg | 4760 |
| Cayman2015 | 10761 | SMYD1 (human recombinant) | 10 μg | 840 |
| Cayman2015 | 10761 | SMYD1 (human recombinant) | 25 μg | 2002 |
| Cayman2015 | 10761 | SMYD1 (human recombinant) | 50 μg | 3780 |
| Cayman2015 | 10762 | SMYD3 (human recombinant) | 10 μg | 840 |
| Cayman2015 | 10762 | SMYD3 (human recombinant) | 25 μg | 2002 |
| Cayman2015 | 10762 | SMYD3 (human recombinant) | 50 μg | 3780 |
| Cayman2015 | 10763 | SUV4-20H1 (human recombinant) | 100 μg | 7966 |
| Cayman2015 | 10763 | SUV4-20H1 (human recombinant) | 25 μg | 2212 |
| Cayman2015 | 10763 | SUV4-20H1 (human recombinant) | 50 μg | 4200 |
| Cayman2015 | 10764 | SUV4-20H2 (human recombinant) | 100 μg | 7966 |
| Cayman2015 | 10764 | SUV4-20H2 (human recombinant) | 25 μg | 2212 |
| Cayman2015 | 10764 | SUV4-20H2 (human recombinant) | 50 μg | 4200 |
| Cayman2015 | 10765 | RIZ1 (human recombinant) | 100 μg | 1736 |
| Cayman2015 | 10765 | RIZ1 (human recombinant) | 250 μg | 4102 |
| Cayman2015 | 10765 | RIZ1 (human recombinant) | 50 μg | 910 |
| Cayman2015 | 10767 | SETD2 (human recombinant) | 100 μg | 4788 |
| Cayman2015 | 10767 | SETD2 (human recombinant) | 25 μg | 1330 |
| Cayman2015 | 10767 | SETD2 (human recombinant) | 50 μg | 2520 |
| Cayman2015 | 10770 | DNA Methyltransferase 3L (human recombinant) | 10 μg | 2660 |
| Cayman2015 | 10770 | DNA Methyltransferase 3L (human recombinant) | 25 μg | 6314 |
| Cayman2015 | 10770 | DNA Methyltransferase 3L (human recombinant) | 50 μg | 11970 |
| Cayman2015 | 10773 | JMJD6 (human recombinant) | 100 μg | 4634 |
| Cayman2015 | 10773 | JMJD6 (human recombinant) | 25 μg | 1288 |
| Cayman2015 | 10773 | JMJD6 (human recombinant) | 50 μg | 2450 |
| Cayman2015 | 10774 | UTX (human recombinant) | 100 μg | 15876 |
| Cayman2015 | 10774 | UTX (human recombinant) | 25 μg | 4410 |
| Cayman2015 | 10774 | UTX (human recombinant) | 50 μg | 8386 |
| Cayman2015 | 10782 | Gcn5 (human recombinant) | 100 μg | 4984 |
| Cayman2015 | 10782 | Gcn5 (human recombinant) | 25 μg | 1386 |
| Cayman2015 | 10782 | Gcn5 (human recombinant) | 50 μg | 2632 |
| Cayman2015 | 10783 | TIP60 (human recombinant) | 100 μg | 5642 |
| Cayman2015 | 10783 | TIP60 (human recombinant) | 25 μg | 1568 |
| Cayman2015 | 10783 | TIP60 (human recombinant) | 50 μg | 2982 |
| Cayman2015 | 10784 | PAD1 (human recombinant) | 100 μg | 1918 |
| Cayman2015 | 10784 | PAD1 (human recombinant) | 250 μg | 4536 |
| Cayman2015 | 10784 | PAD1 (human recombinant) | 50 μg | 1008 |
| Cayman2015 | 10787 | CCG-100602 | 10 mg | 798 |
| Cayman2015 | 10787 | CCG-100602 | 25 mg | 1890 |
| Cayman2015 | 10787 | CCG-100602 | 5 mg | 420 |
| Cayman2015 | 10787 | CCG-100602 | 50 mg | 3360 |
| Cayman2015 | 10790 | Xanomeline oxalate | 1 mg | 420 |
| Cayman2015 | 10790 | Xanomeline oxalate | 10 mg | 3360 |
| Cayman2015 | 10790 | Xanomeline oxalate | 5 mg | 1890 |
| Cayman2015 | 10791 | CAY10647 | 1 mg | 1232 |
| Cayman2015 | 10791 | CAY10647 | 10 mg | 9856 |
| Cayman2015 | 10791 | CAY10647 | 5 mg | 5544 |
| Cayman2015 | 10793 | AG-879 | 10 mg | 1736 |
| Cayman2015 | 10793 | AG-879 | 25 mg | 4102 |
| Cayman2015 | 10793 | AG-879 | 5 mg | 910 |
| Cayman2015 | 10793 | AG-879 | 50 mg | 7280 |
| Cayman2015 | 10794 | 22-Oxacalcitriol | 1 mg | 1652 |
| Cayman2015 | 10794 | 22-Oxacalcitriol | 5 mg | 6944 |
| Cayman2015 | 10794 | 22-Oxacalcitriol | 500 μg | 868 |
| Cayman2015 | 10795 | (±)-JWH 073 N-(3-hydroxybutyl) metabolite | 1 mg | 1330 |
| Cayman2015 | 10795 | (±)-JWH 073 N-(3-hydroxybutyl) metabolite | 10 mg | 4900 |
| Cayman2015 | 10795 | (±)-JWH 073 N-(3-hydroxybutyl) metabolite | 5 mg | 3150 |
| Cayman2015 | 10796 | (±)-JWH 018 N-(4-hydroxypentyl) metabolite | 1 mg | 1330 |
| Cayman2015 | 10796 | (±)-JWH 018 N-(4-hydroxypentyl) metabolite | 10 mg | 4900 |
| Cayman2015 | 10796 | (±)-JWH 018 N-(4-hydroxypentyl) metabolite | 5 mg | 3150 |
| Cayman2015 | 10797 | JWH 307 | 1 mg | 490 |
| Cayman2015 | 10797 | JWH 307 | 10 mg | 2450 |
| Cayman2015 | 10797 | JWH 307 | 25 mg | 6132 |
| Cayman2015 | 10797 | JWH 307 | 5 mg | 1960 |
| Cayman2015 | 10798 | RCS-4-C4 homolog | 1 mg | 686 |
| Cayman2015 | 10798 | RCS-4-C4 homolog | 10 mg | 5488 |
| Cayman2015 | 10798 | RCS-4-C4 homolog | 5 mg | 3094 |
| Cayman2015 | 10801 | Mephedrone (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 10801 | Mephedrone (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 10801 | Mephedrone (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 10803 | Autotaxin (human recombinant) | 100 μg | 5642 |
| Cayman2015 | 10803 | Autotaxin (human recombinant) | 25 μg | 1568 |
| Cayman2015 | 10803 | Autotaxin (human recombinant) | 50 μg | 2982 |
| Cayman2015 | 10804 | CAY10649 | 1 mg | 518 |
| Cayman2015 | 10804 | CAY10649 | 10 mg | 4144 |
| Cayman2015 | 10804 | CAY10649 | 5 mg | 2338 |
| Cayman2015 | 10805 | ANGPTL3 (human) Monoclonal Antibody (Clone Kairos-37) | 100 μg | 3960 |
| Cayman2015 | 10805 | ANGPTL3 (human) Monoclonal Antibody (Clone Kairos-37) | 50 μg | 3225 |
| Cayman2015 | 10806 | ANGPTL3 (mouse) Monoclonal Antibody (Clone Kairos3-1541) | 100 μg | 3960 |
| Cayman2015 | 10806 | ANGPTL3 (mouse) Monoclonal Antibody (Clone Kairos3-1541) | 50 μg | 3225 |
| Cayman2015 | 10807 | ANGPTL3 (mouse) Monoclonal Antibody (Clone Kairos3-3741) | 100 μg | 3960 |
| Cayman2015 | 10807 | ANGPTL3 (mouse) Monoclonal Antibody (Clone Kairos3-3741) | 50 μg | 3225 |
| Cayman2015 | 10808 | ANGPTL6 (human) Monoclonal Antibody (Clone Kairos-60) | 100 μg | 3960 |
| Cayman2015 | 10808 | ANGPTL6 (human) Monoclonal Antibody (Clone Kairos-60) | 50 μg | 3225 |
| Cayman2015 | 10809 | Interleukin-33 (human) Monoclonal Antibody (Clone IL33305B) | 100 μg | 2175 |
| Cayman2015 | 10809 | Interleukin-33 (human) Monoclonal Antibody (Clone IL33305B) | 50 μg | 2625 |
| Cayman2015 | 10810 | Interleukin-33 Monoclonal Antibody (Clone IL333068A) | 100 μg | 3960 |
| Cayman2015 | 10810 | Interleukin-33 Monoclonal Antibody (Clone IL333068A) | 50 μg | 3225 |
| Cayman2015 | 10811 | Interleukin-33 Monoclonal Antibody (Clone IL33026B) | 100 μg | 3960 |
| Cayman2015 | 10811 | Interleukin-33 Monoclonal Antibody (Clone IL33026B) | 50 μg | 3225 |
| Cayman2015 | 10812 | Vaspin (human) Monoclonal Antibody (Clone VP63) | 100 μg | 4620 |
| Cayman2015 | 10812 | Vaspin (human) Monoclonal Antibody (Clone VP63) | 50 μg | 3225 |
| Cayman2015 | 10813 | Nampt Monoclonal Antibody (Clone OMNI 379) | 100 μg | 4170 |
| Cayman2015 | 10813 | Nampt Monoclonal Antibody (Clone OMNI 379) | 50 μg | 2775 |
| Cayman2015 | 10814 | FTO (mouse) Monoclonal Antibody (Clone FT 62-6) | 100 μg | 3960 |
| Cayman2015 | 10814 | FTO (mouse) Monoclonal Antibody (Clone FT 62-6) | 50 μg | 3225 |
| Cayman2015 | 10815 | FTO (mouse) Monoclonal Antibody (Clone FT 342-1) | 100 μg | 3960 |
| Cayman2015 | 10815 | FTO (mouse) Monoclonal Antibody (Clone FT 342-1) | 50 μg | 3225 |
| Cayman2015 | 10816 | FTO (human) Monoclonal Antibody (Clone FT 86-4) | 100 μg | 3960 |
| Cayman2015 | 10816 | FTO (human) Monoclonal Antibody (Clone FT 86-4) | 50 μg | 3225 |
| Cayman2015 | 10817 | Pyrovalerone | 10 mg | 1638 |
| Cayman2015 | 10817 | Pyrovalerone | 5 mg | 910 |
| Cayman2015 | 10817 | Pyrovalerone | 50 mg | 6146 |
| Cayman2015 | 10818 | Coumarin Boronic Acid pinacolate ester | 10 mg | 1610 |
| Cayman2015 | 10818 | Coumarin Boronic Acid pinacolate ester | 100 mg | 12880 |
| Cayman2015 | 10818 | Coumarin Boronic Acid pinacolate ester | 50 mg | 7252 |
| Cayman2015 | 10822 | SMAD1/5/8/9 Polyclonal Antibody | 1 ea | 5300 |
| Cayman2015 | 10823 | SMAD2 Polyclonal Antibody | 1 ea | 5100 |
| Cayman2015 | 10824 | JWH 031 | 10 mg | 1484 |
| Cayman2015 | 10824 | JWH 031 | 25 mg | 3528 |
| Cayman2015 | 10824 | JWH 031 | 5 mg | 784 |
| Cayman2015 | 10825 | JWH 145 | 1 mg | 490 |
| Cayman2015 | 10825 | JWH 145 | 10 mg | 3500 |
| Cayman2015 | 10825 | JWH 145 | 25 mg | 6930 |
| Cayman2015 | 10825 | JWH 145 | 5 mg | 1960 |
| Cayman2015 | 10826 | JWH 147 | 10 mg | 1484 |
| Cayman2015 | 10826 | JWH 147 | 25 mg | 3528 |
| Cayman2015 | 10826 | JWH 147 | 5 mg | 784 |
| Cayman2015 | 10827 | JWH 370 | 1 mg | 490 |
| Cayman2015 | 10827 | JWH 370 | 10 mg | 3500 |
| Cayman2015 | 10827 | JWH 370 | 25 mg | 6930 |
| Cayman2015 | 10827 | JWH 370 | 5 mg | 1960 |
| Cayman2015 | 10828 | JWH 369 | 1 mg | 490 |
| Cayman2015 | 10828 | JWH 369 | 10 mg | 3500 |
| Cayman2015 | 10828 | JWH 369 | 25 mg | 6930 |
| Cayman2015 | 10828 | JWH 369 | 5 mg | 1960 |
| Cayman2015 | 10829 | JWH 368 | 1 mg | 490 |
| Cayman2015 | 10829 | JWH 368 | 10 mg | 3500 |
| Cayman2015 | 10829 | JWH 368 | 25 mg | 6930 |
| Cayman2015 | 10829 | JWH 368 | 5 mg | 1960 |
| Cayman2015 | 10830 | JWH 309 | 1 mg | 490 |
| Cayman2015 | 10830 | JWH 309 | 10 mg | 3500 |
| Cayman2015 | 10830 | JWH 309 | 25 mg | 6930 |
| Cayman2015 | 10830 | JWH 309 | 5 mg | 1960 |
| Cayman2015 | 10831 | JWH 030 | 1 mg | 490 |
| Cayman2015 | 10831 | JWH 030 | 10 mg | 3500 |
| Cayman2015 | 10831 | JWH 030 | 25 mg | 6930 |
| Cayman2015 | 10831 | JWH 030 | 5 mg | 1960 |
| Cayman2015 | 10832 | SMAD3 Polyclonal Antibody | 1 ea | 3570 |
| Cayman2015 | 10836 | Pyrovalerone (hydrochloride) | 10 mg | 1638 |
| Cayman2015 | 10836 | Pyrovalerone (hydrochloride) | 5 mg | 910 |
| Cayman2015 | 10836 | Pyrovalerone (hydrochloride) | 50 mg | 6146 |
| Cayman2015 | 10838 | SMAD4 Polyclonal Antibody | 1 ea | 3570 |
| Cayman2015 | 10839 | SMAD6 Polyclonal Antibody | 1 ea | 3542 |
| Cayman2015 | 10840 | SMAD7 Polyclonal Antibody (azide-free) | 1 ea | 4214 |
| Cayman2015 | 10845 | SMAD7 Polyclonal Antibody | 1 ea | 3570 |
| Cayman2015 | 10848 | JWH 073 2-methylnaphthyl analog | 1 mg | 910 |
| Cayman2015 | 10848 | JWH 073 2-methylnaphthyl analog | 10 mg | 7280 |
| Cayman2015 | 10848 | JWH 073 2-methylnaphthyl analog | 5 mg | 4102 |
| Cayman2015 | 10849 | JWH 016 | 10 mg | 1484 |
| Cayman2015 | 10849 | JWH 016 | 25 mg | 3528 |
| Cayman2015 | 10849 | JWH 016 | 5 mg | 784 |
| Cayman2015 | 10850 | JWH 020 | 10 mg | 1484 |
| Cayman2015 | 10850 | JWH 020 | 25 mg | 3528 |
| Cayman2015 | 10850 | JWH 020 | 5 mg | 784 |
| Cayman2015 | 10851 | Guanabenz (hydrochloride) | 10 mg | 196 |
| Cayman2015 | 10851 | Guanabenz (hydrochloride) | 100 mg | 1372 |
| Cayman2015 | 10851 | Guanabenz (hydrochloride) | 25 mg | 462 |
| Cayman2015 | 10851 | Guanabenz (hydrochloride) | 50 mg | 882 |
| Cayman2015 | 10854 | Histone H4 Peptide Substrate (1-21) | 1 mg | 2142 |
| Cayman2015 | 10857 | CAY10654 | 1 mg | 322 |
| Cayman2015 | 10857 | CAY10654 | 10 mg | 2576 |
| Cayman2015 | 10857 | CAY10654 | 25 mg | 5642 |
| Cayman2015 | 10857 | CAY10654 | 5 mg | 1456 |
| Cayman2015 | 10859 | 4-Fluoromethcathinone (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 10859 | 4-Fluoromethcathinone (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 10859 | 4-Fluoromethcathinone (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 10860 | Kdo2-Lipid A (sodium salt) | 1 mg | 2235 |
| Cayman2015 | 10862 | AM2201 2'-naphthyl isomer | 1 mg | 910 |
| Cayman2015 | 10862 | AM2201 2'-naphthyl isomer | 10 mg | 7280 |
| Cayman2015 | 10862 | AM2201 2'-naphthyl isomer | 5 mg | 4102 |
| Cayman2015 | 10863 | RCS-8 4-methoxy isomer | 1 mg | 910 |
| Cayman2015 | 10863 | RCS-8 4-methoxy isomer | 10 mg | 7280 |
| Cayman2015 | 10863 | RCS-8 4-methoxy isomer | 5 mg | 4102 |
| Cayman2015 | 10864 | RCS-8 3-methoxy isomer | 1 mg | 910 |
| Cayman2015 | 10864 | RCS-8 3-methoxy isomer | 10 mg | 7280 |
| Cayman2015 | 10864 | RCS-8 3-methoxy isomer | 5 mg | 4102 |
| Cayman2015 | 10865 | RCS-4 2-methoxy isomer | 1 mg | 910 |
| Cayman2015 | 10865 | RCS-4 2-methoxy isomer | 10 mg | 7280 |
| Cayman2015 | 10865 | RCS-4 2-methoxy isomer | 5 mg | 4102 |
| Cayman2015 | 10866 | RCS-4 3-methoxy isomer | 1 mg | 910 |
| Cayman2015 | 10866 | RCS-4 3-methoxy isomer | 10 mg | 7280 |
| Cayman2015 | 10866 | RCS-4 3-methoxy isomer | 5 mg | 4102 |
| Cayman2015 | 10867 | JWH 203 4-chlorophenyl isomer | 10 mg | 1484 |
| Cayman2015 | 10867 | JWH 203 4-chlorophenyl isomer | 25 mg | 3528 |
| Cayman2015 | 10867 | JWH 203 4-chlorophenyl isomer | 5 mg | 784 |
| Cayman2015 | 10868 | JWH 203 3-chlorophenyl isomer | 10 mg | 1484 |
| Cayman2015 | 10868 | JWH 203 3-chlorophenyl isomer | 25 mg | 3528 |
| Cayman2015 | 10868 | JWH 203 3-chlorophenyl isomer | 5 mg | 784 |
| Cayman2015 | 10869 | AM694 4-iodo isomer | 1 mg | 910 |
| Cayman2015 | 10869 | AM694 4-iodo isomer | 10 mg | 7280 |
| Cayman2015 | 10869 | AM694 4-iodo isomer | 5 mg | 4102 |
| Cayman2015 | 10870 | AM694 3-iodo isomer | 1 mg | 910 |
| Cayman2015 | 10870 | AM694 3-iodo isomer | 10 mg | 7280 |
| Cayman2015 | 10870 | AM694 3-iodo isomer | 5 mg | 4102 |
| Cayman2015 | 10873 | TRAF5 Monoclonal Antibody (Clone 5219) | 1 ea | 3990 |
| Cayman2015 | 10875 | UNC669 | 10 mg | 672 |
| Cayman2015 | 10875 | UNC669 | 25 mg | 1050 |
| Cayman2015 | 10875 | UNC669 | 5 mg | 350 |
| Cayman2015 | 10875 | UNC669 | 50 mg | 1932 |
| Cayman2015 | 10876 | SC-66 | 10 mg | 798 |
| Cayman2015 | 10876 | SC-66 | 100 mg | 5880 |
| Cayman2015 | 10876 | SC-66 | 25 mg | 1890 |
| Cayman2015 | 10876 | SC-66 | 5 mg | 420 |
| Cayman2015 | 10877 | Histone H3 Peptide Substrate (1-21) | 1 mg | 2142 |
| Cayman2015 | 10878 | Maresin 1 | 10 μg | 826 |
| Cayman2015 | 10878 | Maresin 1 | 100 μg | 6608 |
| Cayman2015 | 10878 | Maresin 1 | 25 μg | 1960 |
| Cayman2015 | 10878 | Maresin 1 | 50 μg | 3724 |
| Cayman2015 | 10879 | JW 480 | 10 mg | 1176 |
| Cayman2015 | 10879 | JW 480 | 25 mg | 2772 |
| Cayman2015 | 10879 | JW 480 | 5 mg | 616 |
| Cayman2015 | 10879 | JW 480 | 50 mg | 4928 |
| Cayman2015 | 10888 | HZ52 | 1 mg | 406 |
| Cayman2015 | 10888 | HZ52 | 10 mg | 2240 |
| Cayman2015 | 10888 | HZ52 | 25 mg | 5082 |
| Cayman2015 | 10888 | HZ52 | 5 mg | 1218 |
| Cayman2015 | 10889 | CP 47,497-para-quinone analog | 1 mg | 2394 |
| Cayman2015 | 10889 | CP 47,497-para-quinone analog | 5 mg | 10150 |
| Cayman2015 | 10889 | CP 47,497-para-quinone analog | 500 μg | 1330 |
| Cayman2015 | 10898 | (S)-(+)-JWH 073 N-(3-hydroxybutyl) metabolite | 1 mg | 1330 |
| Cayman2015 | 10898 | (S)-(+)-JWH 073 N-(3-hydroxybutyl) metabolite | 10 mg | 4900 |
| Cayman2015 | 10898 | (S)-(+)-JWH 073 N-(3-hydroxybutyl) metabolite | 5 mg | 3150 |
| Cayman2015 | 10899 | (R)-(-)-JWH 073 N-(3-hydroxybutyl) metabolite | 1 mg | 1330 |
| Cayman2015 | 10899 | (R)-(-)-JWH 073 N-(3-hydroxybutyl) metabolite | 10 mg | 4900 |
| Cayman2015 | 10899 | (R)-(-)-JWH 073 N-(3-hydroxybutyl) metabolite | 5 mg | 3150 |
| Cayman2015 | 10900 | JWH 018 | 10 mg | 1246 |
| Cayman2015 | 10900 | JWH 018 | 25 mg | 3094 |
| Cayman2015 | 10900 | JWH 018 | 5 mg | 686 |
| Cayman2015 | 10902 | JWH 200 | 10 mg | 1330 |
| Cayman2015 | 10902 | JWH 200 | 25 mg | 3136 |
| Cayman2015 | 10902 | JWH 200 | 5 mg | 784 |
| Cayman2015 | 10903 | JWH 200-d5 | 1 mg | 1736 |
| Cayman2015 | 10903 | JWH 200-d5 | 500 μg | 910 |
| Cayman2015 | 10904 | JWH 073 | 10 mg | 1246 |
| Cayman2015 | 10904 | JWH 073 | 25 mg | 3094 |
| Cayman2015 | 10904 | JWH 073 | 5 mg | 686 |
| Cayman2015 | 10908 | (±)-CP 47,497-C8-homolog | 10 mg | 1568 |
| Cayman2015 | 10908 | (±)-CP 47,497-C8-homolog | 25 mg | 3724 |
| Cayman2015 | 10908 | (±)-CP 47,497-C8-homolog | 5 mg | 826 |
| Cayman2015 | 10910 | (+)-CP 47,497 | 1 mg | 392 |
| Cayman2015 | 10910 | (+)-CP 47,497 | 10 mg | 3136 |
| Cayman2015 | 10910 | (+)-CP 47,497 | 5 mg | 1764 |
| Cayman2015 | 10913 | (±)-CP 47,497 | 10 mg | 1582 |
| Cayman2015 | 10913 | (±)-CP 47,497 | 25 mg | 3570 |
| Cayman2015 | 10913 | (±)-CP 47,497 | 5 mg | 882 |
| Cayman2015 | 10917 | (-)-CP 47, 497 | 1 mg | 392 |
| Cayman2015 | 10917 | (-)-CP 47, 497 | 10 mg | 3136 |
| Cayman2015 | 10917 | (-)-CP 47, 497 | 5 mg | 1764 |
| Cayman2015 | 10918 | (±)3-epi CP 47,497-C8-homolog | 10 mg | 1470 |
| Cayman2015 | 10918 | (±)3-epi CP 47,497-C8-homolog | 25 mg | 3472 |
| Cayman2015 | 10918 | (±)3-epi CP 47,497-C8-homolog | 5 mg | 770 |
| Cayman2015 | 10919 | (±)-epi CP 47, 497 | 10 mg | 1470 |
| Cayman2015 | 10919 | (±)-epi CP 47, 497 | 25 mg | 3472 |
| Cayman2015 | 10919 | (±)-epi CP 47, 497 | 5 mg | 770 |
| Cayman2015 | 10920 | (S)-(+)-JWH 018 N-(4-hydroxypentyl) metabolite | 1 mg | 1330 |
| Cayman2015 | 10920 | (S)-(+)-JWH 018 N-(4-hydroxypentyl) metabolite | 10 mg | 4900 |
| Cayman2015 | 10920 | (S)-(+)-JWH 018 N-(4-hydroxypentyl) metabolite | 5 mg | 3150 |
| Cayman2015 | 10921 | (R)-(-)-JWH 018 N-(4-hydroxypentyl) metabolite | 1 mg | 1330 |
| Cayman2015 | 10921 | (R)-(-)-JWH 018 N-(4-hydroxypentyl) metabolite | 10 mg | 4900 |
| Cayman2015 | 10921 | (R)-(-)-JWH 018 N-(4-hydroxypentyl) metabolite | 5 mg | 3150 |
| Cayman2015 | 10922 | SR 1001 | 1 mg | 350 |
| Cayman2015 | 10922 | SR 1001 | 10 mg | 2128 |
| Cayman2015 | 10922 | SR 1001 | 25 mg | 4662 |
| Cayman2015 | 10922 | SR 1001 | 5 mg | 1190 |
| Cayman2015 | 10924 | Epothilone B | 1 mg | 1232 |
| Cayman2015 | 10924 | Epothilone B | 10 mg | 9856 |
| Cayman2015 | 10924 | Epothilone B | 5 mg | 5544 |
| Cayman2015 | 10925 | JWH 122 N-(5-hydroxypentyl) metabolite | 1 mg | 1330 |
| Cayman2015 | 10925 | JWH 122 N-(5-hydroxypentyl) metabolite | 10 mg | 4900 |
| Cayman2015 | 10925 | JWH 122 N-(5-hydroxypentyl) metabolite | 5 mg | 3150 |
| Cayman2015 | 10926 | (±)-JWH 018 N-(4-hydroxypentyl) metabolite-d5 | 1 mg | 5572 |
| Cayman2015 | 10926 | (±)-JWH 018 N-(4-hydroxypentyl) metabolite-d5 | 100 μg | 1330 |
| Cayman2015 | 10926 | (±)-JWH 018 N-(4-hydroxypentyl) metabolite-d5 | 500 μg | 4102 |
| Cayman2015 | 10927 | (±)-JWH 073 N-(3-hydroxybutyl) metabolite-d5 | 1 mg | 5572 |
| Cayman2015 | 10927 | (±)-JWH 073 N-(3-hydroxybutyl) metabolite-d5 | 100 μg | 1330 |
| Cayman2015 | 10927 | (±)-JWH 073 N-(3-hydroxybutyl) metabolite-d5 | 500 μg | 4102 |
| Cayman2015 | 10928 | SUCNR1 Polyclonal Antibody | 1 ea | 3878 |
| Cayman2015 | 10933 | JWH 018 N-(5-hydroxypentyl) metabolite-d5 | 1 mg | 9310 |
| Cayman2015 | 10933 | JWH 018 N-(5-hydroxypentyl) metabolite-d5 | 100 μg | 1330 |
| Cayman2015 | 10933 | JWH 018 N-(5-hydroxypentyl) metabolite-d5 | 500 μg | 5320 |
| Cayman2015 | 10934 | JWH 073 N-(4-hydroxybutyl) metabolite-d5 | 1 mg | 5572 |
| Cayman2015 | 10934 | JWH 073 N-(4-hydroxybutyl) metabolite-d5 | 100 μg | 1330 |
| Cayman2015 | 10934 | JWH 073 N-(4-hydroxybutyl) metabolite-d5 | 500 μg | 4102 |
| Cayman2015 | 10935 | RCS-4 N-(5-hydroxypentyl) metabolite | 1 mg | 1330 |
| Cayman2015 | 10935 | RCS-4 N-(5-hydroxypentyl) metabolite | 10 mg | 4900 |
| Cayman2015 | 10935 | RCS-4 N-(5-hydroxypentyl) metabolite | 5 mg | 3150 |
| Cayman2015 | 10936 | RCS-4 N-(4-hydroxypentyl) metabolite | 1 mg | 1330 |
| Cayman2015 | 10936 | RCS-4 N-(4-hydroxypentyl) metabolite | 10 mg | 4900 |
| Cayman2015 | 10936 | RCS-4 N-(4-hydroxypentyl) metabolite | 5 mg | 3150 |
| Cayman2015 | 10937 | RCS-4 N-(5-carboxypentyl) metabolite | 1 mg | 1330 |
| Cayman2015 | 10937 | RCS-4 N-(5-carboxypentyl) metabolite | 10 mg | 4900 |
| Cayman2015 | 10937 | RCS-4 N-(5-carboxypentyl) metabolite | 5 mg | 3150 |
| Cayman2015 | 10938 | JWH 250 N-pentanoic acid metabolite | 1 mg | 1330 |
| Cayman2015 | 10938 | JWH 250 N-pentanoic acid metabolite | 10 mg | 4900 |
| Cayman2015 | 10938 | JWH 250 N-pentanoic acid metabolite | 5 mg | 3150 |
| Cayman2015 | 10939 | JWH 250 N-(4-hydroxypentyl) metabolite | 1 mg | 1330 |
| Cayman2015 | 10939 | JWH 250 N-(4-hydroxypentyl) metabolite | 10 mg | 4900 |
| Cayman2015 | 10939 | JWH 250 N-(4-hydroxypentyl) metabolite | 5 mg | 3150 |
| Cayman2015 | 10940 | JWH 210 N-(4-hydroxypentyl) metabolite | 1 mg | 1330 |
| Cayman2015 | 10940 | JWH 210 N-(4-hydroxypentyl) metabolite | 10 mg | 4900 |
| Cayman2015 | 10940 | JWH 210 N-(4-hydroxypentyl) metabolite | 5 mg | 3150 |
| Cayman2015 | 10941 | JWH 210 N-pentanoic acid metabolite | 1 mg | 1330 |
| Cayman2015 | 10941 | JWH 210 N-pentanoic acid metabolite | 10 mg | 4900 |
| Cayman2015 | 10941 | JWH 210 N-pentanoic acid metabolite | 5 mg | 3150 |
| Cayman2015 | 10942 | JWH 398 N-pentanoic acid metabolite | 1 mg | 1330 |
| Cayman2015 | 10942 | JWH 398 N-pentanoic acid metabolite | 10 mg | 4900 |
| Cayman2015 | 10942 | JWH 398 N-pentanoic acid metabolite | 5 mg | 3150 |
| Cayman2015 | 10943 | JWH 398 N-(4-hydroxypentyl) metabolite | 1 mg | 1330 |
| Cayman2015 | 10943 | JWH 398 N-(4-hydroxypentyl) metabolite | 10 mg | 4900 |
| Cayman2015 | 10943 | JWH 398 N-(4-hydroxypentyl) metabolite | 5 mg | 3150 |
| Cayman2015 | 10944 | WDR5 (human recombinant) | 100 μg | 4256 |
| Cayman2015 | 10944 | WDR5 (human recombinant) | 250 μg | 10080 |
| Cayman2015 | 10944 | WDR5 (human recombinant) | 50 μg | 2240 |
| Cayman2015 | 10945 | MLL1/WARD complex (human recombinant) | 100 μg | 8330 |
| Cayman2015 | 10946 | ASH2L (human recombinant) | 100 μg | 7966 |
| Cayman2015 | 10946 | ASH2L (human recombinant) | 25 μg | 2212 |
| Cayman2015 | 10946 | ASH2L (human recombinant) | 50 μg | 4200 |
| Cayman2015 | 10947 | RbBP5 (human recombinant) | 100 μg | 9030 |
| Cayman2015 | 10947 | RbBP5 (human recombinant) | 25 μg | 2506 |
| Cayman2015 | 10947 | RbBP5 (human recombinant) | 50 μg | 4760 |
| Cayman2015 | 10948 | GN25 | 10 mg | 714 |
| Cayman2015 | 10948 | GN25 | 25 mg | 1708 |
| Cayman2015 | 10948 | GN25 | 5 mg | 378 |
| Cayman2015 | 10948 | GN25 | 50 mg | 3024 |
| Cayman2015 | 10949 | Sampling Tubes with PHMB | 100 ea | 10140 |
| Cayman2015 | 10949 | Sampling Tubes with PHMB | 35 ea | 3900 |
| Cayman2015 | 10950 | Sampling Tubes with BHT | 100 ea | 10140 |
| Cayman2015 | 10950 | Sampling Tubes with BHT | 35 ea | 3900 |
| Cayman2015 | 10951 | Sampling Tubes with Indomethacin | 100 ea | 10140 |
| Cayman2015 | 10951 | Sampling Tubes with Indomethacin | 35 ea | 3900 |
| Cayman2015 | 10954 | 1-NA-PP1 | 1 mg | 252 |
| Cayman2015 | 10954 | 1-NA-PP1 | 10 mg | 2058 |
| Cayman2015 | 10954 | 1-NA-PP1 | 5 mg | 1162 |
| Cayman2015 | 10954 | 1-NA-PP1 | 50 mg | 8260 |
| Cayman2015 | 10955 | VU0359595 | 1 mg | 406 |
| Cayman2015 | 10955 | VU0359595 | 10 mg | 2030 |
| Cayman2015 | 10955 | VU0359595 | 25 mg | 4564 |
| Cayman2015 | 10955 | VU0359595 | 5 mg | 1120 |
| Cayman2015 | 10956 | Clofibrate | 1 g | 350 |
| Cayman2015 | 10956 | Clofibrate | 10 g | 2548 |
| Cayman2015 | 10956 | Clofibrate | 5 g | 1456 |
| Cayman2015 | 10956 | Clofibrate | 500 mg | 182 |
| Cayman2015 | 10957 | JWH 018 N-pentanoic acid β-D-Glucuronide | 1 mg | 2604 |
| Cayman2015 | 10957 | JWH 018 N-pentanoic acid β-D-Glucuronide | 500 μg | 1372 |
| Cayman2015 | 10958 | JWH 018 N-(5-hydroxypentyl) β-D-Glucuronide | 1 mg | 1610 |
| Cayman2015 | 10958 | JWH 018 N-(5-hydroxypentyl) β-D-Glucuronide | 10 mg | 4900 |
| Cayman2015 | 10958 | JWH 018 N-(5-hydroxypentyl) β-D-Glucuronide | 5 mg | 3150 |
| Cayman2015 | 10960 | Bisdemethoxycurcumin | 10 mg | 1204 |
| Cayman2015 | 10960 | Bisdemethoxycurcumin | 25 mg | 1736 |
| Cayman2015 | 10960 | Bisdemethoxycurcumin | 5 mg | 630 |
| Cayman2015 | 10960 | Bisdemethoxycurcumin | 50 mg | 3150 |
| Cayman2015 | 10961 | Demethoxycurcumin | 1 mg | 350 |
| Cayman2015 | 10961 | Demethoxycurcumin | 10 mg | 1582 |
| Cayman2015 | 10961 | Demethoxycurcumin | 25 mg | 3850 |
| Cayman2015 | 10961 | Demethoxycurcumin | 5 mg | 1134 |
| Cayman2015 | 10964 | Eicosapentaenoyl Ethanolamide | 10 mg | 1302 |
| Cayman2015 | 10964 | Eicosapentaenoyl Ethanolamide | 100 mg | 9604 |
| Cayman2015 | 10964 | Eicosapentaenoyl Ethanolamide | 5 mg | 686 |
| Cayman2015 | 10964 | Eicosapentaenoyl Ethanolamide | 50 mg | 5488 |
| Cayman2015 | 10965 | Palmitoleoyl Ethanolamide | 10 mg | 1302 |
| Cayman2015 | 10965 | Palmitoleoyl Ethanolamide | 100 mg | 9604 |
| Cayman2015 | 10965 | Palmitoleoyl Ethanolamide | 5 mg | 686 |
| Cayman2015 | 10965 | Palmitoleoyl Ethanolamide | 50 mg | 5488 |
| Cayman2015 | 10974 | CAY10669 | 1 mg | 910 |
| Cayman2015 | 10974 | CAY10669 | 10 mg | 7280 |
| Cayman2015 | 10974 | CAY10669 | 5 mg | 4102 |
| Cayman2015 | 10975 | Zebularine | 1 mg | 280 |
| Cayman2015 | 10975 | Zebularine | 10 mg | 1372 |
| Cayman2015 | 10975 | Zebularine | 5 mg | 1050 |
| Cayman2015 | 10976 | 10-HDA | 1 g | 4480 |
| Cayman2015 | 10976 | 10-HDA | 100 mg | 1092 |
| Cayman2015 | 10976 | 10-HDA | 25 mg | 308 |
| Cayman2015 | 10976 | 10-HDA | 500 mg | 2786 |
| Cayman2015 | 10979 | 3,4-MDMA methylene homolong (hydrochloride)? | 1 mg | 392 |
| Cayman2015 | 10979 | 3,4-MDMA methylene homolong (hydrochloride)? | 10 mg | 1246 |
| Cayman2015 | 10979 | 3,4-MDMA methylene homolong (hydrochloride)? | 5 mg | 686 |
| Cayman2015 | 10986 | Methylone (hydrochloride) | 10 mg | 1190 |
| Cayman2015 | 10986 | Methylone (hydrochloride) | 25 mg | 2380 |
| Cayman2015 | 10986 | Methylone (hydrochloride) | 50 mg | 3864 |
| Cayman2015 | 10988 | Nocloprost | 1 mg | 2604 |
| Cayman2015 | 10988 | Nocloprost | 5 mg | 10976 |
| Cayman2015 | 10988 | Nocloprost | 500 μg | 1372 |
| Cayman2015 | 10989 | Glucokinase (human pancreatic recombinant) | 10 μg | 1140 |
| Cayman2015 | 10989 | Glucokinase (human pancreatic recombinant) | 25 μg | 2700 |
| Cayman2015 | 10989 | Glucokinase (human pancreatic recombinant) | 5 μg | 600 |
| Cayman2015 | 10990 | Glucokinase (human liver recombinant) | 10 μg | 1140 |
| Cayman2015 | 10990 | Glucokinase (human liver recombinant) | 25 μg | 2700 |
| Cayman2015 | 10990 | Glucokinase (human liver recombinant) | 5 μg | 600 |
| Cayman2015 | 10991 | 16(R)-AFP 07 (free acid) | 1 mg | 5992 |
| Cayman2015 | 10991 | 16(R)-AFP 07 (free acid) | 5 mg | 25200 |
| Cayman2015 | 10991 | 16(R)-AFP 07 (free acid) | 500 μg | 3150 |
| Cayman2015 | 10995 | Harmaline | 10 mg | 1484 |
| Cayman2015 | 10995 | Harmaline | 25 mg | 3528 |
| Cayman2015 | 10995 | Harmaline | 5 mg | 784 |
| Cayman2015 | 10997 | Torin 1 | 10 mg | 1680 |
| Cayman2015 | 10997 | Torin 1 | 25 mg | 3780 |
| Cayman2015 | 10997 | Torin 1 | 50 mg | 6174 |
| Cayman2015 | 11001 | ?(R,S)-Anatabine | 10 mg | 686 |
| Cayman2015 | 11001 | ?(R,S)-Anatabine | 100 mg | 4900 |
| Cayman2015 | 11001 | ?(R,S)-Anatabine | 5 mg | 406 |
| Cayman2015 | 11001 | ?(R,S)-Anatabine | 50 mg | 2772 |
| Cayman2015 | 11003 | RORγ Polyclonal Antibody | 1 ea | 3150 |
| Cayman2015 | 11004 | Podoplanin Monoclonal Antibody (Clone NZ-1.2) | 1 ea | 2450 |
| Cayman2015 | 11005 | Podoplanin Monoclonal Antibody (Clone pmab-1) | 1 ea | 1330 |
| Cayman2015 | 11006 | Piperlongumine | 1 g | 9730 |
| Cayman2015 | 11006 | Piperlongumine | 100 mg | 1456 |
| Cayman2015 | 11006 | Piperlongumine | 25 mg | 406 |
| Cayman2015 | 11006 | Piperlongumine | 500 mg | 5460 |
| Cayman2015 | 11008 | AM2233 | 1 mg | 350 |
| Cayman2015 | 11008 | AM2233 | 10 mg | 1946 |
| Cayman2015 | 11008 | AM2233 | 25 mg | 3640 |
| Cayman2015 | 11008 | AM2233 | 5 mg | 910 |
| Cayman2015 | 11009 | 18-methyl Eicosanoic Acid | 1 mg | 1736 |
| Cayman2015 | 11009 | 18-methyl Eicosanoic Acid | 10 mg | 12740 |
| Cayman2015 | 11009 | 18-methyl Eicosanoic Acid | 5 mg | 7280 |
| Cayman2015 | 11009 | 18-methyl Eicosanoic Acid | 500 μg | 910 |
| Cayman2015 | 11010 | Core Histones (human) | 100 μg | 2772 |
| Cayman2015 | 11010 | Core Histones (human) | 25 μg | 770 |
| Cayman2015 | 11010 | Core Histones (human) | 50 μg | 1470 |
| Cayman2015 | 11011 | Pentedrone (hydrochloride) | 10 mg | 1246 |
| Cayman2015 | 11011 | Pentedrone (hydrochloride) | 100 mg | 6160 |
| Cayman2015 | 11011 | Pentedrone (hydrochloride) | 50 mg | 3850 |
| Cayman2015 | 11012 | Delphinidin (chloride) | 1 mg | 336 |
| Cayman2015 | 11012 | Delphinidin (chloride) | 10 mg | 2688 |
| Cayman2015 | 11012 | Delphinidin (chloride) | 5 mg | 1512 |
| Cayman2015 | 11015 | Dexamethasone | 1000 mg | 770 |
| Cayman2015 | 11015 | Dexamethasone | 500 mg | 546 |
| Cayman2015 | 11015 | Dexamethasone | 5000 mg | 3080 |
| Cayman2015 | 11016 | A-23187 | 1 mg | 252 |
| Cayman2015 | 11016 | A-23187 | 10 mg | 1288 |
| Cayman2015 | 11016 | A-23187 | 25 mg | 2772 |
| Cayman2015 | 11016 | A-23187 | 5 mg | 1008 |
| Cayman2015 | 11017 | Retinoic Acid | 50 mg | 350 |
| Cayman2015 | 11017 | Retinoic Acid | 500 mg | 602 |
| Cayman2015 | 11018 | Forskolin | 1 mg | 280 |
| Cayman2015 | 11018 | Forskolin | 10 mg | 840 |
| Cayman2015 | 11018 | Forskolin | 5 mg | 630 |
| Cayman2015 | 11018 | Forskolin | 50 mg | 1680 |
| Cayman2015 | 11019 | SB 366791 | 10 mg | 1246 |
| Cayman2015 | 11019 | SB 366791 | 25 mg | 2968 |
| Cayman2015 | 11019 | SB 366791 | 5 mg | 658 |
| Cayman2015 | 11019 | SB 366791 | 50 mg | 5264 |
| Cayman2015 | 11020 | Bisindolylmaleimide II | 1 mg | 675 |
| Cayman2015 | 11020 | Bisindolylmaleimide II | 5 mg | 2100 |
| Cayman2015 | 11021 | CHS-828 | 10 mg | 1568 |
| Cayman2015 | 11021 | CHS-828 | 25 mg | 3724 |
| Cayman2015 | 11021 | CHS-828 | 5 mg | 826 |
| Cayman2015 | 11021 | CHS-828 | 50 mg | 6608 |
| Cayman2015 | 11022 | BIBF 1120 | 10 mg | 1064 |
| Cayman2015 | 11022 | BIBF 1120 | 100 mg | 7840 |
| Cayman2015 | 11022 | BIBF 1120 | 5 mg | 560 |
| Cayman2015 | 11022 | BIBF 1120 | 50 mg | 4480 |
| Cayman2015 | 11023 | 1,2-Dilauroyl-sn-glycero-3-PC | 1 g | 1176 |
| Cayman2015 | 11023 | 1,2-Dilauroyl-sn-glycero-3-PC | 250 mg | 490 |
| Cayman2015 | 11023 | 1,2-Dilauroyl-sn-glycero-3-PC | 500 mg | 784 |
| Cayman2015 | 11029 | SMI-4a | 1 mg | 525 |
| Cayman2015 | 11029 | SMI-4a | 10 mg | 1215 |
| Cayman2015 | 11029 | SMI-4a | 5 mg | 765 |
| Cayman2015 | 11029 | SMI-4a | 50 mg | 4725 |
| Cayman2015 | 11030 | Fumitremorgin C | 250 μg | 2475 |
| Cayman2015 | 11032 | 7α,25-dihydroxy Cholesterol | 1 mg | 630 |
| Cayman2015 | 11032 | 7α,25-dihydroxy Cholesterol | 10 mg | 5670 |
| Cayman2015 | 11032 | 7α,25-dihydroxy Cholesterol | 5 mg | 2996 |
| Cayman2015 | 11035 | 5-IAI (hydrochloride) | 10 mg | 1638 |
| Cayman2015 | 11035 | 5-IAI (hydrochloride) | 5 mg | 910 |
| Cayman2015 | 11035 | 5-IAI (hydrochloride) | 50 mg | 6146 |
| Cayman2015 | 11036 | 17-DMAG | 1 mg | 420 |
| Cayman2015 | 11036 | 17-DMAG | 10 mg | 2070 |
| Cayman2015 | 11036 | 17-DMAG | 5 mg | 1335 |
| Cayman2015 | 11037 | Kendomycin | 100 μg | 1080 |
| Cayman2015 | 11037 | Kendomycin | 500 μg | 3375 |
| Cayman2015 | 11038 | Bafilomycin A1 | 1 mg | 2430 |
| Cayman2015 | 11038 | Bafilomycin A1 | 5 mg | 10200 |
| Cayman2015 | 11038 | Bafilomycin A1 | 500 μg | 1275 |
| Cayman2015 | 11039 | 17-AAG | 1 mg | 1800 |
| Cayman2015 | 11039 | 17-AAG | 100 μg | 450 |
| Cayman2015 | 11040 | Nodinitib-1 | 10 mg | 938 |
| Cayman2015 | 11040 | Nodinitib-1 | 25 mg | 2212 |
| Cayman2015 | 11040 | Nodinitib-1 | 5 mg | 490 |
| Cayman2015 | 11040 | Nodinitib-1 | 50 mg | 3920 |
| Cayman2015 | 11041 | Betulin | 1 g | 1260 |
| Cayman2015 | 11041 | Betulin | 250 mg | 350 |
| Cayman2015 | 11041 | Betulin | 5 g | 5572 |
| Cayman2015 | 11041 | Betulin | 500 mg | 672 |
| Cayman2015 | 11042 | CAY10662 | 100 μg | 1918 |
| Cayman2015 | 11042 | CAY10662 | 25 μg | 532 |
| Cayman2015 | 11042 | CAY10662 | 50 μg | 1008 |
| Cayman2015 | 11042 | CAY10662 | 500 μg | 8512 |
| Cayman2015 | 11044 | CAY10665 | 100 μg | 1918 |
| Cayman2015 | 11044 | CAY10665 | 25 μg | 532 |
| Cayman2015 | 11044 | CAY10665 | 50 μg | 1008 |
| Cayman2015 | 11044 | CAY10665 | 500 μg | 8512 |
| Cayman2015 | 11045 | ITF 2357 | 1 mg | 546 |
| Cayman2015 | 11045 | ITF 2357 | 10 mg | 3822 |
| Cayman2015 | 11045 | ITF 2357 | 5 mg | 2044 |
| Cayman2015 | 11046 | 2-NBDG | 1 mg | 420 |
| Cayman2015 | 11046 | 2-NBDG | 10 mg | 3360 |
| Cayman2015 | 11046 | 2-NBDG | 5 mg | 1890 |
| Cayman2015 | 11047 | JWH 018 N-(5-bromopentyl) analog | 1 mg | 910 |
| Cayman2015 | 11047 | JWH 018 N-(5-bromopentyl) analog | 10 mg | 7280 |
| Cayman2015 | 11047 | JWH 018 N-(5-bromopentyl) analog | 5 mg | 4102 |
| Cayman2015 | 11048 | 2-AI (hydrochloride) | 1 mg | 420 |
| Cayman2015 | 11048 | 2-AI (hydrochloride) | 10 mg | 1680 |
| Cayman2015 | 11048 | 2-AI (hydrochloride) | 5 mg | 952 |
| Cayman2015 | 11049 | Echinomycin | 1 mg | 1185 |
| Cayman2015 | 11049 | Echinomycin | 5 mg | 5340 |
| Cayman2015 | 11050 | Concanamycin A | 100 μg | 2805 |
| Cayman2015 | 11050 | Concanamycin A | 25 μg | 1170 |
| Cayman2015 | 11051 | 2-amino-4-(1-adamantyl) Thiazole | 1 g | 3276 |
| Cayman2015 | 11051 | 2-amino-4-(1-adamantyl) Thiazole | 100 mg | 406 |
| Cayman2015 | 11051 | 2-amino-4-(1-adamantyl) Thiazole | 250 mg | 910 |
| Cayman2015 | 11051 | 2-amino-4-(1-adamantyl) Thiazole | 500 mg | 1736 |
| Cayman2015 | 11052 | BRD4 bromodomains 1 and 2 (human recombinant; aa 49-460) | 100 μg | 3990 |
| Cayman2015 | 11052 | BRD4 bromodomains 1 and 2 (human recombinant; aa 49-460) | 25 μg | 1330 |
| Cayman2015 | 11052 | BRD4 bromodomains 1 and 2 (human recombinant; aa 49-460) | 50 μg | 2394 |
| Cayman2015 | 11053 | 4-amino Benzamidoxime | 1 g | 686 |
| Cayman2015 | 11053 | 4-amino Benzamidoxime | 5 g | 2912 |
| Cayman2015 | 11053 | 4-amino Benzamidoxime | 500 mg | 364 |
| Cayman2015 | 11054 | Biphenyl-4-amidoxime | 1 g | 1680 |
| Cayman2015 | 11054 | Biphenyl-4-amidoxime | 5 g | 7056 |
| Cayman2015 | 11054 | Biphenyl-4-amidoxime | 500 mg | 882 |
| Cayman2015 | 11055 | ethyl 2-(3-hydroxyphenyl)-4-methylthiazole-5-Carboxylate | 1 g | 1680 |
| Cayman2015 | 11055 | ethyl 2-(3-hydroxyphenyl)-4-methylthiazole-5-Carboxylate | 5 g | 7056 |
| Cayman2015 | 11055 | ethyl 2-(3-hydroxyphenyl)-4-methylthiazole-5-Carboxylate | 500 mg | 882 |
| Cayman2015 | 11056 | ethyl 4-methyl-2-(2-thienyl)-thiazole-5 Carboxylate | 1 g | 1680 |
| Cayman2015 | 11056 | ethyl 4-methyl-2-(2-thienyl)-thiazole-5 Carboxylate | 5 g | 7056 |
| Cayman2015 | 11056 | ethyl 4-methyl-2-(2-thienyl)-thiazole-5 Carboxylate | 500 mg | 882 |
| Cayman2015 | 11057 | 2-phenyl-3-methyl-Quinoxaline | 1 g | 1330 |
| Cayman2015 | 11057 | 2-phenyl-3-methyl-Quinoxaline | 5 g | 5600 |
| Cayman2015 | 11057 | 2-phenyl-3-methyl-Quinoxaline | 500 mg | 700 |
| Cayman2015 | 11058 | 2-amino-4-(4-pyridyl)-Thiazole | 1 g | 1414 |
| Cayman2015 | 11058 | 2-amino-4-(4-pyridyl)-Thiazole | 5 g | 5936 |
| Cayman2015 | 11058 | 2-amino-4-(4-pyridyl)-Thiazole | 500 mg | 742 |
| Cayman2015 | 11059 | Pyrazine-2-amidoxime | 1 g | 560 |
| Cayman2015 | 11059 | Pyrazine-2-amidoxime | 5 g | 2380 |
| Cayman2015 | 11059 | Pyrazine-2-amidoxime | 500 mg | 294 |
| Cayman2015 | 11060 | Indole-3-amidoxime | 1 g | 4466 |
| Cayman2015 | 11060 | Indole-3-amidoxime | 5 g | 17416 |
| Cayman2015 | 11060 | Indole-3-amidoxime | 500 mg | 2352 |
| Cayman2015 | 11061 | Thiophene-2-amidoxime | 1 g | 686 |
| Cayman2015 | 11061 | Thiophene-2-amidoxime | 5 g | 2912 |
| Cayman2015 | 11061 | Thiophene-2-amidoxime | 500 mg | 364 |
| Cayman2015 | 11062 | 2-amino Benzamidoxime | 1 g | 672 |
| Cayman2015 | 11062 | 2-amino Benzamidoxime | 5 g | 2800 |
| Cayman2015 | 11062 | 2-amino Benzamidoxime | 500 mg | 350 |
| Cayman2015 | 11063 | 4-amino Benzthioamide | 1 g | 686 |
| Cayman2015 | 11063 | 4-amino Benzthioamide | 5 g | 2912 |
| Cayman2015 | 11063 | 4-amino Benzthioamide | 500 mg | 364 |
| Cayman2015 | 11064 | 3-amino Benzthioamide | 1 g | 686 |
| Cayman2015 | 11064 | 3-amino Benzthioamide | 5 g | 2912 |
| Cayman2015 | 11064 | 3-amino Benzthioamide | 500 mg | 364 |
| Cayman2015 | 11065 | Indole-3-thio Carboxamide | 1 g | 3780 |
| Cayman2015 | 11065 | Indole-3-thio Carboxamide | 250 mg | 1050 |
| Cayman2015 | 11065 | Indole-3-thio Carboxamide | 500 mg | 2002 |
| Cayman2015 | 11066 | BRD4 bromodomain 2 (human recombinant; GST-tagged) | 100 μg | 3990 |
| Cayman2015 | 11066 | BRD4 bromodomain 2 (human recombinant; GST-tagged) | 25 μg | 1330 |
| Cayman2015 | 11066 | BRD4 bromodomain 2 (human recombinant; GST-tagged) | 50 μg | 2394 |
| Cayman2015 | 11068 | BRD4 bromodomain 1 (human recombinant; GST-tagged) | 100 μg | 3990 |
| Cayman2015 | 11068 | BRD4 bromodomain 1 (human recombinant; GST-tagged) | 25 μg | 1330 |
| Cayman2015 | 11068 | BRD4 bromodomain 1 (human recombinant; GST-tagged) | 50 μg | 2394 |
| Cayman2015 | 11069 | BRD2 bromodomains 1 and 2 (human recombinant) | 100 μg | 3990 |
| Cayman2015 | 11069 | BRD2 bromodomains 1 and 2 (human recombinant) | 25 μg | 1330 |
| Cayman2015 | 11069 | BRD2 bromodomains 1 and 2 (human recombinant) | 50 μg | 2394 |
| Cayman2015 | 11070 | BRD2 bromodomain 2 (human recombinant; GST-tagged) | 100 μg | 3990 |
| Cayman2015 | 11070 | BRD2 bromodomain 2 (human recombinant; GST-tagged) | 25 μg | 1330 |
| Cayman2015 | 11070 | BRD2 bromodomain 2 (human recombinant; GST-tagged) | 50 μg | 2394 |
| Cayman2015 | 11071 | BRD2 bromodomain 1 (human recombinant; GST-tagged) | 100 μg | 3990 |
| Cayman2015 | 11071 | BRD2 bromodomain 1 (human recombinant; GST-tagged) | 25 μg | 1330 |
| Cayman2015 | 11071 | BRD2 bromodomain 1 (human recombinant; GST-tagged) | 50 μg | 2394 |
| Cayman2015 | 11072 | Bisindolylmaleimide III | 1 mg | 675 |
| Cayman2015 | 11072 | Bisindolylmaleimide III | 5 mg | 2100 |
| Cayman2015 | 11073 | Bisindolylmaleimide XI (hydrochloride) | 1 mg | 975 |
| Cayman2015 | 11073 | Bisindolylmaleimide XI (hydrochloride) | 5 mg | 4140 |
| Cayman2015 | 11074 | 3-amino Benzamidoxime | 1 g | 532 |
| Cayman2015 | 11074 | 3-amino Benzamidoxime | 5 g | 2450 |
| Cayman2015 | 11074 | 3-amino Benzamidoxime | 500 mg | 350 |
| Cayman2015 | 11075 | JWH 018 N-(4,5-epoxypentyl) analog | 1 mg | 910 |
| Cayman2015 | 11075 | JWH 018 N-(4,5-epoxypentyl) analog | 10 mg | 7280 |
| Cayman2015 | 11075 | JWH 018 N-(4,5-epoxypentyl) analog | 5 mg | 4102 |
| Cayman2015 | 11076 | Epigenetics Screening Library (96-Well) | 100 μL | 11690 |
| Cayman2015 | 11076 | Epigenetics Screening Library (96-Well) | 200 μL | 22050 |
| Cayman2015 | 11076 | Epigenetics Screening Library (96-Well) | 50 μL | 6930 |
| Cayman2015 | 11079 | 6-APB (hydrochloride) | 1 mg | 910 |
| Cayman2015 | 11079 | 6-APB (hydrochloride) | 10 mg | 3192 |
| Cayman2015 | 11079 | 6-APB (hydrochloride) | 5 mg | 2044 |
| Cayman2015 | 11084 | UNC0631 | 1 mg | 406 |
| Cayman2015 | 11084 | UNC0631 | 10 mg | 1624 |
| Cayman2015 | 11084 | UNC0631 | 25 mg | 3052 |
| Cayman2015 | 11084 | UNC0631 | 5 mg | 1022 |
| Cayman2015 | 11085 | UNC0646 | 10 mg | 1638 |
| Cayman2015 | 11085 | UNC0646 | 25 mg | 3192 |
| Cayman2015 | 11085 | UNC0646 | 5 mg | 910 |
| Cayman2015 | 11085 | UNC0646 | 50 mg | 5460 |
| Cayman2015 | 11086 | SR 1664 | 1 mg | 490 |
| Cayman2015 | 11086 | SR 1664 | 10 mg | 2310 |
| Cayman2015 | 11086 | SR 1664 | 25 mg | 5516 |
| Cayman2015 | 11086 | SR 1664 | 5 mg | 1722 |
| Cayman2015 | 11087 | SR 1824 | 1 mg | 686 |
| Cayman2015 | 11087 | SR 1824 | 10 mg | 5348 |
| Cayman2015 | 11087 | SR 1824 | 25 mg | 11494 |
| Cayman2015 | 11087 | SR 1824 | 5 mg | 2912 |
| Cayman2015 | 11092 | Ceranib-2 | 10 mg | 1302 |
| Cayman2015 | 11092 | Ceranib-2 | 25 mg | 3094 |
| Cayman2015 | 11092 | Ceranib-2 | 5 mg | 686 |
| Cayman2015 | 11092 | Ceranib-2 | 50 mg | 5488 |
| Cayman2015 | 11093 | 4-Quinolone-3-Carboxamide CB2 Ligand | 1 mg | 392 |
| Cayman2015 | 11093 | 4-Quinolone-3-Carboxamide CB2 Ligand | 10 mg | 3136 |
| Cayman2015 | 11093 | 4-Quinolone-3-Carboxamide CB2 Ligand | 25 mg | 6860 |
| Cayman2015 | 11093 | 4-Quinolone-3-Carboxamide CB2 Ligand | 5 mg | 1764 |
| Cayman2015 | 11094 | 4-Quinolone-3-Carboxamide Furan CB2 Agonist | 1 mg | 490 |
| Cayman2015 | 11094 | 4-Quinolone-3-Carboxamide Furan CB2 Agonist | 10 mg | 3920 |
| Cayman2015 | 11094 | 4-Quinolone-3-Carboxamide Furan CB2 Agonist | 25 mg | 8582 |
| Cayman2015 | 11094 | 4-Quinolone-3-Carboxamide Furan CB2 Agonist | 5 mg | 2212 |
| Cayman2015 | 11095 | DL-Palmitoylcarnitine (chloride) | 100 mg | 826 |
| Cayman2015 | 11095 | DL-Palmitoylcarnitine (chloride) | 50 mg | 546 |
| Cayman2015 | 11095 | DL-Palmitoylcarnitine (chloride) | 500 mg | 3850 |
| Cayman2015 | 11096 | Exendin-4 (acetate) | 1 mg | 2142 |
| Cayman2015 | 11096 | Exendin-4 (acetate) | 5 mg | 9520 |
| Cayman2015 | 11096 | Exendin-4 (acetate) | 500 μg | 1190 |
| Cayman2015 | 11097 | 25-hydroxy Cholesterol | 10 mg | 756 |
| Cayman2015 | 11097 | 25-hydroxy Cholesterol | 100 mg | 4200 |
| Cayman2015 | 11097 | 25-hydroxy Cholesterol | 25 mg | 1470 |
| Cayman2015 | 11097 | 25-hydroxy Cholesterol | 5 mg | 420 |
| Cayman2015 | 11099 | 25-hydroxy Cholesterol-d6 | 1 mg | 1330 |
| Cayman2015 | 11099 | 25-hydroxy Cholesterol-d6 | 5 mg | 5600 |
| Cayman2015 | 11099 | 25-hydroxy Cholesterol-d6 | 500 μg | 700 |
| Cayman2015 | 11102 | 3-Deazaneplanocin A (hydrochloride) | 1 mg | 1974 |
| Cayman2015 | 11102 | 3-Deazaneplanocin A (hydrochloride) | 5 mg | 5488 |
| Cayman2015 | 11102 | 3-Deazaneplanocin A (hydrochloride) | 500 μg | 1036 |
| Cayman2015 | 11103 | Branched Chain Amino-Acid Transferase 2 (human recombinant) | 10 μg | 1140 |
| Cayman2015 | 11103 | Branched Chain Amino-Acid Transferase 2 (human recombinant) | 25 μg | 2700 |
| Cayman2015 | 11103 | Branched Chain Amino-Acid Transferase 2 (human recombinant) | 5 μg | 600 |
| Cayman2015 | 11104 | Fructose 1,6-bisphosphatase (human recombinant) | 10 μg | 1140 |
| Cayman2015 | 11104 | Fructose 1,6-bisphosphatase (human recombinant) | 25 μg | 2700 |
| Cayman2015 | 11104 | Fructose 1,6-bisphosphatase (human recombinant) | 5 μg | 600 |
| Cayman2015 | 11105 | TNF Receptor-Associated Protein 1 (human recombinant) | 10 μg | 1140 |
| Cayman2015 | 11105 | TNF Receptor-Associated Protein 1 (human recombinant) | 25 μg | 2700 |
| Cayman2015 | 11105 | TNF Receptor-Associated Protein 1 (human recombinant) | 5 μg | 600 |
| Cayman2015 | 11106 | Nifedipine | 1 g | 210 |
| Cayman2015 | 11106 | Nifedipine | 10 g | 700 |
| Cayman2015 | 11106 | Nifedipine | 5 g | 420 |
| Cayman2015 | 11110 | Prostaglandin B1 | 1 mg | 266 |
| Cayman2015 | 11110 | Prostaglandin B1 | 10 mg | 2128 |
| Cayman2015 | 11110 | Prostaglandin B1 | 5 mg | 1204 |
| Cayman2015 | 11110 | Prostaglandin B1 | 50 mg | 9310 |
| Cayman2015 | 11112 | 1-(4-Fluorobenzyl) piperazine (hydrochloride) | 10 mg | 490 |
| Cayman2015 | 11112 | 1-(4-Fluorobenzyl) piperazine (hydrochloride) | 100 mg | 2016 |
| Cayman2015 | 11112 | 1-(4-Fluorobenzyl) piperazine (hydrochloride) | 50 mg | 1134 |
| Cayman2015 | 11113 | 2C-I (hydrochloride) | 10 mg | 952 |
| Cayman2015 | 11113 | 2C-I (hydrochloride) | 5 mg | 616 |
| Cayman2015 | 11113 | 2C-I (hydrochloride) | 50 mg | 3696 |
| Cayman2015 | 11116 | Mouse Anti-c-myc IgG conjugated to DyLight? 550 | 1 ea | 4710 |
| Cayman2015 | 11117 | Mouse Anti-6HIS IgG conjugated to DyLight? 650 | 1 ea | 4710 |
| Cayman2015 | 11118 | (±)-JWH 018 N-(3-hydroxypentyl) metabolite | 1 mg | 1330 |
| Cayman2015 | 11118 | (±)-JWH 018 N-(3-hydroxypentyl) metabolite | 10 mg | 4900 |
| Cayman2015 | 11118 | (±)-JWH 018 N-(3-hydroxypentyl) metabolite | 5 mg | 3150 |
| Cayman2015 | 11119 | (±)-JWH 018 N-(2-hydroxypentyl) metabolite | 1 mg | 1330 |
| Cayman2015 | 11119 | (±)-JWH 018 N-(2-hydroxypentyl) metabolite | 10 mg | 4900 |
| Cayman2015 | 11119 | (±)-JWH 018 N-(2-hydroxypentyl) metabolite | 5 mg | 3150 |
| Cayman2015 | 11120 | TPPU | 1 mg | 350 |
| Cayman2015 | 11120 | TPPU | 10 mg | 1932 |
| Cayman2015 | 11120 | TPPU | 25 mg | 4382 |
| Cayman2015 | 11120 | TPPU | 5 mg | 1050 |
| Cayman2015 | 11126 | Suramin (sodium salt) | 100 mg | 686 |
| Cayman2015 | 11126 | Suramin (sodium salt) | 500 mg | 3094 |
| Cayman2015 | 11128 | 3,4-DMMA (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 11128 | 3,4-DMMA (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 11128 | 3,4-DMMA (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 11132 | Δ2-trans-Hexadecenoic Acid | 10 mg | 1148 |
| Cayman2015 | 11132 | Δ2-trans-Hexadecenoic Acid | 100 mg | 8428 |
| Cayman2015 | 11132 | Δ2-trans-Hexadecenoic Acid | 5 mg | 602 |
| Cayman2015 | 11132 | Δ2-trans-Hexadecenoic Acid | 50 mg | 4816 |
| Cayman2015 | 11133 | Δ2-cis-Hexadecenoic Acid | 10 mg | 1148 |
| Cayman2015 | 11133 | Δ2-cis-Hexadecenoic Acid | 25 mg | 2716 |
| Cayman2015 | 11133 | Δ2-cis-Hexadecenoic Acid | 5 mg | 602 |
| Cayman2015 | 11133 | Δ2-cis-Hexadecenoic Acid | 50 mg | 4816 |
| Cayman2015 | 11134 | 5-APB (hydrochloride) | 1 mg | 686 |
| Cayman2015 | 11134 | 5-APB (hydrochloride) | 10 mg | 2744 |
| Cayman2015 | 11134 | 5-APB (hydrochloride) | 5 mg | 1722 |
| Cayman2015 | 11135 | α-Methyltryptamine (hydrochloride) | 10 mg | 952 |
| Cayman2015 | 11135 | α-Methyltryptamine (hydrochloride) | 5 mg | 616 |
| Cayman2015 | 11135 | α-Methyltryptamine (hydrochloride) | 50 mg | 3696 |
| Cayman2015 | 11136 | 4-methoxy PCP (hydrochloride) | 10 mg | 1638 |
| Cayman2015 | 11136 | 4-methoxy PCP (hydrochloride) | 5 mg | 910 |
| Cayman2015 | 11136 | 4-methoxy PCP (hydrochloride) | 50 mg | 6146 |
| Cayman2015 | 11137 | 3-methoxy PCP (hydrochloride) | 10 mg | 1638 |
| Cayman2015 | 11137 | 3-methoxy PCP (hydrochloride) | 5 mg | 910 |
| Cayman2015 | 11137 | 3-methoxy PCP (hydrochloride) | 50 mg | 6146 |
| Cayman2015 | 11138 | 2,4-Pyridinedicarboxylic Acid | 1 g | 350 |
| Cayman2015 | 11138 | 2,4-Pyridinedicarboxylic Acid | 5 g | 1400 |
| Cayman2015 | 11139 | Methoxetamine (hydrochloride) | 1 mg | 686 |
| Cayman2015 | 11139 | Methoxetamine (hydrochloride) | 10 mg | 4802 |
| Cayman2015 | 11139 | Methoxetamine (hydrochloride) | 5 mg | 2576 |
| Cayman2015 | 11140 | CAY10657 | 1 mg | 476 |
| Cayman2015 | 11140 | CAY10657 | 10 mg | 3332 |
| Cayman2015 | 11140 | CAY10657 | 5 mg | 1904 |
| Cayman2015 | 11141 | DOET | 10 mg | 1638 |
| Cayman2015 | 11141 | DOET | 5 mg | 910 |
| Cayman2015 | 11141 | DOET | 50 mg | 6146 |
| Cayman2015 | 11142 | 4-bromo-2,5-DMA (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 11142 | 4-bromo-2,5-DMA (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 11142 | 4-bromo-2,5-DMA (hydrochloride) | 50 mg | 3850 |
| Cayman2015 | 11144 | 2,4,5-Trimethoxyamphetamine | 10 mg | 1638 |
| Cayman2015 | 11144 | 2,4,5-Trimethoxyamphetamine | 5 mg | 910 |
| Cayman2015 | 11144 | 2,4,5-Trimethoxyamphetamine | 50 mg | 6146 |
| Cayman2015 | 11145 | DOM | 10 mg | 1232 |
| Cayman2015 | 11145 | DOM | 5 mg | 686 |
| Cayman2015 | 11145 | DOM | 50 mg | 3780 |
| Cayman2015 | 11146 | 6-APDB (hydrochloride) | 1 mg | 910 |
| Cayman2015 | 11146 | 6-APDB (hydrochloride) | 10 mg | 3192 |
| Cayman2015 | 11146 | 6-APDB (hydrochloride) | 5 mg | 2044 |
| Cayman2015 | 11148 | 4-hydroxy MET | 10 mg | 952 |
| Cayman2015 | 11148 | 4-hydroxy MET | 25 mg | 2310 |
| Cayman2015 | 11148 | 4-hydroxy MET | 5 mg | 616 |
| Cayman2015 | 11151 | Mitragynine | 1 mg | 910 |
| Cayman2015 | 11151 | Mitragynine | 10 mg | 7280 |
| Cayman2015 | 11151 | Mitragynine | 5 mg | 4102 |
| Cayman2015 | 11152 | Etaqualone | 1 mg | 910 |
| Cayman2015 | 11152 | Etaqualone | 10 mg | 7280 |
| Cayman2015 | 11152 | Etaqualone | 5 mg | 4102 |
| Cayman2015 | 11153 | JWH 249 | 10 mg | 1484 |
| Cayman2015 | 11153 | JWH 249 | 25 mg | 3528 |
| Cayman2015 | 11153 | JWH 249 | 5 mg | 784 |
| Cayman2015 | 11155 | PFI-1 | 1 mg | 406 |
| Cayman2015 | 11155 | PFI-1 | 10 mg | 1904 |
| Cayman2015 | 11155 | PFI-1 | 25 mg | 4172 |
| Cayman2015 | 11155 | PFI-1 | 5 mg | 1078 |
| Cayman2015 | 11156 | 4-Fluoroamphetamine (hydrochloride) | 10 mg | 1638 |
| Cayman2015 | 11156 | 4-Fluoroamphetamine (hydrochloride) | 5 mg | 910 |
| Cayman2015 | 11156 | 4-Fluoroamphetamine (hydrochloride) | 50 mg | 6146 |
| Cayman2015 | 11158 | Diphenhydramine (hydrochloride) | 100 mg | 350 |
| Cayman2015 | 11158 | Diphenhydramine (hydrochloride) | 250 mg | 826 |
| Cayman2015 | 11159 | Dimethocaine (hydrochloride) | 1 mg | 686 |
| Cayman2015 | 11159 | Dimethocaine (hydrochloride) | 10 mg | 5488 |
| Cayman2015 | 11159 | Dimethocaine (hydrochloride) | 5 mg | 3094 |
| Cayman2015 | 11160 | D2PM (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 11160 | D2PM (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 11160 | D2PM (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 11161 | Methiopropamine (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 11161 | Methiopropamine (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 11161 | Methiopropamine (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 11163 | A-834735 | 1 mg | 910 |
| Cayman2015 | 11163 | A-834735 | 10 mg | 7280 |
| Cayman2015 | 11163 | A-834735 | 5 mg | 4102 |
| Cayman2015 | 11164 | 5-Azacytidine | 100 mg | 406 |
| Cayman2015 | 11164 | 5-Azacytidine | 250 mg | 952 |
| Cayman2015 | 11164 | 5-Azacytidine | 50 mg | 210 |
| Cayman2015 | 11166 | Decitabine | 10 mg | 980 |
| Cayman2015 | 11166 | Decitabine | 25 mg | 2338 |
| Cayman2015 | 11166 | Decitabine | 5 mg | 518 |
| Cayman2015 | 11166 | Decitabine | 50 mg | 4144 |
| Cayman2015 | 11167 | (+)-YK-4-279 | 1 mg | 840 |
| Cayman2015 | 11167 | (+)-YK-4-279 | 10 mg | 6720 |
| Cayman2015 | 11167 | (+)-YK-4-279 | 25 mg | 14700 |
| Cayman2015 | 11167 | (+)-YK-4-279 | 5 mg | 3780 |
| Cayman2015 | 11168 | (-)-YK-4-279 | 1 mg | 840 |
| Cayman2015 | 11168 | (-)-YK-4-279 | 10 mg | 6720 |
| Cayman2015 | 11168 | (-)-YK-4-279 | 25 mg | 14700 |
| Cayman2015 | 11168 | (-)-YK-4-279 | 5 mg | 3780 |
| Cayman2015 | 11169 | 13(R),14(R)-epoxy Fluprostenol isopropyl ester | 1 mg | 1288 |
| Cayman2015 | 11169 | 13(R),14(R)-epoxy Fluprostenol isopropyl ester | 10 mg | 10304 |
| Cayman2015 | 11169 | 13(R),14(R)-epoxy Fluprostenol isopropyl ester | 5 mg | 5796 |
| Cayman2015 | 11170 | 13(S),14(S)-epoxy Fluprostenol isopropyl ester | 1 mg | 1288 |
| Cayman2015 | 11170 | 13(S),14(S)-epoxy Fluprostenol isopropyl ester | 10 mg | 10304 |
| Cayman2015 | 11170 | 13(S),14(S)-epoxy Fluprostenol isopropyl ester | 5 mg | 5796 |
| Cayman2015 | 11174 | 1,25-dihydroxy Vitamin D2 | 1 mg | 1652 |
| Cayman2015 | 11174 | 1,25-dihydroxy Vitamin D2 | 5 mg | 6944 |
| Cayman2015 | 11174 | 1,25-dihydroxy Vitamin D2 | 500 μg | 868 |
| Cayman2015 | 11176 | O6-methylguanine-DNA Methyltransferase (human recombinant) | 100 μg | 4410 |
| Cayman2015 | 11176 | O6-methylguanine-DNA Methyltransferase (human recombinant) | 25 μg | 1750 |
| Cayman2015 | 11176 | O6-methylguanine-DNA Methyltransferase (human recombinant) | 50 μg | 2800 |
| Cayman2015 | 11178 | DPY-30 (human recombinant) | 100 μg | 7966 |
| Cayman2015 | 11178 | DPY-30 (human recombinant) | 25 μg | 2226 |
| Cayman2015 | 11178 | DPY-30 (human recombinant) | 50 μg | 4200 |
| Cayman2015 | 11179 | WSP-1 | 1 mg | 420 |
| Cayman2015 | 11179 | WSP-1 | 10 mg | 3360 |
| Cayman2015 | 11179 | WSP-1 | 5 mg | 1890 |
| Cayman2015 | 11181 | I-BET151 | 1 mg | 490 |
| Cayman2015 | 11181 | I-BET151 | 10 mg | 2450 |
| Cayman2015 | 11181 | I-BET151 | 5 mg | 1344 |
| Cayman2015 | 11181 | I-BET151 | 50 mg | 8330 |
| Cayman2015 | 11182 | Resolvin D1-d5 | 10 μg | 2170 |
| Cayman2015 | 11182 | Resolvin D1-d5 | 100 μg | 13020 |
| Cayman2015 | 11182 | Resolvin D1-d5 | 25 μg | 4340 |
| Cayman2015 | 11182 | Resolvin D1-d5 | 50 μg | 7602 |
| Cayman2015 | 11184 | Resolvin D2-d5 | 10 μg | 2170 |
| Cayman2015 | 11184 | Resolvin D2-d5 | 100 μg | 13020 |
| Cayman2015 | 11184 | Resolvin D2-d5 | 25 μg | 4340 |
| Cayman2015 | 11184 | Resolvin D2-d5 | 50 μg | 7602 |
| Cayman2015 | 11187 | (+)-JQ1 | 1 mg | 630 |
| Cayman2015 | 11187 | (+)-JQ1 | 10 mg | 3780 |
| Cayman2015 | 11187 | (+)-JQ1 | 25 mg | 7882 |
| Cayman2015 | 11187 | (+)-JQ1 | 5 mg | 2366 |
| Cayman2015 | 11188 | Prolyl-glycyl-proline Peptide | 25 mg | 4102 |
| Cayman2015 | 11188 | Prolyl-glycyl-proline Peptide | 5 mg | 910 |
| Cayman2015 | 11189 | N-acetyl-Pro-Gly-Pro Peptide | 25 mg | 4354 |
| Cayman2015 | 11189 | N-acetyl-Pro-Gly-Pro Peptide | 5 mg | 966 |
| Cayman2015 | 11190 | Termitomycamide B | 10 mg | 938 |
| Cayman2015 | 11190 | Termitomycamide B | 25 mg | 2212 |
| Cayman2015 | 11190 | Termitomycamide B | 5 mg | 490 |
| Cayman2015 | 11190 | Termitomycamide B | 50 mg | 3920 |
| Cayman2015 | 11191 | Termitomycamide E | 10 mg | 938 |
| Cayman2015 | 11191 | Termitomycamide E | 25 mg | 2212 |
| Cayman2015 | 11191 | Termitomycamide E | 5 mg | 490 |
| Cayman2015 | 11191 | Termitomycamide E | 50 mg | 3920 |
| Cayman2015 | 11192 | AM2201 6-hydroxyindole metabolite | 1 mg | 1330 |
| Cayman2015 | 11192 | AM2201 6-hydroxyindole metabolite | 10 mg | 4900 |
| Cayman2015 | 11192 | AM2201 6-hydroxyindole metabolite | 5 mg | 3150 |
| Cayman2015 | 11193 | AM2201 7-hydroxyindole metabolite | 1 mg | 1330 |
| Cayman2015 | 11193 | AM2201 7-hydroxyindole metabolite | 10 mg | 4900 |
| Cayman2015 | 11193 | AM2201 7-hydroxyindole metabolite | 5 mg | 3150 |
| Cayman2015 | 11194 | AM2201 2-hydroxyindole metabolite | 1 mg | 1330 |
| Cayman2015 | 11194 | AM2201 2-hydroxyindole metabolite | 10 mg | 4900 |
| Cayman2015 | 11194 | AM2201 2-hydroxyindole metabolite | 5 mg | 3150 |
| Cayman2015 | 11196 | AM2201 5-hydroxyindole metabolite | 1 mg | 1330 |
| Cayman2015 | 11196 | AM2201 5-hydroxyindole metabolite | 10 mg | 4900 |
| Cayman2015 | 11196 | AM2201 5-hydroxyindole metabolite | 5 mg | 3150 |
| Cayman2015 | 11197 | 4-Ethylethcathinone (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 11197 | 4-Ethylethcathinone (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 11197 | 4-Ethylethcathinone (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 11198 | 3-Ethylethcathinone (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 11198 | 3-Ethylethcathinone (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 11198 | 3-Ethylethcathinone (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 11199 | 2-Ethylethcathinone (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 11199 | 2-Ethylethcathinone (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 11199 | 2-Ethylethcathinone (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 11200 | 2C-T-7 (hydrochloride) | 10 mg | 952 |
| Cayman2015 | 11200 | 2C-T-7 (hydrochloride) | 5 mg | 616 |
| Cayman2015 | 11200 | 2C-T-7 (hydrochloride) | 50 mg | 3696 |
| Cayman2015 | 11201 | JWH 175 | 10 mg | 1484 |
| Cayman2015 | 11201 | JWH 175 | 25 mg | 3528 |
| Cayman2015 | 11201 | JWH 175 | 5 mg | 784 |
| Cayman2015 | 11202 | BZP (hydrochloride) | 10 mg | 490 |
| Cayman2015 | 11202 | BZP (hydrochloride) | 100 mg | 2016 |
| Cayman2015 | 11202 | BZP (hydrochloride) | 50 mg | 1134 |
| Cayman2015 | 11203 | Phenylpiperazine (hydrochloride) | 10 mg | 490 |
| Cayman2015 | 11203 | Phenylpiperazine (hydrochloride) | 100 mg | 2016 |
| Cayman2015 | 11203 | Phenylpiperazine (hydrochloride) | 50 mg | 1134 |
| Cayman2015 | 11204 | 1-(p-Fluorophenyl) piperazine (hydrochloride) | 10 mg | 490 |
| Cayman2015 | 11204 | 1-(p-Fluorophenyl) piperazine (hydrochloride) | 100 mg | 2016 |
| Cayman2015 | 11204 | 1-(p-Fluorophenyl) piperazine (hydrochloride) | 50 mg | 1134 |
| Cayman2015 | 11205 | 1-(m-Trifluoromethylphenyl) piperazine (hydrochloride) | 10 mg | 490 |
| Cayman2015 | 11205 | 1-(m-Trifluoromethylphenyl) piperazine (hydrochloride) | 100 mg | 2016 |
| Cayman2015 | 11205 | 1-(m-Trifluoromethylphenyl) piperazine (hydrochloride) | 50 mg | 1134 |
| Cayman2015 | 11206 | 1,4-Dibenzylpiperazine (hydrochloride) | 10 mg | 490 |
| Cayman2015 | 11206 | 1,4-Dibenzylpiperazine (hydrochloride) | 100 mg | 2016 |
| Cayman2015 | 11206 | 1,4-Dibenzylpiperazine (hydrochloride) | 50 mg | 1134 |
| Cayman2015 | 11207 | 4-ethyl-N,N-Dimethylcathinone (hydrochloride) | 10 mg | 1638 |
| Cayman2015 | 11207 | 4-ethyl-N,N-Dimethylcathinone (hydrochloride) | 5 mg | 910 |
| Cayman2015 | 11207 | 4-ethyl-N,N-Dimethylcathinone (hydrochloride) | 50 mg | 6146 |
| Cayman2015 | 11208 | KRN 7000 | 1 mg | 3270 |
| Cayman2015 | 11208 | KRN 7000 | 250 μg | 1170 |
| Cayman2015 | 11209 | PRDM9 (human recombinant) | 10 μg | 1946 |
| Cayman2015 | 11209 | PRDM9 (human recombinant) | 25 μg | 4620 |
| Cayman2015 | 11209 | PRDM9 (human recombinant) | 50 μg | 8750 |
| Cayman2015 | 11210 | Prostaglandin B2 | 1 mg | 490 |
| Cayman2015 | 11210 | Prostaglandin B2 | 10 mg | 3220 |
| Cayman2015 | 11210 | Prostaglandin B2 | 25 mg | 6132 |
| Cayman2015 | 11210 | Prostaglandin B2 | 5 mg | 2086 |
| Cayman2015 | 11211 | Sulfosuccinimidyl Oleate (sodium salt) | 10 mg | 1708 |
| Cayman2015 | 11211 | Sulfosuccinimidyl Oleate (sodium salt) | 25 mg | 2856 |
| Cayman2015 | 11211 | Sulfosuccinimidyl Oleate (sodium salt) | 5 mg | 952 |
| Cayman2015 | 11211 | Sulfosuccinimidyl Oleate (sodium salt) | 50 mg | 5236 |
| Cayman2015 | 11213 | tetranor-PGDM lactone-d6 | 100 μg | 10024 |
| Cayman2015 | 11213 | tetranor-PGDM lactone-d6 | 25 μg | 2786 |
| Cayman2015 | 11213 | tetranor-PGDM lactone-d6 | 50 μg | 5292 |
| Cayman2015 | 11214 | NKH477 (hydrochloride) | 1 mg | 266 |
| Cayman2015 | 11214 | NKH477 (hydrochloride) | 10 mg | 1596 |
| Cayman2015 | 11214 | NKH477 (hydrochloride) | 5 mg | 1064 |
| Cayman2015 | 11215 | Lupeol | 10 mg | 406 |
| Cayman2015 | 11215 | Lupeol | 25 mg | 952 |
| Cayman2015 | 11215 | Lupeol | 5 mg | 210 |
| Cayman2015 | 11216 | DMABA NHS ester | 100 mg | 770 |
| Cayman2015 | 11216 | DMABA NHS ester | 50 mg | 406 |
| Cayman2015 | 11216 | DMABA NHS ester | 500 mg | 3248 |
| Cayman2015 | 11217 | DMABA-d4 NHS ester | 1 mg | 1218 |
| Cayman2015 | 11217 | DMABA-d4 NHS ester | 10 mg | 9744 |
| Cayman2015 | 11217 | DMABA-d4 NHS ester | 5 mg | 5488 |
| Cayman2015 | 11218 | DMABA-d6 NHS ester | 1 mg | 1218 |
| Cayman2015 | 11218 | DMABA-d6 NHS ester | 10 mg | 9744 |
| Cayman2015 | 11218 | DMABA-d6 NHS ester | 5 mg | 5488 |
| Cayman2015 | 11219 | DMABA-d10 NHS ester | 1 mg | 1218 |
| Cayman2015 | 11219 | DMABA-d10 NHS ester | 10 mg | 9744 |
| Cayman2015 | 11219 | DMABA-d10 NHS ester | 5 mg | 5488 |
| Cayman2015 | 11220 | DYn-2 | 1 mg | 588 |
| Cayman2015 | 11220 | DYn-2 | 10 mg | 4704 |
| Cayman2015 | 11220 | DYn-2 | 25 mg | 10290 |
| Cayman2015 | 11220 | DYn-2 | 5 mg | 2646 |
| Cayman2015 | 11221 | 2-Methylethcathinone (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 11221 | 2-Methylethcathinone (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 11221 | 2-Methylethcathinone (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 11222 | 3-Methylethcathinone (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 11222 | 3-Methylethcathinone (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 11222 | 3-Methylethcathinone (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 11223 | 2-Methylmethcathinone (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 11223 | 2-Methylmethcathinone (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 11223 | 2-Methylmethcathinone (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 11224 | 3-Methylmethcathinone (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 11224 | 3-Methylmethcathinone (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 11224 | 3-Methylmethcathinone (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 11225 | 2,3-Dimethylmethcathinone (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 11225 | 2,3-Dimethylmethcathinone (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 11225 | 2,3-Dimethylmethcathinone (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 11226 | AS-703026 | 1 mg | 350 |
| Cayman2015 | 11226 | AS-703026 | 10 mg | 1582 |
| Cayman2015 | 11226 | AS-703026 | 25 mg | 2184 |
| Cayman2015 | 11226 | AS-703026 | 5 mg | 1050 |
| Cayman2015 | 11227 | 2,3-Dimethylethcathinone (hydrochloride) | 1 mg | 546 |
| Cayman2015 | 11227 | 2,3-Dimethylethcathinone (hydrochloride) | 10 mg | 4102 |
| Cayman2015 | 11227 | 2,3-Dimethylethcathinone (hydrochloride) | 5 mg | 2464 |
| Cayman2015 | 11228 | 3,4-Dimethylethcathinone (hydrochloride) | 10 mg | 1484 |
| Cayman2015 | 11228 | 3,4-Dimethylethcathinone (hydrochloride) | 25 mg | 3528 |
| Cayman2015 | 11228 | 3,4-Dimethylethcathinone (hydrochloride) | 5 mg | 784 |
| Cayman2015 | 11229 | 2-Fluoroethcathinone (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 11229 | 2-Fluoroethcathinone (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 11229 | 2-Fluoroethcathinone (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 11230 | 3-Fluoroethcathinone (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 11230 | 3-Fluoroethcathinone (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 11230 | 3-Fluoroethcathinone (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 11231 | 4-Fluoroethcathinone (hydrochloride) | 10 mg | 1638 |
| Cayman2015 | 11231 | 4-Fluoroethcathinone (hydrochloride) | 5 mg | 910 |
| Cayman2015 | 11231 | 4-Fluoroethcathinone (hydrochloride) | 50 mg | 6146 |
| Cayman2015 | 11232 | (?)-JQ1 | 1 mg | 1330 |
| Cayman2015 | 11232 | (?)-JQ1 | 10 mg | 10640 |
| Cayman2015 | 11232 | (?)-JQ1 | 5 mg | 5992 |
| Cayman2015 | 11235 | CBX5 (human recombinant) | 100 μg | 3486 |
| Cayman2015 | 11235 | CBX5 (human recombinant) | 25 μg | 1246 |
| Cayman2015 | 11235 | CBX5 (human recombinant) | 50 μg | 2114 |
| Cayman2015 | 11237 | JMJD2E-Strep tagged (human recombinant) | 100 μg | 4788 |
| Cayman2015 | 11237 | JMJD2E-Strep tagged (human recombinant) | 25 μg | 1330 |
| Cayman2015 | 11237 | JMJD2E-Strep tagged (human recombinant) | 50 μg | 2534 |
| Cayman2015 | 11240 | Naphyrone 1-naphthyl isomer (hydrochloride) | 1 mg | 686 |
| Cayman2015 | 11240 | Naphyrone 1-naphthyl isomer (hydrochloride) | 10 mg | 3430 |
| Cayman2015 | 11240 | Naphyrone 1-naphthyl isomer (hydrochloride) | 5 mg | 1890 |
| Cayman2015 | 11241 | Ethcathinone (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 11241 | Ethcathinone (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 11241 | Ethcathinone (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 11242 | 2,4-Dimethylethcathinone (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 11242 | 2,4-Dimethylethcathinone (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 11242 | 2,4-Dimethylethcathinone (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 11243 | 2,4-Dimethylmethcathinone (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 11243 | 2,4-Dimethylmethcathinone (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 11243 | 2,4-Dimethylmethcathinone (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 11245 | Goat Anti-GST IgG:DyLight? 488 | 1 ea | 4710 |
| Cayman2015 | 11246 | Mouse Anti-6HIS IgG:DyLight? 488 | 1 ea | 4710 |
| Cayman2015 | 11247 | Mouse Anti-c-myc IgG:DyLight? 488 | 1 ea | 4710 |
| Cayman2015 | 11248 | Mouse Anti-DYKDDDDK IgG:DyLight? 488 | 1 ea | 4710 |
| Cayman2015 | 11249 | Mouse Anti-HA IgG:DyLight? 488 | 1 ea | 4710 |
| Cayman2015 | 11250 | Rabbit Anti-HA IgG:DyLight? 488 | 1 ea | 4710 |
| Cayman2015 | 11251 | Rabbit Anti-T7 IgG:DyLight? 488 | 1 ea | 4710 |
| Cayman2015 | 11252 | Rabbit Anti-V5 tag IgG:DyLight? 488 | 1 ea | 4710 |
| Cayman2015 | 11253 | Streptavidin:DyLight? 488 | 1 ea | 2250 |
| Cayman2015 | 11254 | Goat Anti-GST IgG:DyLight? 550 | 1 ea | 4710 |
| Cayman2015 | 11255 | Mouse Anti-6HIS IgG:DyLight? 550 | 1 ea | 4710 |
| Cayman2015 | 11256 | Mouse Anti-DYKDDDDK IgG:DyLight? 550 | 1 ea | 4710 |
| Cayman2015 | 11257 | Mouse Anti-HA IgG:DyLight? 550 | 1 ea | 4710 |
| Cayman2015 | 11258 | Rabbit Anti-HA IgG:DyLight? 550 | 1 ea | 4710 |
| Cayman2015 | 11259 | Rabbit Anti-S tag IgG:DyLight? 550 | 1 ea | 4710 |
| Cayman2015 | 11260 | Rabbit Anti-T7 IgG:DyLight? 550 | 1 ea | 4710 |
| Cayman2015 | 11261 | Rabbit Anti-V5 tag IgG:DyLight? 550 | 1 ea | 4710 |
| Cayman2015 | 11262 | Streptavidin:DyLight? 550 | 1 ea | 2250 |
| Cayman2015 | 11263 | Goat Anti-GST IgG:DyLight? 650 | 1 ea | 4710 |
| Cayman2015 | 11264 | Mouse Anti-c-myc IgG:DyLight? 650 | 1 ea | 4710 |
| Cayman2015 | 11265 | Mouse Anti-DYKDDDDK IgG:DyLight? 650 | 1 ea | 4710 |
| Cayman2015 | 11266 | Mouse Anti-HA IgG:DyLight? 650 | 1 ea | 4710 |
| Cayman2015 | 11267 | Rabbit Anti-HA IgG:DyLight? 650 | 1 ea | 4710 |
| Cayman2015 | 11268 | Rabbit Anti-S tag IgG:DyLight? 650 | 1 ea | 4710 |
| Cayman2015 | 11269 | Rabbit Anti-V5 tag IgG:DyLight? 650 | 1 ea | 4710 |
| Cayman2015 | 11270 | Streptavidin:DyLight? 650 | 1 ea | 2250 |
| Cayman2015 | 11271 | SureLight? Peridinin-Chlorophyll Protein Complex (PerCP) | 1 ea | 600 |
| Cayman2015 | 11272 | Goat Anti-GST IgG:PerCP | 1 ea | 4710 |
| Cayman2015 | 11273 | Mouse Anti-6HIS IgG:PerCP | 1 ea | 4710 |
| Cayman2015 | 11274 | Mouse Anti-c-myc IgG:PerCP | 1 ea | 4710 |
| Cayman2015 | 11275 | Mouse Anti-DYKDDDDK IgG:PerCP | 1 ea | 4710 |
| Cayman2015 | 11276 | Mouse Anti-HA IgG:PerCP | 1 ea | 4710 |
| Cayman2015 | 11277 | Rabbit Anti-HA IgG:PerCP | 1 ea | 4710 |
| Cayman2015 | 11278 | Rabbit Anti-S tag IgG:PerCP | 1 ea | 4710 |
| Cayman2015 | 11279 | Rabbit Anti-T7 IgG:SureLight? PerCP | 1 ea | 4710 |
| Cayman2015 | 11280 | Rabbit Anti-V5 tag IgG:PerCP | 1 ea | 4710 |
| Cayman2015 | 11281 | Streptavidin:SureLight? PerCP | 1 ea | 4575 |
| Cayman2015 | 11282 | AM1248 | 10 mg | 1484 |
| Cayman2015 | 11282 | AM1248 | 25 mg | 3528 |
| Cayman2015 | 11282 | AM1248 | 5 mg | 784 |
| Cayman2015 | 11283 | Buphedrone (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 11283 | Buphedrone (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 11283 | Buphedrone (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 11284 | BRG1 bromodomain (human recombinant) | 100 μg | 3990 |
| Cayman2015 | 11284 | BRG1 bromodomain (human recombinant) | 25 μg | 1330 |
| Cayman2015 | 11284 | BRG1 bromodomain (human recombinant) | 50 μg | 2394 |
| Cayman2015 | 11285 | BRD3 bromodomain 1 (human recombinant) | 100 μg | 3990 |
| Cayman2015 | 11285 | BRD3 bromodomain 1 (human recombinant) | 25 μg | 1330 |
| Cayman2015 | 11285 | BRD3 bromodomain 1 (human recombinant) | 50 μg | 2394 |
| Cayman2015 | 11286 | MBD2 (human recombinant; methyl binding domain aa 150-220) | 100 μg | 5642 |
| Cayman2015 | 11286 | MBD2 (human recombinant; methyl binding domain aa 150-220) | 25 μg | 1568 |
| Cayman2015 | 11286 | MBD2 (human recombinant; methyl binding domain aa 150-220) | 50 μg | 2982 |
| Cayman2015 | 11287 | MeCP2 (human recombinant; methyl binding domain aa 77-166) | 100 μg | 5642 |
| Cayman2015 | 11287 | MeCP2 (human recombinant; methyl binding domain aa 77-166) | 25 μg | 1568 |
| Cayman2015 | 11287 | MeCP2 (human recombinant; methyl binding domain aa 77-166) | 50 μg | 2982 |
| Cayman2015 | 11288 | CREB-binding protein bromodomain (human recombinant) | 100 μg | 3990 |
| Cayman2015 | 11288 | CREB-binding protein bromodomain (human recombinant) | 25 μg | 1330 |
| Cayman2015 | 11288 | CREB-binding protein bromodomain (human recombinant) | 50 μg | 2394 |
| Cayman2015 | 11289 | BRM bromodomain (human recombinant) | 100 μg | 3990 |
| Cayman2015 | 11289 | BRM bromodomain (human recombinant) | 25 μg | 1330 |
| Cayman2015 | 11289 | BRM bromodomain (human recombinant) | 50 μg | 2394 |
| Cayman2015 | 11293 | Aflatoxin B1 | 1 mg | 336 |
| Cayman2015 | 11293 | Aflatoxin B1 | 5 mg | 1344 |
| Cayman2015 | 11294 | Aflatoxin B2 | 1 mg | 686 |
| Cayman2015 | 11294 | Aflatoxin B2 | 5 mg | 2744 |
| Cayman2015 | 11299 | JMJD2A-Strep tagged (human recombinant) | 100 μg | 4788 |
| Cayman2015 | 11299 | JMJD2A-Strep tagged (human recombinant) | 25 μg | 1330 |
| Cayman2015 | 11299 | JMJD2A-Strep tagged (human recombinant) | 50 μg | 2534 |
| Cayman2015 | 11300 | JMJD2D-Strep tagged (human recombinant) | 100 μg | 4788 |
| Cayman2015 | 11300 | JMJD2D-Strep tagged (human recombinant) | 25 μg | 1330 |
| Cayman2015 | 11300 | JMJD2D-Strep tagged (human recombinant) | 50 μg | 2534 |
| Cayman2015 | 11304 | BSI-201 | 10 mg | 1372 |
| Cayman2015 | 11304 | BSI-201 | 100 mg | 5446 |
| Cayman2015 | 11304 | BSI-201 | 50 mg | 4130 |
| Cayman2015 | 11305 | Kynurenine | 100 mg | 406 |
| Cayman2015 | 11305 | Kynurenine | 250 mg | 952 |
| Cayman2015 | 11305 | Kynurenine | 50 mg | 210 |
| Cayman2015 | 11305 | Kynurenine | 500 mg | 1680 |
| Cayman2015 | 11306 | Alternariol | 1 mg | 812 |
| Cayman2015 | 11306 | Alternariol | 5 mg | 2450 |
| Cayman2015 | 11308 | Anisomycin | 10 mg | 490 |
| Cayman2015 | 11308 | Anisomycin | 100 mg | 2240 |
| Cayman2015 | 11308 | Anisomycin | 5 mg | 350 |
| Cayman2015 | 11308 | Anisomycin | 50 mg | 1372 |
| Cayman2015 | 11309 | Ascomycin | 10 mg | 1036 |
| Cayman2015 | 11309 | Ascomycin | 25 mg | 1680 |
| Cayman2015 | 11309 | Ascomycin | 5 mg | 546 |
| Cayman2015 | 11311 | 4-acetoxy DiPT (hydrochloride) | 1 mg | 686 |
| Cayman2015 | 11311 | 4-acetoxy DiPT (hydrochloride) | 10 mg | 5488 |
| Cayman2015 | 11311 | 4-acetoxy DiPT (hydrochloride) | 5 mg | 3094 |
| Cayman2015 | 11312 | 4-hydroxy DiPT (hydrochloride) | 10 mg | 952 |
| Cayman2015 | 11312 | 4-hydroxy DiPT (hydrochloride) | 25 mg | 2310 |
| Cayman2015 | 11312 | 4-hydroxy DiPT (hydrochloride) | 5 mg | 616 |
| Cayman2015 | 11313 | Castanospermine | 10 mg | 980 |
| Cayman2015 | 11313 | Castanospermine | 5 mg | 546 |
| Cayman2015 | 11314 | Chelerythrine (chloride) | 1 mg | 350 |
| Cayman2015 | 11314 | Chelerythrine (chloride) | 10 mg | 1330 |
| Cayman2015 | 11314 | Chelerythrine (chloride) | 5 mg | 910 |
| Cayman2015 | 11319 | Citreoviridin | 1 mg | 686 |
| Cayman2015 | 11319 | Citreoviridin | 5 mg | 2926 |
| Cayman2015 | 11319 | Citreoviridin | 500 μg | 406 |
| Cayman2015 | 11320 | Citrinin | 1 mg | 392 |
| Cayman2015 | 11320 | Citrinin | 10 mg | 2506 |
| Cayman2015 | 11320 | Citrinin | 5 mg | 1386 |
| Cayman2015 | 11321 | Cyclopamine | 1 mg | 252 |
| Cayman2015 | 11321 | Cyclopamine | 10 mg | 1176 |
| Cayman2015 | 11321 | Cyclopamine | 5 mg | 784 |
| Cayman2015 | 11323 | Sodium 4-Phenylbutyrate | 1 g | 490 |
| Cayman2015 | 11323 | Sodium 4-Phenylbutyrate | 10 g | 1960 |
| Cayman2015 | 11323 | Sodium 4-Phenylbutyrate | 5 g | 1344 |
| Cayman2015 | 11324 | b-AP15 | 1 mg | 490 |
| Cayman2015 | 11324 | b-AP15 | 10 mg | 1722 |
| Cayman2015 | 11324 | b-AP15 | 25 mg | 3682 |
| Cayman2015 | 11324 | b-AP15 | 5 mg | 980 |
| Cayman2015 | 11326 | Cyclopiazonic Acid | 1 mg | 252 |
| Cayman2015 | 11326 | Cyclopiazonic Acid | 10 mg | 1344 |
| Cayman2015 | 11326 | Cyclopiazonic Acid | 5 mg | 756 |
| Cayman2015 | 11327 | Cytochalasin A | 1 mg | 560 |
| Cayman2015 | 11327 | Cytochalasin A | 10 mg | 4186 |
| Cayman2015 | 11327 | Cytochalasin A | 5 mg | 2240 |
| Cayman2015 | 11328 | Cytochalasin B | 1 mg | 490 |
| Cayman2015 | 11328 | Cytochalasin B | 10 mg | 2450 |
| Cayman2015 | 11328 | Cytochalasin B | 5 mg | 1344 |
| Cayman2015 | 11329 | Cytochalasin C | 1 mg | 966 |
| Cayman2015 | 11329 | Cytochalasin C | 5 mg | 4354 |
| Cayman2015 | 11330 | Cytochalasin D | 1 mg | 910 |
| Cayman2015 | 11330 | Cytochalasin D | 10 mg | 6370 |
| Cayman2015 | 11330 | Cytochalasin D | 5 mg | 3416 |
| Cayman2015 | 11331 | Cytochalasin E | 1 mg | 560 |
| Cayman2015 | 11331 | Cytochalasin E | 10 mg | 4186 |
| Cayman2015 | 11331 | Cytochalasin E | 5 mg | 2240 |
| Cayman2015 | 11332 | Fumagillin | 1 mg | 1092 |
| Cayman2015 | 11332 | Fumagillin | 10 mg | 7840 |
| Cayman2015 | 11332 | Fumagillin | 5 mg | 4368 |
| Cayman2015 | 11333 | Diethylcathinone (hydrochloride) | 10 mg | 546 |
| Cayman2015 | 11333 | Diethylcathinone (hydrochloride) | 5 mg | 406 |
| Cayman2015 | 11333 | Diethylcathinone (hydrochloride) | 50 mg | 2646 |
| Cayman2015 | 11338 | K252a | 1 mg | 5390 |
| Cayman2015 | 11338 | K252a | 100 μg | 882 |
| Cayman2015 | 11338 | K252a | 50 μg | 490 |
| Cayman2015 | 11338 | K252a | 500 μg | 3430 |
| Cayman2015 | 11339 | K252b | 1 mg | 4256 |
| Cayman2015 | 11339 | K252b | 500 μg | 2240 |
| Cayman2015 | 11341 | Oligomycin Complex | 10 mg | 1050 |
| Cayman2015 | 11341 | Oligomycin Complex | 5 mg | 630 |
| Cayman2015 | 11342 | Oligomycin A | 1 mg | 546 |
| Cayman2015 | 11342 | Oligomycin A | 10 mg | 1638 |
| Cayman2015 | 11342 | Oligomycin A | 5 mg | 952 |
| Cayman2015 | 11343 | Oligomycin B | 1 mg | 532 |
| Cayman2015 | 11343 | Oligomycin B | 10 mg | 3724 |
| Cayman2015 | 11343 | Oligomycin B | 5 mg | 2128 |
| Cayman2015 | 11344 | PGDM-d4 | 100 μg | 7252 |
| Cayman2015 | 11344 | PGDM-d4 | 25 μg | 2016 |
| Cayman2015 | 11344 | PGDM-d4 | 50 μg | 3836 |
| Cayman2015 | 11345 | Paxilline | 1 mg | 364 |
| Cayman2015 | 11345 | Paxilline | 10 mg | 1904 |
| Cayman2015 | 11345 | Paxilline | 5 mg | 1078 |
| Cayman2015 | 11346 | Patulin | 10 mg | 1540 |
| Cayman2015 | 11346 | Patulin | 5 mg | 812 |
| Cayman2015 | 11347 | Penitrem A | 1 mg | 476 |
| Cayman2015 | 11347 | Penitrem A | 10 mg | 3430 |
| Cayman2015 | 11347 | Penitrem A | 5 mg | 1904 |
| Cayman2015 | 11349 | Resiniferatoxin | 1 mg | 1246 |
| Cayman2015 | 11350 | Thiolutin | 1 mg | 812 |
| Cayman2015 | 11350 | Thiolutin | 10 mg | 4256 |
| Cayman2015 | 11350 | Thiolutin | 5 mg | 2394 |
| Cayman2015 | 11351 | Verruculogen | 1 mg | 1246 |
| Cayman2015 | 11351 | Verruculogen | 5 mg | 4676 |
| Cayman2015 | 11352 | Withaferin A | 1 mg | 1050 |
| Cayman2015 | 11352 | Withaferin A | 5 mg | 3990 |
| Cayman2015 | 11353 | Zearalenone | 10 mg | 826 |
| Cayman2015 | 11353 | Zearalenone | 25 mg | 1960 |
| Cayman2015 | 11353 | Zearalenone | 5 mg | 434 |
| Cayman2015 | 11355 | (1R,3R)-3-Amino-cyclopentanol | 50 mg | 952 |
| Cayman2015 | 11356 | (1S,3R)-3-Amino-cyclopentanol | 50 mg | 952 |
| Cayman2015 | 11357 | (1R,3S)-3-Amino-cyclopentanol | 50 mg | 952 |
| Cayman2015 | 11358 | (1S,3S)-3-Aminomethyl-cyclopentanol | 50 mg | 952 |
| Cayman2015 | 11359 | (1R,3R)-3-Aminomethyl cyclopentanol | 50 mg | 952 |
| Cayman2015 | 11360 | (1R,3S)-3-Aminomethyl-cyclopentanol | 50 mg | 952 |
| Cayman2015 | 11361 | (1S,3R)-3-Aminomethyl-cyclopentanol | 50 mg | 952 |
| Cayman2015 | 11364 | (1S,3S)-3-Benzoic acid 3-carboxycyclopentyl ester | 50 mg | 952 |
| Cayman2015 | 11365 | (1S,3R)-3-Benzoic acid 3-carboxycyclopentyl ester | 50 mg | 952 |
| Cayman2015 | 11366 | (1R,3R)-3-Benzoic acid 3-carboxycyclopentyl ester | 50 mg | 952 |
| Cayman2015 | 11367 | (1R,3S)-3-Benzoic acid 3-carboxycyclopentyl ester | 50 mg | 952 |
| Cayman2015 | 11368 | (1R,3R)-3-Hydroxycyclopentane carboxylic acid benzyl ester | 50 mg | 952 |
| Cayman2015 | 11369 | (1S,3S)-3-Hydroxycyclopentane carboxylic acid benzyl ester | 50 mg | 952 |
| Cayman2015 | 11370 | (1R,3S)-3-Hydroxycyclopentane carboxylic acid benzyl ester | 50 mg | 952 |
| Cayman2015 | 11371 | (1S,3R)-3-Hydroxycyclopentane carboxylic acid benzyl ester | 50 mg | 952 |
| Cayman2015 | 11372 | (1R,3R)-3-Hydroxycyclopentane carboxylic acid methyl ester | 50 mg | 952 |
| Cayman2015 | 11374 | (1R,3S)-3-Hydroxycyclopentane carboxylic acid methyl ester | 50 mg | 952 |
| Cayman2015 | 11375 | (1S,3R)-3-Hydroxycyclopentane carboxylic acid methyl ester | 50 mg | 952 |
| Cayman2015 | 11380 | (1R,3R)-3-Hydroxycyclopentane acetic acid | 50 mg | 952 |
| Cayman2015 | 11381 | (1S,3S)-3-Hydroxycyclopentane acetic acid | 50 mg | 952 |
| Cayman2015 | 11382 | (1S,3R)-3-Hydroxycyclopentane acetic acid | 50 mg | 952 |
| Cayman2015 | 11383 | (1R,3S)-3-Hydroxycyclopentane acetic acid | 50 mg | 952 |
| Cayman2015 | 11384 | (1R,3R)-3-Hydroxycyclopentane acetic acid methyl ester | 50 mg | 952 |
| Cayman2015 | 11385 | (1S,3S)-3-Hydroxycyclopentane acetic acid methyl ester | 50 mg | 952 |
| Cayman2015 | 11386 | (1S,3R)-3-Hydroxycyclopentane acetic acid methyl ester | 50 mg | 952 |
| Cayman2015 | 11387 | (1R,3S)-3-Hydroxycyclopentane acetic acid methyl ester | 50 mg | 952 |
| Cayman2015 | 11388 | (S)-Tetrahydrofuran-2-yl-methylamine | 50 mg | 952 |
| Cayman2015 | 11389 | (R)-Tetrahydrofuran-2-yl-methylamine | 50 mg | 952 |
| Cayman2015 | 11390 | (S)-Tetrahydrofuran-3-ylamine | 50 mg | 952 |
| Cayman2015 | 11391 | (R)-Tetrahydrofuran-3-ylamine | 50 mg | 952 |
| Cayman2015 | 11394 | (1S,3S)-(3-Aminocyclopentyl) methanol | 50 mg | 952 |
| Cayman2015 | 11395 | (1R,3R)-(3-Aminocyclopentyl) methanol | 50 mg | 952 |
| Cayman2015 | 11396 | (1R,3S)-(3-Aminocyclopentyl) methanol | 50 mg | 952 |
| Cayman2015 | 11397 | 7-Aminoactinomycin D | 1 mg | 1050 |
| Cayman2015 | 11397 | 7-Aminoactinomycin D | 5 mg | 4130 |
| Cayman2015 | 11398 | (1S,3R)-(3-Aminocyclopentyl) methanol | 50 mg | 952 |
| Cayman2015 | 11399 | (1S,3S)-3-Aminocyclopentane carboxylic acid | 50 mg | 952 |
| Cayman2015 | 11400 | (1R,3R)-3-Aminocyclopentane carboxylic acid | 50 mg | 952 |
| Cayman2015 | 11401 | (1R,3S)-3-Aminocyclopentane carboxylic acid | 50 mg | 952 |
| Cayman2015 | 11402 | (1S,3R)-3-Aminocyclopentane carboxylic acid | 50 mg | 952 |
| Cayman2015 | 11403 | BOC-(1S,3S)-3-Aminocyclopentane carboxylic acid | 50 mg | 952 |
| Cayman2015 | 11404 | BOC-(1R,3R)-3-Aminocyclopentane carboxylic acid | 50 mg | 952 |
| Cayman2015 | 11405 | BOC-(1R,3S)-3-Aminocyclopentane carboxylic acid | 50 mg | 952 |
| Cayman2015 | 11406 | BOC-(1S,3R)-3-Aminocyclopentanecarboxylic acid | 50 mg | 952 |
| Cayman2015 | 11415 | (R)-3-Oxo-cyclopentaneacetic acid methyl ester | 50 mg | 952 |
| Cayman2015 | 11416 | (R)-3-Oxo-cyclopentanecarboxylic acid methyl ester | 50 mg | 952 |
| Cayman2015 | 11417 | (S)-3-Oxo-cyclopentaneacetic acid methyl ester | 50 mg | 952 |
| Cayman2015 | 11418 | (S)-3-Oxo-cyclopentanecarboxylic acid methyl ester | 50 mg | 952 |
| Cayman2015 | 11419 | 2-Fluoroamphetamine (hydrochloride) | 10 mg | 1638 |
| Cayman2015 | 11419 | 2-Fluoroamphetamine (hydrochloride) | 5 mg | 910 |
| Cayman2015 | 11419 | 2-Fluoroamphetamine (hydrochloride) | 50 mg | 6146 |
| Cayman2015 | 11420 | 2-Fluoromethamphetamine (hydrochloride) | 10 mg | 1484 |
| Cayman2015 | 11420 | 2-Fluoromethamphetamine (hydrochloride) | 5 mg | 784 |
| Cayman2015 | 11420 | 2-Fluoromethamphetamine (hydrochloride) | 50 mg | 5880 |
| Cayman2015 | 11421 | Actinomycin D | 1 mg | 182 |
| Cayman2015 | 11421 | Actinomycin D | 10 mg | 1316 |
| Cayman2015 | 11421 | Actinomycin D | 5 mg | 728 |
| Cayman2015 | 11422 | R406 | 1 mg | 770 |
| Cayman2015 | 11422 | R406 | 10 mg | 3472 |
| Cayman2015 | 11422 | R406 | 25 mg | 7504 |
| Cayman2015 | 11422 | R406 | 5 mg | 2114 |
| Cayman2015 | 11425 | Alamethicin | 1 mg | 490 |
| Cayman2015 | 11425 | Alamethicin | 10 mg | 2520 |
| Cayman2015 | 11425 | Alamethicin | 5 mg | 1330 |
| Cayman2015 | 11426 | Beauvericin | 1 mg | 336 |
| Cayman2015 | 11426 | Beauvericin | 10 mg | 2688 |
| Cayman2015 | 11426 | Beauvericin | 5 mg | 1512 |
| Cayman2015 | 11427 | Diacetoxyscirpenol | 1 mg | 686 |
| Cayman2015 | 11427 | Diacetoxyscirpenol | 10 mg | 3024 |
| Cayman2015 | 11427 | Diacetoxyscirpenol | 5 mg | 1708 |
| Cayman2015 | 11428 | Deoxynivalenol | 1 mg | 826 |
| Cayman2015 | 11428 | Deoxynivalenol | 5 mg | 3276 |
| Cayman2015 | 11428 | Deoxynivalenol | 500 μg | 546 |
| Cayman2015 | 11433 | Gliotoxin | 1 mg | 518 |
| Cayman2015 | 11433 | Gliotoxin | 10 mg | 4144 |
| Cayman2015 | 11433 | Gliotoxin | 5 mg | 2338 |
| Cayman2015 | 11434 | Mithramycin A | 1 mg | 532 |
| Cayman2015 | 11434 | Mithramycin A | 5 mg | 1792 |
| Cayman2015 | 11435 | Mitomycin C | 1 mg | 280 |
| Cayman2015 | 11435 | Mitomycin C | 10 mg | 1456 |
| Cayman2015 | 11435 | Mitomycin C | 25 mg | 3192 |
| Cayman2015 | 11435 | Mitomycin C | 5 mg | 826 |
| Cayman2015 | 11437 | Nigericin (sodium salt) | 10 mg | 910 |
| Cayman2015 | 11437 | Nigericin (sodium salt) | 25 mg | 2016 |
| Cayman2015 | 11437 | Nigericin (sodium salt) | 5 mg | 630 |
| Cayman2015 | 11439 | Ochratoxin A | 1 mg | 672 |
| Cayman2015 | 11439 | Ochratoxin A | 10 mg | 5040 |
| Cayman2015 | 11439 | Ochratoxin A | 5 mg | 2688 |
| Cayman2015 | 11440 | Penicillic Acid | 10 mg | 644 |
| Cayman2015 | 11440 | Penicillic Acid | 25 mg | 1512 |
| Cayman2015 | 11440 | Penicillic Acid | 5 mg | 336 |
| Cayman2015 | 11443 | Tenuazonic Acid | 1 mg | 490 |
| Cayman2015 | 11443 | Tenuazonic Acid | 10 mg | 3528 |
| Cayman2015 | 11443 | Tenuazonic Acid | 25 mg | 6370 |
| Cayman2015 | 11443 | Tenuazonic Acid | 5 mg | 1960 |
| Cayman2015 | 11444 | T-2 Toxin | 1 mg | 448 |
| Cayman2015 | 11444 | T-2 Toxin | 5 mg | 1736 |
| Cayman2015 | 11445 | Tunicamycin | 1 mg | 266 |
| Cayman2015 | 11445 | Tunicamycin | 10 mg | 1596 |
| Cayman2015 | 11445 | Tunicamycin | 5 mg | 1064 |
| Cayman2015 | 11449 | Ketazolam | 1 mg | 448 |
| Cayman2015 | 11449 | Ketazolam | 10 mg | 3584 |
| Cayman2015 | 11449 | Ketazolam | 5 mg | 2016 |
| Cayman2015 | 11451 | Irisin (human recombinant) | 100 μg | 5544 |
| Cayman2015 | 11451 | Irisin (human recombinant) | 25 μg | 1540 |
| Cayman2015 | 11451 | Irisin (human recombinant) | 50 μg | 2926 |
| Cayman2015 | 11456 | 5-APDB (hydrochloride) | 1 mg | 686 |
| Cayman2015 | 11456 | 5-APDB (hydrochloride) | 10 mg | 2744 |
| Cayman2015 | 11456 | 5-APDB (hydrochloride) | 5 mg | 1722 |
| Cayman2015 | 11457 | AM2201 N-(4-hydroxypentyl) metabolite-d5 | 1 mg | 6552 |
| Cayman2015 | 11457 | AM2201 N-(4-hydroxypentyl) metabolite-d5 | 100 μg | 1092 |
| Cayman2015 | 11457 | AM2201 N-(4-hydroxypentyl) metabolite-d5 | 500 μg | 4102 |
| Cayman2015 | 11463 | 2,3-Pentylone isomer (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 11463 | 2,3-Pentylone isomer (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 11463 | 2,3-Pentylone isomer (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 11464 | JWH 073 N-(4-hydroxybutyl) β-D-Glucuronide | 1 mg | 2604 |
| Cayman2015 | 11464 | JWH 073 N-(4-hydroxybutyl) β-D-Glucuronide | 500 μg | 1372 |
| Cayman2015 | 11465 | JWH 018 N-(5-hydroxypentyl) β-D-Glucuronide-d5 | 1 mg | 3332 |
| Cayman2015 | 11465 | JWH 018 N-(5-hydroxypentyl) β-D-Glucuronide-d5 | 500 μg | 1750 |
| Cayman2015 | 11466 | JWH 019 N-(6-hydroxyhexyl) β-D-Glucuronide | 1 mg | 2604 |
| Cayman2015 | 11466 | JWH 019 N-(6-hydroxyhexyl) β-D-Glucuronide | 500 μg | 1372 |
| Cayman2015 | 11472 | 3-hydroxy Phenazepam | 1 mg | 616 |
| Cayman2015 | 11472 | 3-hydroxy Phenazepam | 10 mg | 4928 |
| Cayman2015 | 11472 | 3-hydroxy Phenazepam | 5 mg | 2772 |
| Cayman2015 | 11473 | 2C-B-fly (hydrochloride) | 1 mg | 910 |
| Cayman2015 | 11473 | 2C-B-fly (hydrochloride) | 10 mg | 7280 |
| Cayman2015 | 11473 | 2C-B-fly (hydrochloride) | 5 mg | 4102 |
| Cayman2015 | 11474 | JWH 250 N-(5-hydroxypentyl) metabolite-d5 | 1 mg | 9310 |
| Cayman2015 | 11474 | JWH 250 N-(5-hydroxypentyl) metabolite-d5 | 100 μg | 1330 |
| Cayman2015 | 11474 | JWH 250 N-(5-hydroxypentyl) metabolite-d5 | 500 μg | 5320 |
| Cayman2015 | 11475 | JWH 122 N-(5-hydroxypentyl) metabolite-d5 | 1 mg | 9310 |
| Cayman2015 | 11475 | JWH 122 N-(5-hydroxypentyl) metabolite-d5 | 100 μg | 1330 |
| Cayman2015 | 11475 | JWH 122 N-(5-hydroxypentyl) metabolite-d5 | 500 μg | 5320 |
| Cayman2015 | 11480 | 5-methoxy DMT | 10 mg | 952 |
| Cayman2015 | 11480 | 5-methoxy DMT | 25 mg | 2310 |
| Cayman2015 | 11480 | 5-methoxy DMT | 5 mg | 616 |
| Cayman2015 | 11481 | 2-DPMP (hydrochloride) | 10 mg | 1484 |
| Cayman2015 | 11481 | 2-DPMP (hydrochloride) | 25 mg | 3528 |
| Cayman2015 | 11481 | 2-DPMP (hydrochloride) | 5 mg | 784 |
| Cayman2015 | 11482 | 5-methoxy MiPT | 10 mg | 952 |
| Cayman2015 | 11482 | 5-methoxy MiPT | 25 mg | 2310 |
| Cayman2015 | 11482 | 5-methoxy MiPT | 5 mg | 616 |
| Cayman2015 | 11483 | JWH 309 5'-isomer | 1 mg | 686 |
| Cayman2015 | 11483 | JWH 309 5'-isomer | 10 mg | 5488 |
| Cayman2015 | 11483 | JWH 309 5'-isomer | 5 mg | 3094 |
| Cayman2015 | 11484 | 2-methyl-α-Pyrrolidinopropiophenone (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 11484 | 2-methyl-α-Pyrrolidinopropiophenone (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 11484 | 2-methyl-α-Pyrrolidinopropiophenone (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 11485 | 3-methyl-α-Pyrrolidinopropiophenone (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 11485 | 3-methyl-α-Pyrrolidinopropiophenone (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 11485 | 3-methyl-α-Pyrrolidinopropiophenone (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 11486 | 4-Methylbuphedrone (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 11486 | 4-Methylbuphedrone (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 11486 | 4-Methylbuphedrone (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 11487 | Salvinorin A | 10 mg | 1386 |
| Cayman2015 | 11487 | Salvinorin A | 100 mg | 8764 |
| Cayman2015 | 11487 | Salvinorin A | 5 mg | 812 |
| Cayman2015 | 11487 | Salvinorin A | 50 mg | 5516 |
| Cayman2015 | 11488 | Salvinorin B | 10 mg | 1064 |
| Cayman2015 | 11488 | Salvinorin B | 100 mg | 3080 |
| Cayman2015 | 11488 | Salvinorin B | 5 mg | 672 |
| Cayman2015 | 11488 | Salvinorin B | 50 mg | 1904 |
| Cayman2015 | 11489 | 4-Methyl-α-ethylaminobutiophenone (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 11489 | 4-Methyl-α-ethylaminobutiophenone (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 11489 | 4-Methyl-α-ethylaminobutiophenone (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 11490 | YM155 | 1 mg | 490 |
| Cayman2015 | 11490 | YM155 | 10 mg | 1386 |
| Cayman2015 | 11490 | YM155 | 25 mg | 3640 |
| Cayman2015 | 11490 | YM155 | 5 mg | 910 |
| Cayman2015 | 11491 | AZD 7762 | 1 mg | 280 |
| Cayman2015 | 11491 | AZD 7762 | 10 mg | 2240 |
| Cayman2015 | 11491 | AZD 7762 | 25 mg | 4900 |
| Cayman2015 | 11491 | AZD 7762 | 5 mg | 1260 |
| Cayman2015 | 11492 | BIBW 2992 | 1 mg | 546 |
| Cayman2015 | 11492 | BIBW 2992 | 10 mg | 2464 |
| Cayman2015 | 11492 | BIBW 2992 | 5 mg | 1372 |
| Cayman2015 | 11492 | BIBW 2992 | 50 mg | 7644 |
| Cayman2015 | 11493 | Lapatinib | 10 mg | 826 |
| Cayman2015 | 11493 | Lapatinib | 100 mg | 2772 |
| Cayman2015 | 11493 | Lapatinib | 25 mg | 1260 |
| Cayman2015 | 11493 | Lapatinib | 5 mg | 630 |
| Cayman2015 | 11494 | Ponatinib | 1 mg | 406 |
| Cayman2015 | 11494 | Ponatinib | 10 mg | 1428 |
| Cayman2015 | 11494 | Ponatinib | 5 mg | 1022 |
| Cayman2015 | 11494 | Ponatinib | 50 mg | 4872 |
| Cayman2015 | 11495 | Cediranib | 10 mg | 1988 |
| Cayman2015 | 11495 | Cediranib | 25 mg | 3598 |
| Cayman2015 | 11495 | Cediranib | 5 mg | 1106 |
| Cayman2015 | 11496 | AT-9283 | 10 mg | 3542 |
| Cayman2015 | 11496 | AT-9283 | 25 mg | 7098 |
| Cayman2015 | 11496 | AT-9283 | 5 mg | 2086 |
| Cayman2015 | 11496 | AT-9283 | 50 mg | 10010 |
| Cayman2015 | 11497 | Saracatinib | 10 mg | 868 |
| Cayman2015 | 11497 | Saracatinib | 25 mg | 2044 |
| Cayman2015 | 11497 | Saracatinib | 5 mg | 546 |
| Cayman2015 | 11497 | Saracatinib | 50 mg | 3822 |
| Cayman2015 | 11498 | Dasatinib | 10 mg | 826 |
| Cayman2015 | 11498 | Dasatinib | 100 mg | 2898 |
| Cayman2015 | 11498 | Dasatinib | 25 mg | 1344 |
| Cayman2015 | 11498 | Dasatinib | 50 mg | 2072 |
| Cayman2015 | 11499 | Obatoclax (mesylate) | 1 mg | 686 |
| Cayman2015 | 11499 | Obatoclax (mesylate) | 10 mg | 3780 |
| Cayman2015 | 11499 | Obatoclax (mesylate) | 5 mg | 2058 |
| Cayman2015 | 11499 | Obatoclax (mesylate) | 50 mg | 10290 |
| Cayman2015 | 11500 | ABT-263 | 1 mg | 490 |
| Cayman2015 | 11500 | ABT-263 | 10 mg | 2506 |
| Cayman2015 | 11500 | ABT-263 | 25 mg | 4900 |
| Cayman2015 | 11500 | ABT-263 | 5 mg | 1526 |
| Cayman2015 | 11501 | ABT-737 | 1 mg | 910 |
| Cayman2015 | 11501 | ABT-737 | 10 mg | 2548 |
| Cayman2015 | 11501 | ABT-737 | 25 mg | 3864 |
| Cayman2015 | 11501 | ABT-737 | 5 mg | 1554 |
| Cayman2015 | 11502 | UR-144 | 10 mg | 1960 |
| Cayman2015 | 11502 | UR-144 | 25 mg | 4172 |
| Cayman2015 | 11502 | UR-144 | 50 mg | 7350 |
| Cayman2015 | 11503 | AM2232 | 10 mg | 1204 |
| Cayman2015 | 11503 | AM2232 | 25 mg | 2674 |
| Cayman2015 | 11503 | AM2232 | 5 mg | 630 |
| Cayman2015 | 11504 | AM679 | 10 mg | 1484 |
| Cayman2015 | 11504 | AM679 | 25 mg | 3528 |
| Cayman2015 | 11504 | AM679 | 5 mg | 784 |
| Cayman2015 | 11505 | ABT-888 (hydrochloride) | 1 mg | 686 |
| Cayman2015 | 11505 | ABT-888 (hydrochloride) | 10 mg | 1582 |
| Cayman2015 | 11505 | ABT-888 (hydrochloride) | 25 mg | 3430 |
| Cayman2015 | 11505 | ABT-888 (hydrochloride) | 5 mg | 1092 |
| Cayman2015 | 11506 | Coenzyme Q10 | 1 g | 2352 |
| Cayman2015 | 11506 | Coenzyme Q10 | 100 mg | 392 |
| Cayman2015 | 11506 | Coenzyme Q10 | 200 mg | 630 |
| Cayman2015 | 11507 | BRD1 bromodomain (human recombinant) | 100 μg | 3990 |
| Cayman2015 | 11507 | BRD1 bromodomain (human recombinant) | 25 μg | 1330 |
| Cayman2015 | 11507 | BRD1 bromodomain (human recombinant) | 50 μg | 2394 |
| Cayman2015 | 11509 | BRD9 bromodomain (human recombinant) | 100 μg | 3990 |
| Cayman2015 | 11509 | BRD9 bromodomain (human recombinant) | 25 μg | 1330 |
| Cayman2015 | 11509 | BRD9 bromodomain (human recombinant) | 50 μg | 2394 |
| Cayman2015 | 11510 | Prostaglandin Bx | 1 mg | 644 |
| Cayman2015 | 11510 | Prostaglandin Bx | 10 mg | 4704 |
| Cayman2015 | 11510 | Prostaglandin Bx | 5 mg | 2688 |
| Cayman2015 | 11510 | Prostaglandin Bx | 500 μg | 336 |
| Cayman2015 | 11512 | HMGB1 Monoclonal Antibody (Clone IMG19N10B7) | 1 ea | 3766 |
| Cayman2015 | 11513 | HMGB1 Monoclonal Antibody (Clone IMG19N15F4) | 1 ea | 3766 |
| Cayman2015 | 11514 | HMGB1 Monoclonal Antibody (Clone IMG19N12A1) | 1 ea | 4186 |
| Cayman2015 | 11515 | HMGB1 Polyclonal Antibody (aa 100-150) | 1 ea | 3276 |
| Cayman2015 | 11517 | Thioredoxin 1 from E. coli (oxidized form) | 2 mg | 5544 |
| Cayman2015 | 11518 | Thioredoxin 1 (human recombinant) | 1.2 mg | 7000 |
| Cayman2015 | 11518 | Thioredoxin 1 (human recombinant) | 250 μg | 3528 |
| Cayman2015 | 11520 | Thioredoxin 1 (human mutant C61S/C72S) | 250 μg | 3850 |
| Cayman2015 | 11521 | Thioredoxin 1 (mouse recombinant) | 100 μg | 3850 |
| Cayman2015 | 11522 | Thioredoxin 1 Truncated (human recombinant) | 100 μg | 3850 |
| Cayman2015 | 11523 | Thioredoxin Reductase from E. coli | 350 μg | 5418 |
| Cayman2015 | 11526 | Thioredoxin/Thioredoxin Reductase Mammalian Assay Kit | 1 ea | 7000 |
| Cayman2015 | 11527 | Thioredoxin Activity Fluorescent Assay Kit | 1 ea | 6440 |
| Cayman2015 | 11528 | Fluorescent Substrate for Thioredoxin or Thioredoxin Reductase Assay | 1 ea | 2380 |
| Cayman2015 | 11529 | Thioredoxin Reductase Fluorescent Activity Assay Kit | 1 ea | 6062 |
| Cayman2015 | 11530 | Glutaredoxin 1 from E. coli | 1 mg | 3850 |
| Cayman2015 | 11530 | Glutaredoxin 1 from E. coli | 3 mg | 6678 |
| Cayman2015 | 11532 | Glutaredoxin 2 (human recombinant) | 250 μg | 5110 |
| Cayman2015 | 11533 | Glutaredoxin 1 (human recombinant) | 250 μg | 4634 |
| Cayman2015 | 11534 | Glutaredoxin 1 from E. coli (mutant C14S) | 250 μg | 5110 |
| Cayman2015 | 11536 | Glutaredoxin Fluorescent Activity Assay Kit | 1 ea | 6216 |
| Cayman2015 | 11537 | Thioredoxin 1 (E. coli) Polyclonal Antiserum | 1 ea | 4634 |
| Cayman2015 | 11538 | Thioredoxin 1 (human) Pure Polyclonal Antibody | 1 ea | 4172 |
| Cayman2015 | 11539 | Thioredoxin 1 (human) Monoclonal Antibody (Clone 2G11) | 1 ea | 3850 |
| Cayman2015 | 11540 | Thioredoxin 1 (mouse) Polyclonal Antibody | 1 ea | 5460 |
| Cayman2015 | 11541 | Thioredoxin 1 (human) Polyclonal Antibody - biotinylated | 1 ea | 4634 |
| Cayman2015 | 11542 | Thioredoxin 1 (human) Polyclonal Antibody | 1 ea | 4634 |
| Cayman2015 | 11543 | Thioredoxin 1 Truncated (human) Monoclonal Antibody (Clone 7D11) | 1 ea | 4326 |
| Cayman2015 | 11544 | Glutaredoxin 2 (human) Polyclonal Antibody | 1 ea | 4634 |
| Cayman2015 | 11545 | Glutaredoxin 1 (human) Pure Polyclonal Antibody | 1 ea | 4634 |
| Cayman2015 | 11546 | Glutaredoxin 1 (human) Polyclonal Antibody - biotinylated | 1 ea | 3850 |
| Cayman2015 | 11547 | Dieosinediglutathione | 1 mg | 3850 |
| Cayman2015 | 11548 | BRDT bromodomain 1 (human recombinant) | 100 μg | 5236 |
| Cayman2015 | 11548 | BRDT bromodomain 1 (human recombinant) | 25 μg | 1750 |
| Cayman2015 | 11548 | BRDT bromodomain 1 (human recombinant) | 50 μg | 2772 |
| Cayman2015 | 11549 | WDR9 bromodomain 2 (human recombinant) | 100 μg | 3990 |
| Cayman2015 | 11549 | WDR9 bromodomain 2 (human recombinant) | 25 μg | 1330 |
| Cayman2015 | 11549 | WDR9 bromodomain 2 (human recombinant) | 50 μg | 2394 |
| Cayman2015 | 11550 | DiPT | 10 mg | 952 |
| Cayman2015 | 11550 | DiPT | 25 mg | 2310 |
| Cayman2015 | 11550 | DiPT | 5 mg | 616 |
| Cayman2015 | 11551 | DPT (hydrochloride) | 10 mg | 952 |
| Cayman2015 | 11551 | DPT (hydrochloride) | 25 mg | 2310 |
| Cayman2015 | 11551 | DPT (hydrochloride) | 5 mg | 616 |
| Cayman2015 | 11552 | 4-hydroxy MiPT | 10 mg | 952 |
| Cayman2015 | 11552 | 4-hydroxy MiPT | 25 mg | 2310 |
| Cayman2015 | 11552 | 4-hydroxy MiPT | 5 mg | 616 |
| Cayman2015 | 11553 | 5-methoxy AMT | 10 mg | 952 |
| Cayman2015 | 11553 | 5-methoxy AMT | 25 mg | 2310 |
| Cayman2015 | 11553 | 5-methoxy AMT | 5 mg | 616 |
| Cayman2015 | 11554 | MDA (hydrochloride) | 10 mg | 770 |
| Cayman2015 | 11554 | MDA (hydrochloride) | 5 mg | 406 |
| Cayman2015 | 11554 | MDA (hydrochloride) | 50 mg | 3248 |
| Cayman2015 | 11555 | 4-MTA | 1 mg | 448 |
| Cayman2015 | 11555 | 4-MTA | 10 mg | 1568 |
| Cayman2015 | 11555 | 4-MTA | 5 mg | 1008 |
| Cayman2015 | 11556 | N,N-DMA (hydrochloride) | 10 mg | 938 |
| Cayman2015 | 11556 | N,N-DMA (hydrochloride) | 5 mg | 490 |
| Cayman2015 | 11556 | N,N-DMA (hydrochloride) | 50 mg | 3920 |
| Cayman2015 | 11557 | N-Ethylamphetamine (hydrochloride) | 10 mg | 770 |
| Cayman2015 | 11557 | N-Ethylamphetamine (hydrochloride) | 5 mg | 406 |
| Cayman2015 | 11557 | N-Ethylamphetamine (hydrochloride) | 50 mg | 3248 |
| Cayman2015 | 11561 | Bromo-DragonFLY (hydrochloride) | 1 mg | 910 |
| Cayman2015 | 11561 | Bromo-DragonFLY (hydrochloride) | 10 mg | 7280 |
| Cayman2015 | 11561 | Bromo-DragonFLY (hydrochloride) | 5 mg | 4102 |
| Cayman2015 | 11562 | para-Methoxymethamphetamine (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 11562 | para-Methoxymethamphetamine (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 11562 | para-Methoxymethamphetamine (hydrochloride) | 50 mg | 3920 |
| Cayman2015 | 11563 | Isopentedrone (hydrochloride) | 1 mg | 686 |
| Cayman2015 | 11563 | Isopentedrone (hydrochloride) | 10 mg | 5488 |
| Cayman2015 | 11563 | Isopentedrone (hydrochloride) | 5 mg | 3094 |
| Cayman2015 | 11564 | STS-135 | 10 mg | 1960 |
| Cayman2015 | 11564 | STS-135 | 25 mg | 4172 |
| Cayman2015 | 11564 | STS-135 | 50 mg | 7350 |
| Cayman2015 | 11565 | XLR11 | 10 mg | 1960 |
| Cayman2015 | 11565 | XLR11 | 25 mg | 4172 |
| Cayman2015 | 11565 | XLR11 | 50 mg | 7350 |
| Cayman2015 | 11566 | AKB48 | 10 mg | 1960 |
| Cayman2015 | 11566 | AKB48 | 25 mg | 4172 |
| Cayman2015 | 11566 | AKB48 | 50 mg | 7350 |
| Cayman2015 | 11567 | Venlaine (hydrochloride) | 10 mg | 630 |
| Cayman2015 | 11567 | Venlaine (hydrochloride) | 100 mg | 3528 |
| Cayman2015 | 11567 | Venlaine (hydrochloride) | 25 mg | 1260 |
| Cayman2015 | 11567 | Venlaine (hydrochloride) | 50 mg | 2212 |
| Cayman2015 | 11568 | Letrozole | 10 mg | 490 |
| Cayman2015 | 11568 | Letrozole | 100 mg | 2940 |
| Cayman2015 | 11568 | Letrozole | 25 mg | 1036 |
| Cayman2015 | 11568 | Letrozole | 50 mg | 1722 |
| Cayman2015 | 11569 | GSK 1059615 | 10 mg | 1624 |
| Cayman2015 | 11569 | GSK 1059615 | 25 mg | 3780 |
| Cayman2015 | 11569 | GSK 1059615 | 5 mg | 1162 |
| Cayman2015 | 11570 | Rucaparib (phosphate) | 1 mg | 350 |
| Cayman2015 | 11570 | Rucaparib (phosphate) | 10 mg | 2800 |
| Cayman2015 | 11570 | Rucaparib (phosphate) | 5 mg | 1582 |
| Cayman2015 | 11571 | Bexarotene | 10 mg | 602 |
| Cayman2015 | 11571 | Bexarotene | 5 mg | 350 |
| Cayman2015 | 11571 | Bexarotene | 50 mg | 1316 |
| Cayman2015 | 11572 | IOX1 | 1 mg | 266 |
| Cayman2015 | 11572 | IOX1 | 5 mg | 1064 |
| Cayman2015 | 11573 | IOX2 | 1 mg | 266 |
| Cayman2015 | 11573 | IOX2 | 10 mg | 2128 |
| Cayman2015 | 11573 | IOX2 | 5 mg | 1064 |
| Cayman2015 | 11573 | IOX2 | 50 mg | 9310 |
| Cayman2015 | 11574 | Dapagliflozin | 1 mg | 490 |
| Cayman2015 | 11574 | Dapagliflozin | 10 mg | 2212 |
| Cayman2015 | 11574 | Dapagliflozin | 5 mg | 1344 |
| Cayman2015 | 11574 | Dapagliflozin | 50 mg | 9800 |
| Cayman2015 | 11576 | Phlorizin | 1 g | 784 |
| Cayman2015 | 11576 | Phlorizin | 10 g | 6272 |
| Cayman2015 | 11576 | Phlorizin | 5 g | 3528 |
| Cayman2015 | 11578 | Eprosartan (mesylate) | 10 mg | 560 |
| Cayman2015 | 11578 | Eprosartan (mesylate) | 100 mg | 3080 |
| Cayman2015 | 11578 | Eprosartan (mesylate) | 50 mg | 1750 |
| Cayman2015 | 11579 | Glipizide | 1 g | 322 |
| Cayman2015 | 11579 | Glipizide | 5 g | 1344 |
| Cayman2015 | 11580 | CI-1040 | 10 mg | 1638 |
| Cayman2015 | 11580 | CI-1040 | 25 mg | 3640 |
| Cayman2015 | 11580 | CI-1040 | 5 mg | 910 |
| Cayman2015 | 11580 | CI-1040 | 50 mg | 6832 |
| Cayman2015 | 11583 | AM1220 azepane isomer | 1 mg | 910 |
| Cayman2015 | 11583 | AM1220 azepane isomer | 10 mg | 7280 |
| Cayman2015 | 11583 | AM1220 azepane isomer | 5 mg | 4102 |
| Cayman2015 | 11584 | AM2233 azepane isomer | 1 mg | 910 |
| Cayman2015 | 11584 | AM2233 azepane isomer | 10 mg | 7280 |
| Cayman2015 | 11584 | AM2233 azepane isomer | 5 mg | 4102 |
| Cayman2015 | 11585 | JWH 018 N-(1-ethylpropyl) isomer | 1 mg | 686 |
| Cayman2015 | 11585 | JWH 018 N-(1-ethylpropyl) isomer | 10 mg | 5488 |
| Cayman2015 | 11585 | JWH 018 N-(1-ethylpropyl) isomer | 5 mg | 3094 |
| Cayman2015 | 11586 | JWH 018 2’-naphthyl-N-(1-ethylpropyl) isomer | 1 mg | 686 |
| Cayman2015 | 11586 | JWH 018 2’-naphthyl-N-(1-ethylpropyl) isomer | 10 mg | 5488 |
| Cayman2015 | 11586 | JWH 018 2’-naphthyl-N-(1-ethylpropyl) isomer | 5 mg | 3094 |
| Cayman2015 | 11587 | NVP-BKM120 | 1 mg | 490 |
| Cayman2015 | 11587 | NVP-BKM120 | 10 mg | 3682 |
| Cayman2015 | 11587 | NVP-BKM120 | 25 mg | 6734 |
| Cayman2015 | 11587 | NVP-BKM120 | 5 mg | 2086 |
| Cayman2015 | 11589 | IC-87114 | 1 mg | 490 |
| Cayman2015 | 11589 | IC-87114 | 10 mg | 1960 |
| Cayman2015 | 11589 | IC-87114 | 5 mg | 1106 |
| Cayman2015 | 11589 | IC-87114 | 50 mg | 8582 |
| Cayman2015 | 11590 | Temsirolimus | 1 mg | 630 |
| Cayman2015 | 11590 | Temsirolimus | 10 mg | 2100 |
| Cayman2015 | 11590 | Temsirolimus | 25 mg | 3598 |
| Cayman2015 | 11590 | Temsirolimus | 5 mg | 1106 |
| Cayman2015 | 11593 | MK 2206 (hydrochloride) | 1 mg | 490 |
| Cayman2015 | 11593 | MK 2206 (hydrochloride) | 10 mg | 2212 |
| Cayman2015 | 11593 | MK 2206 (hydrochloride) | 25 mg | 4900 |
| Cayman2015 | 11593 | MK 2206 (hydrochloride) | 5 mg | 1372 |
| Cayman2015 | 11594 | Fluconazole | 1 g | 686 |
| Cayman2015 | 11594 | Fluconazole | 10 g | 4466 |
| Cayman2015 | 11594 | Fluconazole | 5 g | 2436 |
| Cayman2015 | 11594 | Fluconazole | 500 mg | 406 |
| Cayman2015 | 11596 | MDV 3100 | 10 mg | 2338 |
| Cayman2015 | 11596 | MDV 3100 | 25 mg | 5418 |
| Cayman2015 | 11596 | MDV 3100 | 5 mg | 1666 |
| Cayman2015 | 11596 | MDV 3100 | 50 mg | 9996 |
| Cayman2015 | 11597 | Everolimus | 10 mg | 1372 |
| Cayman2015 | 11597 | Everolimus | 25 mg | 2730 |
| Cayman2015 | 11597 | Everolimus | 5 mg | 910 |
| Cayman2015 | 11598 | CP 690,550 | 10 mg | 1736 |
| Cayman2015 | 11598 | CP 690,550 | 25 mg | 4102 |
| Cayman2015 | 11598 | CP 690,550 | 5 mg | 910 |
| Cayman2015 | 11598 | CP 690,550 | 50 mg | 6370 |
| Cayman2015 | 11599 | AZD 6244 | 10 mg | 686 |
| Cayman2015 | 11599 | AZD 6244 | 100 mg | 1722 |
| Cayman2015 | 11599 | AZD 6244 | 25 mg | 854 |
| Cayman2015 | 11599 | AZD 6244 | 50 mg | 1204 |
| Cayman2015 | 11600 | GDC 0941 | 10 mg | 1666 |
| Cayman2015 | 11600 | GDC 0941 | 100 mg | 6664 |
| Cayman2015 | 11600 | GDC 0941 | 50 mg | 4172 |
| Cayman2015 | 11601 | Enzastaurin | 10 mg | 1386 |
| Cayman2015 | 11601 | Enzastaurin | 25 mg | 2926 |
| Cayman2015 | 11601 | Enzastaurin | 5 mg | 966 |
| Cayman2015 | 11601 | Enzastaurin | 50 mg | 4872 |
| Cayman2015 | 11603 | Ostarine | 1 mg | 826 |
| Cayman2015 | 11603 | Ostarine | 10 mg | 4130 |
| Cayman2015 | 11603 | Ostarine | 25 mg | 9296 |
| Cayman2015 | 11603 | Ostarine | 5 mg | 2268 |
| Cayman2015 | 11604 | N-ethyl-N-Methylcathinone (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 11604 | N-ethyl-N-Methylcathinone (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 11604 | N-ethyl-N-Methylcathinone (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 11605 | D-α-Hydroxyglutaric Acid (sodium salt) | 10 mg | 546 |
| Cayman2015 | 11605 | D-α-Hydroxyglutaric Acid (sodium salt) | 100 mg | 4648 |
| Cayman2015 | 11605 | D-α-Hydroxyglutaric Acid (sodium salt) | 25 mg | 1232 |
| Cayman2015 | 11605 | D-α-Hydroxyglutaric Acid (sodium salt) | 250 mg | 10234 |
| Cayman2015 | 11606 | A-796260 | 1 mg | 910 |
| Cayman2015 | 11606 | A-796260 | 10 mg | 7280 |
| Cayman2015 | 11606 | A-796260 | 5 mg | 4102 |
| Cayman2015 | 11607 | 2-Fluoroisocathinone (hydrochloride) | 1 mg | 686 |
| Cayman2015 | 11607 | 2-Fluoroisocathinone (hydrochloride) | 10 mg | 5488 |
| Cayman2015 | 11607 | 2-Fluoroisocathinone (hydrochloride) | 5 mg | 3094 |
| Cayman2015 | 11609 | Ruxolitinib | 1 mg | 350 |
| Cayman2015 | 11609 | Ruxolitinib | 10 mg | 2982 |
| Cayman2015 | 11609 | Ruxolitinib | 25 mg | 4410 |
| Cayman2015 | 11609 | Ruxolitinib | 5 mg | 1666 |
| Cayman2015 | 11610 | Amyloid-β Monoclonal Antibody (Clone 6C3, MOAB-2) | 200 μg | 3906 |
| Cayman2015 | 11610 | Amyloid-β Monoclonal Antibody (Clone 6C3, MOAB-2) | 50 μg | 1106 |
| Cayman2015 | 11611 | JWH 122 N-(4-pentenyl) analog | 1 mg | 910 |
| Cayman2015 | 11611 | JWH 122 N-(4-pentenyl) analog | 10 mg | 7280 |
| Cayman2015 | 11611 | JWH 122 N-(4-pentenyl) analog | 5 mg | 4102 |
| Cayman2015 | 11612 | Tafluprost ethyl ester | 1 mg | 1162 |
| Cayman2015 | 11612 | Tafluprost ethyl ester | 10 mg | 9296 |
| Cayman2015 | 11612 | Tafluprost ethyl ester | 5 mg | 5236 |
| Cayman2015 | 11613 | Isopropyl dodec-11-enylfluorophosphonate | 1 mg | 1484 |
| Cayman2015 | 11613 | Isopropyl dodec-11-enylfluorophosphonate | 10 mg | 10976 |
| Cayman2015 | 11613 | Isopropyl dodec-11-enylfluorophosphonate | 5 mg | 6272 |
| Cayman2015 | 11613 | Isopropyl dodec-11-enylfluorophosphonate | 500 μg | 784 |
| Cayman2015 | 11614 | Olmesartan Medoxomil | 10 mg | 350 |
| Cayman2015 | 11614 | Olmesartan Medoxomil | 100 mg | 2128 |
| Cayman2015 | 11614 | Olmesartan Medoxomil | 50 mg | 1204 |
| Cayman2015 | 11615 | misartan | 10 mg | 406 |
| Cayman2015 | 11615 | misartan | 100 mg | 1946 |
| Cayman2015 | 11615 | misartan | 50 mg | 1162 |
| Cayman2015 | 11615 | misartan | 500 mg | 6860 |
| Cayman2015 | 11617 | JWH 176 | 1 mg | 910 |
| Cayman2015 | 11617 | JWH 176 | 10 mg | 7280 |
| Cayman2015 | 11617 | JWH 176 | 5 mg | 4102 |
| Cayman2015 | 11618 | Fluorescent Substrate for Glutaredoxin Assay | 1 ea | 2268 |
| Cayman2015 | 11619 | MAM2201-d5 | 1 mg | 1736 |
| Cayman2015 | 11619 | MAM2201-d5 | 5 mg | 7280 |
| Cayman2015 | 11619 | MAM2201-d5 | 500 μg | 910 |
| Cayman2015 | 11620 | MI-2 (hydrochloride) | 1 mg | 686 |
| Cayman2015 | 11620 | MI-2 (hydrochloride) | 10 mg | 5488 |
| Cayman2015 | 11620 | MI-2 (hydrochloride) | 25 mg | 12012 |
| Cayman2015 | 11620 | MI-2 (hydrochloride) | 5 mg | 3094 |
| Cayman2015 | 11621 | MI-nc (hydrochloride) | 1 mg | 686 |
| Cayman2015 | 11621 | MI-nc (hydrochloride) | 10 mg | 5488 |
| Cayman2015 | 11621 | MI-nc (hydrochloride) | 25 mg | 12012 |
| Cayman2015 | 11621 | MI-nc (hydrochloride) | 5 mg | 3094 |
| Cayman2015 | 11622 | Heneicosapentaenoic Acid methyl ester | 1 mg | 1218 |
| Cayman2015 | 11622 | Heneicosapentaenoic Acid methyl ester | 10 mg | 9744 |
| Cayman2015 | 11622 | Heneicosapentaenoic Acid methyl ester | 5 mg | 5488 |
| Cayman2015 | 11623 | JWH 145 2-phenyl isomer | 1 mg | 686 |
| Cayman2015 | 11623 | JWH 145 2-phenyl isomer | 10 mg | 5488 |
| Cayman2015 | 11623 | JWH 145 2-phenyl isomer | 5 mg | 3094 |
| Cayman2015 | 11624 | 3,4-Methylenedioxy Pyrovalerone (hydrochloride) (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 11626 | Methylone (hydrochloride) (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 11628 | 5-methoxy DMT (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 11629 | Tamoxifen (citrate) | 1 g | 966 |
| Cayman2015 | 11629 | Tamoxifen (citrate) | 5 g | 3360 |
| Cayman2015 | 11629 | Tamoxifen (citrate) | 500 mg | 448 |
| Cayman2015 | 11630 | Ketamine (hydrochloride) | 10 mg | 378 |
| Cayman2015 | 11630 | Ketamine (hydrochloride) | 5 mg | 266 |
| Cayman2015 | 11630 | Ketamine (hydrochloride) | 50 mg | 798 |
| Cayman2015 | 11631 | JWH 031 2'-isomer | 1 mg | 686 |
| Cayman2015 | 11631 | JWH 031 2'-isomer | 10 mg | 5488 |
| Cayman2015 | 11631 | JWH 031 2'-isomer | 5 mg | 3094 |
| Cayman2015 | 11632 | JWH 030 2-naphthoyl isomer | 1 mg | 910 |
| Cayman2015 | 11632 | JWH 030 2-naphthoyl isomer | 10 mg | 7280 |
| Cayman2015 | 11632 | JWH 030 2-naphthoyl isomer | 5 mg | 4102 |
| Cayman2015 | 11633 | NCOR2/SMRT (human recombinant) | 50 μg | 5250 |
| Cayman2015 | 11634 | Natamycin | 1 g | 5600 |
| Cayman2015 | 11634 | Natamycin | 100 mg | 1330 |
| Cayman2015 | 11634 | Natamycin | 50 mg | 700 |
| Cayman2015 | 11635 | 5-Fluorocytosine | 1 g | 952 |
| Cayman2015 | 11635 | 5-Fluorocytosine | 10 g | 4480 |
| Cayman2015 | 11635 | 5-Fluorocytosine | 5 g | 3766 |
| Cayman2015 | 11635 | 5-Fluorocytosine | 500 mg | 546 |
| Cayman2015 | 11636 | Amphotericin B | 1 g | 812 |
| Cayman2015 | 11636 | Amphotericin B | 5 g | 2590 |
| Cayman2015 | 11636 | Amphotericin B | 500 mg | 448 |
| Cayman2015 | 11637 | Docetaxel | 10 mg | 854 |
| Cayman2015 | 11637 | Docetaxel | 250 mg | 12544 |
| Cayman2015 | 11637 | Docetaxel | 5 mg | 448 |
| Cayman2015 | 11637 | Docetaxel | 50 mg | 3584 |
| Cayman2015 | 11638 | Indiplon | 10 mg | 1540 |
| Cayman2015 | 11638 | Indiplon | 5 mg | 812 |
| Cayman2015 | 11638 | Indiplon | 50 mg | 6090 |
| Cayman2015 | 11639 | Methylphenidate (hydrochloride) | 10 mg | 350 |
| Cayman2015 | 11639 | Methylphenidate (hydrochloride) | 50 mg | 784 |
| Cayman2015 | 11640 | Lazabemide | 10 mg | 686 |
| Cayman2015 | 11640 | Lazabemide | 5 mg | 364 |
| Cayman2015 | 11640 | Lazabemide | 50 mg | 2912 |
| Cayman2015 | 11642 | PRMT3 (human recombinant) | 100 μg | 3332 |
| Cayman2015 | 11642 | PRMT3 (human recombinant) | 25 μg | 924 |
| Cayman2015 | 11642 | PRMT3 (human recombinant) | 50 μg | 1750 |
| Cayman2015 | 11644 | PRMT8 (human recombinant) | 100 μg | 3332 |
| Cayman2015 | 11644 | PRMT8 (human recombinant) | 25 μg | 924 |
| Cayman2015 | 11644 | PRMT8 (human recombinant) | 50 μg | 1750 |
| Cayman2015 | 11649 | BRDT bromodomain 2 (human recombinant) | 100 μg | 3990 |
| Cayman2015 | 11649 | BRDT bromodomain 2 (human recombinant) | 25 μg | 1330 |
| Cayman2015 | 11649 | BRDT bromodomain 2 (human recombinant) | 50 μg | 2394 |
| Cayman2015 | 11650 | BRPF3 bromodomain 1 (human recombinant) | 100 μg | 3990 |
| Cayman2015 | 11650 | BRPF3 bromodomain 1 (human recombinant) | 25 μg | 1330 |
| Cayman2015 | 11650 | BRPF3 bromodomain 1 (human recombinant) | 50 μg | 2394 |
| Cayman2015 | 11652 | Polybromo-1D bromodomain 1 (human recombinant) | 100 μg | 3990 |
| Cayman2015 | 11652 | Polybromo-1D bromodomain 1 (human recombinant) | 25 μg | 1330 |
| Cayman2015 | 11652 | Polybromo-1D bromodomain 1 (human recombinant) | 50 μg | 2394 |
| Cayman2015 | 11653 | TRIM24 bromodomain (human recombinant) | 100 μg | 3990 |
| Cayman2015 | 11653 | TRIM24 bromodomain (human recombinant) | 25 μg | 1330 |
| Cayman2015 | 11653 | TRIM24 bromodomain (human recombinant) | 50 μg | 2394 |
| Cayman2015 | 11655 | Cannabipiperidiethanone | 10 mg | 1484 |
| Cayman2015 | 11655 | Cannabipiperidiethanone | 25 mg | 3528 |
| Cayman2015 | 11655 | Cannabipiperidiethanone | 5 mg | 784 |
| Cayman2015 | 11658 | Necrostatin-1 | 10 mg | 700 |
| Cayman2015 | 11658 | Necrostatin-1 | 100 mg | 3920 |
| Cayman2015 | 11658 | Necrostatin-1 | 5 mg | 392 |
| Cayman2015 | 11658 | Necrostatin-1 | 50 mg | 2352 |
| Cayman2015 | 11659 | JWH 213 | 10 mg | 1484 |
| Cayman2015 | 11659 | JWH 213 | 25 mg | 3528 |
| Cayman2015 | 11659 | JWH 213 | 5 mg | 784 |
| Cayman2015 | 11660 | Brinzolamide | 10 mg | 938 |
| Cayman2015 | 11660 | Brinzolamide | 100 mg | 6860 |
| Cayman2015 | 11660 | Brinzolamide | 5 mg | 490 |
| Cayman2015 | 11660 | Brinzolamide | 50 mg | 3920 |
| Cayman2015 | 11665 | N-Ethylbuphedrone (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 11665 | N-Ethylbuphedrone (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 11665 | N-Ethylbuphedrone (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 11666 | 4-methoxy-N,N-Dimethylcathinone (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 11666 | 4-methoxy-N,N-Dimethylcathinone (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 11666 | 4-methoxy-N,N-Dimethylcathinone (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 11667 | 4-methyl-N-Methylbuphedrone (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 11667 | 4-methyl-N-Methylbuphedrone (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 11667 | 4-methyl-N-Methylbuphedrone (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 11675 | (Z-Ala-Ala-Ala-Ala)2Rh110 | 1 mg | 350 |
| Cayman2015 | 11675 | (Z-Ala-Ala-Ala-Ala)2Rh110 | 10 mg | 2800 |
| Cayman2015 | 11675 | (Z-Ala-Ala-Ala-Ala)2Rh110 | 5 mg | 1582 |
| Cayman2015 | 11679 | Andrographolide | 100 mg | 406 |
| Cayman2015 | 11679 | Andrographolide | 250 mg | 952 |
| Cayman2015 | 11679 | Andrographolide | 50 mg | 210 |
| Cayman2015 | 11679 | Andrographolide | 500 mg | 1680 |
| Cayman2015 | 11681 | α-Asarone | 1 g | 532 |
| Cayman2015 | 11681 | α-Asarone | 5 g | 2240 |
| Cayman2015 | 11681 | α-Asarone | 500 mg | 280 |
| Cayman2015 | 11683 | Angelicin | 10 mg | 1792 |
| Cayman2015 | 11683 | Angelicin | 25 mg | 4130 |
| Cayman2015 | 11683 | Angelicin | 5 mg | 1120 |
| Cayman2015 | 11684 | Bakuchiol | 1 mg | 350 |
| Cayman2015 | 11684 | Bakuchiol | 10 mg | 1932 |
| Cayman2015 | 11684 | Bakuchiol | 5 mg | 1316 |
| Cayman2015 | 11686 | Betulinic Acid | 100 mg | 795 |
| Cayman2015 | 11686 | Betulinic Acid | 250 mg | 1575 |
| Cayman2015 | 11686 | Betulinic Acid | 50 mg | 420 |
| Cayman2015 | 11686 | Betulinic Acid | 500 mg | 2730 |
| Cayman2015 | 11687 | 1'-Naphthoyl Indole | 10 mg | 1484 |
| Cayman2015 | 11687 | 1'-Naphthoyl Indole | 25 mg | 3528 |
| Cayman2015 | 11687 | 1'-Naphthoyl Indole | 5 mg | 784 |
| Cayman2015 | 11688 | XLR11 N-(4-pentenyl) analog | 1 mg | 910 |
| Cayman2015 | 11688 | XLR11 N-(4-pentenyl) analog | 10 mg | 7280 |
| Cayman2015 | 11688 | XLR11 N-(4-pentenyl) analog | 5 mg | 4102 |
| Cayman2015 | 11690 | Gemcitabine | 10 mg | 560 |
| Cayman2015 | 11690 | Gemcitabine | 100 mg | 3360 |
| Cayman2015 | 11690 | Gemcitabine | 25 mg | 994 |
| Cayman2015 | 11690 | Gemcitabine | 50 mg | 1890 |
| Cayman2015 | 11694 | Camptothecin | 100 mg | 532 |
| Cayman2015 | 11694 | Camptothecin | 250 mg | 1260 |
| Cayman2015 | 11694 | Camptothecin | 50 mg | 280 |
| Cayman2015 | 11694 | Camptothecin | 500 mg | 2240 |
| Cayman2015 | 11695 | Catharanthine | 100 mg | 798 |
| Cayman2015 | 11695 | Catharanthine | 50 mg | 420 |
| Cayman2015 | 11695 | Catharanthine | 500 mg | 3780 |
| Cayman2015 | 11696 | 2C-P (hydrochloride) | 10 mg | 952 |
| Cayman2015 | 11696 | 2C-P (hydrochloride) | 5 mg | 616 |
| Cayman2015 | 11696 | 2C-P (hydrochloride) | 50 mg | 3696 |
| Cayman2015 | 11697 | GW 6471 | 1 mg | 490 |
| Cayman2015 | 11697 | GW 6471 | 10 mg | 2212 |
| Cayman2015 | 11697 | GW 6471 | 5 mg | 1596 |
| Cayman2015 | 11700 | Conessine | 100 mg | 2604 |
| Cayman2015 | 11700 | Conessine | 250 mg | 5810 |
| Cayman2015 | 11700 | Conessine | 50 mg | 1372 |
| Cayman2015 | 11704 | SL 0101-1 | 100 μg | 448 |
| Cayman2015 | 11704 | SL 0101-1 | 500 μg | 2016 |
| Cayman2015 | 11705 | Jasplakinolide | 100 μg | 3705 |
| Cayman2015 | 11705 | Jasplakinolide | 50 μg | 1950 |
| Cayman2015 | 11706 | BAPTA | 1 g | 1400 |
| Cayman2015 | 11706 | BAPTA | 100 mg | 350 |
| Cayman2015 | 11706 | BAPTA | 250 mg | 434 |
| Cayman2015 | 11706 | BAPTA | 500 mg | 784 |
| Cayman2015 | 11707 | 6-Gingerol | 1 mg | 546 |
| Cayman2015 | 11707 | 6-Gingerol | 10 mg | 2464 |
| Cayman2015 | 11707 | 6-Gingerol | 25 mg | 5460 |
| Cayman2015 | 11707 | 6-Gingerol | 5 mg | 1372 |
| Cayman2015 | 11709 | Methcathinone (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 11709 | Methcathinone (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 11709 | Methcathinone (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 11710 | Diacerein | 100 mg | 1666 |
| Cayman2015 | 11710 | Diacerein | 25 mg | 490 |
| Cayman2015 | 11710 | Diacerein | 250 mg | 3430 |
| Cayman2015 | 11710 | Diacerein | 50 mg | 938 |
| Cayman2015 | 11720 | BRD4 bromodomain 1 (human recombinant; His-tagged) | 100 μg | 3990 |
| Cayman2015 | 11720 | BRD4 bromodomain 1 (human recombinant; His-tagged) | 25 μg | 1330 |
| Cayman2015 | 11720 | BRD4 bromodomain 1 (human recombinant; His-tagged) | 50 μg | 2394 |
| Cayman2015 | 11721 | BRD4 bromodomain 2 (human recombinant; His-tagged) | 100 μg | 3990 |
| Cayman2015 | 11721 | BRD4 bromodomain 2 (human recombinant; His-tagged) | 25 μg | 1330 |
| Cayman2015 | 11721 | BRD4 bromodomain 2 (human recombinant; His-tagged) | 50 μg | 2394 |
| Cayman2015 | 11724 | Veratramine | 10 mg | 1302 |
| Cayman2015 | 11724 | Veratramine | 25 mg | 3094 |
| Cayman2015 | 11724 | Veratramine | 5 mg | 686 |
| Cayman2015 | 11724 | Veratramine | 50 mg | 5488 |
| Cayman2015 | 11725 | Platycodin D | 1 mg | 350 |
| Cayman2015 | 11725 | Platycodin D | 10 mg | 2800 |
| Cayman2015 | 11725 | Platycodin D | 25 mg | 6132 |
| Cayman2015 | 11725 | Platycodin D | 5 mg | 1582 |
| Cayman2015 | 11726 | Oleanolic Acid | 1 g | 1232 |
| Cayman2015 | 11726 | Oleanolic Acid | 100 mg | 504 |
| Cayman2015 | 11726 | Oleanolic Acid | 500 mg | 812 |
| Cayman2015 | 11727 | Bicuculline | 100 mg | 770 |
| Cayman2015 | 11727 | Bicuculline | 50 mg | 392 |
| Cayman2015 | 11727 | Bicuculline | 500 mg | 3248 |
| Cayman2015 | 11730 | Coumestrol | 1 mg | 490 |
| Cayman2015 | 11730 | Coumestrol | 10 mg | 1750 |
| Cayman2015 | 11730 | Coumestrol | 5 mg | 1050 |
| Cayman2015 | 11731 | Bosentan | 10 mg | 938 |
| Cayman2015 | 11731 | Bosentan | 5 mg | 490 |
| Cayman2015 | 11731 | Bosentan | 50 mg | 3920 |
| Cayman2015 | 11732 | Lomeguatrib | 10 mg | 756 |
| Cayman2015 | 11732 | Lomeguatrib | 25 mg | 1680 |
| Cayman2015 | 11732 | Lomeguatrib | 5 mg | 420 |
| Cayman2015 | 11732 | Lomeguatrib | 50 mg | 3150 |
| Cayman2015 | 11733 | Atazanavir | 1 mg | 490 |
| Cayman2015 | 11733 | Atazanavir | 5 mg | 1470 |
| Cayman2015 | 11734 | 2C-B (hydrochloride) | 10 mg | 798 |
| Cayman2015 | 11734 | 2C-B (hydrochloride) | 5 mg | 616 |
| Cayman2015 | 11734 | 2C-B (hydrochloride) | 50 mg | 3696 |
| Cayman2015 | 11735 | 2C-C (hydrochloride) | 10 mg | 952 |
| Cayman2015 | 11735 | 2C-C (hydrochloride) | 5 mg | 616 |
| Cayman2015 | 11735 | 2C-C (hydrochloride) | 50 mg | 3696 |
| Cayman2015 | 11736 | MBZP (hydrochloride) | 10 mg | 910 |
| Cayman2015 | 11736 | MBZP (hydrochloride) | 100 mg | 5012 |
| Cayman2015 | 11736 | MBZP (hydrochloride) | 50 mg | 3192 |
| Cayman2015 | 11737 | Benocyclidine | 10 mg | 1638 |
| Cayman2015 | 11737 | Benocyclidine | 5 mg | 910 |
| Cayman2015 | 11737 | Benocyclidine | 50 mg | 6146 |
| Cayman2015 | 11741 | Muristerone A | 1 mg | 1890 |
| Cayman2015 | 11741 | Muristerone A | 250 μg | 675 |
| Cayman2015 | 11743 | SER-601 | 10 mg | 2002 |
| Cayman2015 | 11743 | SER-601 | 5 mg | 1050 |
| Cayman2015 | 11743 | SER-601 | 50 mg | 8400 |
| Cayman2015 | 11746 | Lonafarnib | 1 mg | 644 |
| Cayman2015 | 11746 | Lonafarnib | 10 mg | 2898 |
| Cayman2015 | 11746 | Lonafarnib | 5 mg | 1610 |
| Cayman2015 | 11748 | JWH 018 N-pentanoic acid metabolite-d5 | 1 mg | 1680 |
| Cayman2015 | 11748 | JWH 018 N-pentanoic acid metabolite-d5 | 5 mg | 5880 |
| Cayman2015 | 11748 | JWH 018 N-pentanoic acid metabolite-d5 | 500 μg | 1050 |
| Cayman2015 | 11749 | JWH 250 N-(4-hydroxypentyl) metabolite-d5 | 1 mg | 5572 |
| Cayman2015 | 11749 | JWH 250 N-(4-hydroxypentyl) metabolite-d5 | 100 μg | 1330 |
| Cayman2015 | 11749 | JWH 250 N-(4-hydroxypentyl) metabolite-d5 | 500 μg | 4102 |
| Cayman2015 | 11750 | Piperine | 10 g | 616 |
| Cayman2015 | 11750 | Piperine | 100 g | 2898 |
| Cayman2015 | 11750 | Piperine | 25 g | 1204 |
| Cayman2015 | 11750 | Piperine | 5 g | 322 |
| Cayman2015 | 11751 | Psoralen | 10 mg | 770 |
| Cayman2015 | 11751 | Psoralen | 100 mg | 3850 |
| Cayman2015 | 11751 | Psoralen | 25 mg | 1344 |
| Cayman2015 | 11751 | Psoralen | 50 mg | 2506 |
| Cayman2015 | 11752 | Purpurin | 10 g | 672 |
| Cayman2015 | 11752 | Purpurin | 25 g | 1582 |
| Cayman2015 | 11752 | Purpurin | 5 g | 350 |
| Cayman2015 | 11756 | β-Sitosterol | 10 g | 672 |
| Cayman2015 | 11756 | β-Sitosterol | 25 g | 1582 |
| Cayman2015 | 11756 | β-Sitosterol | 5 g | 350 |
| Cayman2015 | 11759 | (+)-ar-Turmerone | 1 mg | 686 |
| Cayman2015 | 11759 | (+)-ar-Turmerone | 10 mg | 5488 |
| Cayman2015 | 11759 | (+)-ar-Turmerone | 5 mg | 3094 |
| Cayman2015 | 11762 | Vinblastine (sulfate) | 10 mg | 1204 |
| Cayman2015 | 11762 | Vinblastine (sulfate) | 25 mg | 2366 |
| Cayman2015 | 11762 | Vinblastine (sulfate) | 5 mg | 630 |
| Cayman2015 | 11762 | Vinblastine (sulfate) | 50 mg | 4102 |
| Cayman2015 | 11763 | Vincamine | 1 g | 1204 |
| Cayman2015 | 11763 | Vincamine | 5 g | 4410 |
| Cayman2015 | 11763 | Vincamine | 500 mg | 630 |
| Cayman2015 | 11764 | Vincristine (sulfate) | 10 mg | 770 |
| Cayman2015 | 11764 | Vincristine (sulfate) | 25 mg | 1834 |
| Cayman2015 | 11764 | Vincristine (sulfate) | 5 mg | 406 |
| Cayman2015 | 11765 | Vindoline | 10 mg | 770 |
| Cayman2015 | 11765 | Vindoline | 25 mg | 1834 |
| Cayman2015 | 11765 | Vindoline | 5 mg | 406 |
| Cayman2015 | 11765 | Vindoline | 50 mg | 3248 |
| Cayman2015 | 11766 | AB-005 | 1 mg | 910 |
| Cayman2015 | 11766 | AB-005 | 10 mg | 7280 |
| Cayman2015 | 11766 | AB-005 | 5 mg | 4102 |
| Cayman2015 | 11767 | XLR11 N-(2-fluoropentyl) isomer | 1 mg | 3528 |
| Cayman2015 | 11767 | XLR11 N-(2-fluoropentyl) isomer | 100 μg | 784 |
| Cayman2015 | 11767 | XLR11 N-(2-fluoropentyl) isomer | 500 μg | 2156 |
| Cayman2015 | 11768 | XLR11 N-(3-fluoropentyl) isomer | 1 mg | 3528 |
| Cayman2015 | 11768 | XLR11 N-(3-fluoropentyl) isomer | 100 μg | 784 |
| Cayman2015 | 11768 | XLR11 N-(3-fluoropentyl) isomer | 500 μg | 2156 |
| Cayman2015 | 11769 | XLR11 N-(4-fluoropentyl) isomer | 1 mg | 3528 |
| Cayman2015 | 11769 | XLR11 N-(4-fluoropentyl) isomer | 100 μg | 784 |
| Cayman2015 | 11769 | XLR11 N-(4-fluoropentyl) isomer | 500 μg | 2156 |
| Cayman2015 | 11770 | XLR11 N-(4-hydroxypentyl) metabolite | 1 mg | 5460 |
| Cayman2015 | 11770 | XLR11 N-(4-hydroxypentyl) metabolite | 100 μg | 910 |
| Cayman2015 | 11770 | XLR11 N-(4-hydroxypentyl) metabolite | 500 μg | 3416 |
| Cayman2015 | 11771 | XLR11-d5 | 1 mg | 1736 |
| Cayman2015 | 11771 | XLR11-d5 | 5 mg | 7280 |
| Cayman2015 | 11771 | XLR11-d5 | 500 μg | 910 |
| Cayman2015 | 11772 | UR-144-d5 | 1 mg | 3094 |
| Cayman2015 | 11772 | UR-144-d5 | 5 mg | 5488 |
| Cayman2015 | 11772 | UR-144-d5 | 500 μg | 686 |
| Cayman2015 | 11773 | UR-144 N-pentanoic acid metabolite | 1 mg | 1330 |
| Cayman2015 | 11773 | UR-144 N-pentanoic acid metabolite | 10 mg | 4900 |
| Cayman2015 | 11773 | UR-144 N-pentanoic acid metabolite | 5 mg | 3150 |
| Cayman2015 | 11774 | (±)-UR-144 N-(4-hydroxypentyl) metabolite | 1 mg | 1330 |
| Cayman2015 | 11774 | (±)-UR-144 N-(4-hydroxypentyl) metabolite | 10 mg | 4900 |
| Cayman2015 | 11774 | (±)-UR-144 N-(4-hydroxypentyl) metabolite | 5 mg | 3150 |
| Cayman2015 | 11775 | UR-144 N-(5-hydroxypentyl) metabolite | 1 mg | 1330 |
| Cayman2015 | 11775 | UR-144 N-(5-hydroxypentyl) metabolite | 10 mg | 4900 |
| Cayman2015 | 11775 | UR-144 N-(5-hydroxypentyl) metabolite | 5 mg | 3150 |
| Cayman2015 | 11776 | UR-144 N-(5-hydroxypentyl) β-D-Glucuronide | 1 mg | 2646 |
| Cayman2015 | 11776 | UR-144 N-(5-hydroxypentyl) β-D-Glucuronide | 500 μg | 1330 |
| Cayman2015 | 11777 | KML29 | 10 mg | 1274 |
| Cayman2015 | 11777 | KML29 | 100 mg | 9408 |
| Cayman2015 | 11777 | KML29 | 5 mg | 672 |
| Cayman2015 | 11777 | KML29 | 50 mg | 5376 |
| Cayman2015 | 11778 | MAM2201 N-(4-hydroxypentyl) metabolite | 1 mg | 5460 |
| Cayman2015 | 11778 | MAM2201 N-(4-hydroxypentyl) metabolite | 100 μg | 910 |
| Cayman2015 | 11778 | MAM2201 N-(4-hydroxypentyl) metabolite | 500 μg | 3416 |
| Cayman2015 | 11779 | MAM2201 N-pentanoic acid metabolite | 1 mg | 1330 |
| Cayman2015 | 11779 | MAM2201 N-pentanoic acid metabolite | 10 mg | 4900 |
| Cayman2015 | 11779 | MAM2201 N-pentanoic acid metabolite | 5 mg | 3150 |
| Cayman2015 | 11780 | MAM2201 N-(2-fluoropentyl) isomer | 1 mg | 3136 |
| Cayman2015 | 11780 | MAM2201 N-(2-fluoropentyl) isomer | 100 μg | 448 |
| Cayman2015 | 11780 | MAM2201 N-(2-fluoropentyl) isomer | 500 μg | 1988 |
| Cayman2015 | 11781 | MAM2201 N-(3-fluoropentyl) isomer | 1 mg | 3136 |
| Cayman2015 | 11781 | MAM2201 N-(3-fluoropentyl) isomer | 100 μg | 448 |
| Cayman2015 | 11781 | MAM2201 N-(3-fluoropentyl) isomer | 500 μg | 1988 |
| Cayman2015 | 11782 | MAM2201 N-(4-fluoropentyl) isomer | 1 mg | 3528 |
| Cayman2015 | 11782 | MAM2201 N-(4-fluoropentyl) isomer | 100 μg | 784 |
| Cayman2015 | 11782 | MAM2201 N-(4-fluoropentyl) isomer | 500 μg | 2156 |
| Cayman2015 | 11784 | JWH 122 N-(4-hydroxypentyl) metabolite | 1 mg | 1330 |
| Cayman2015 | 11784 | JWH 122 N-(4-hydroxypentyl) metabolite | 10 mg | 4900 |
| Cayman2015 | 11784 | JWH 122 N-(4-hydroxypentyl) metabolite | 5 mg | 3150 |
| Cayman2015 | 11787 | BRD4770 | 1 mg | 350 |
| Cayman2015 | 11787 | BRD4770 | 10 mg | 1932 |
| Cayman2015 | 11787 | BRD4770 | 25 mg | 4382 |
| Cayman2015 | 11787 | BRD4770 | 5 mg | 1050 |
| Cayman2015 | 11789 | JW 642 | 10 mg | 1218 |
| Cayman2015 | 11789 | JW 642 | 100 mg | 9016 |
| Cayman2015 | 11789 | JW 642 | 5 mg | 644 |
| Cayman2015 | 11789 | JW 642 | 50 mg | 5152 |
| Cayman2015 | 11790 | JW 618 | 10 mg | 1218 |
| Cayman2015 | 11790 | JW 618 | 25 mg | 2898 |
| Cayman2015 | 11790 | JW 618 | 5 mg | 644 |
| Cayman2015 | 11790 | JW 618 | 50 mg | 5152 |
| Cayman2015 | 11791 | Vitamin D2 | 1 g | 266 |
| Cayman2015 | 11791 | Vitamin D2 | 10 g | 2128 |
| Cayman2015 | 11791 | Vitamin D2 | 5 g | 1204 |
| Cayman2015 | 11792 | Vitamin D3 | 1 g | 350 |
| Cayman2015 | 11792 | Vitamin D3 | 10 g | 1932 |
| Cayman2015 | 11792 | Vitamin D3 | 5 g | 1050 |
| Cayman2015 | 11793 | SB 505124 | 1 mg | 252 |
| Cayman2015 | 11793 | SB 505124 | 10 mg | 2016 |
| Cayman2015 | 11793 | SB 505124 | 25 mg | 4102 |
| Cayman2015 | 11793 | SB 505124 | 5 mg | 1134 |
| Cayman2015 | 11799 | Oxytocin | 1 mg | 532 |
| Cayman2015 | 11799 | Oxytocin | 10 mg | 3192 |
| Cayman2015 | 11799 | Oxytocin | 25 mg | 7210 |
| Cayman2015 | 11799 | Oxytocin | 5 mg | 2128 |
| Cayman2015 | 11800 | 6α-Methylprednisolone 21-hemisuccinate | 10 mg | 266 |
| Cayman2015 | 11800 | 6α-Methylprednisolone 21-hemisuccinate | 100 mg | 2128 |
| Cayman2015 | 11800 | 6α-Methylprednisolone 21-hemisuccinate | 25 mg | 630 |
| Cayman2015 | 11800 | 6α-Methylprednisolone 21-hemisuccinate | 50 mg | 1204 |
| Cayman2015 | 11801 | ML-7 (hydrochloride) | 1 mg | 350 |
| Cayman2015 | 11801 | ML-7 (hydrochloride) | 10 mg | 1470 |
| Cayman2015 | 11801 | ML-7 (hydrochloride) | 5 mg | 994 |
| Cayman2015 | 11801 | ML-7 (hydrochloride) | 50 mg | 4130 |
| Cayman2015 | 11802 | LDN193189 | 1 mg | 490 |
| Cayman2015 | 11802 | LDN193189 | 10 mg | 2940 |
| Cayman2015 | 11802 | LDN193189 | 5 mg | 1960 |
| Cayman2015 | 11803 | 5-hydroxy DMT (hydrochloride) | 10 mg | 952 |
| Cayman2015 | 11803 | 5-hydroxy DMT (hydrochloride) | 25 mg | 2310 |
| Cayman2015 | 11803 | 5-hydroxy DMT (hydrochloride) | 5 mg | 616 |
| Cayman2015 | 11807 | (-)-Epicatechin | 1 mg | 350 |
| Cayman2015 | 11807 | (-)-Epicatechin | 10 mg | 1932 |
| Cayman2015 | 11807 | (-)-Epicatechin | 25 mg | 3934 |
| Cayman2015 | 11807 | (-)-Epicatechin | 5 mg | 1232 |
| Cayman2015 | 11808 | (-)-Epicatechin Gallate | 1 mg | 350 |
| Cayman2015 | 11808 | (-)-Epicatechin Gallate | 10 mg | 2086 |
| Cayman2015 | 11808 | (-)-Epicatechin Gallate | 25 mg | 3486 |
| Cayman2015 | 11808 | (-)-Epicatechin Gallate | 5 mg | 1134 |
| Cayman2015 | 11809 | (-)-Epigallocatechin | 1 mg | 350 |
| Cayman2015 | 11809 | (-)-Epigallocatechin | 10 mg | 1750 |
| Cayman2015 | 11809 | (-)-Epigallocatechin | 25 mg | 3934 |
| Cayman2015 | 11809 | (-)-Epigallocatechin | 5 mg | 1134 |
| Cayman2015 | 11811 | INK128 | 1 mg | 406 |
| Cayman2015 | 11811 | INK128 | 10 mg | 3248 |
| Cayman2015 | 11811 | INK128 | 5 mg | 1834 |
| Cayman2015 | 11815 | Artemether | 1 g | 1330 |
| Cayman2015 | 11815 | Artemether | 500 mg | 910 |
| Cayman2015 | 11816 | Artemisinin | 1 g | 2464 |
| Cayman2015 | 11816 | Artemisinin | 100 mg | 546 |
| Cayman2015 | 11816 | Artemisinin | 500 mg | 1302 |
| Cayman2015 | 11817 | Artesunate | 1 g | 4410 |
| Cayman2015 | 11817 | Artesunate | 100 mg | 700 |
| Cayman2015 | 11817 | Artesunate | 250 mg | 1260 |
| Cayman2015 | 11817 | Artesunate | 500 mg | 2450 |
| Cayman2015 | 11818 | Asiatic Acid | 10 mg | 1470 |
| Cayman2015 | 11818 | Asiatic Acid | 100 mg | 5152 |
| Cayman2015 | 11818 | Asiatic Acid | 50 mg | 3570 |
| Cayman2015 | 11819 | Asiaticoside | 10 mg | 1470 |
| Cayman2015 | 11819 | Asiaticoside | 50 mg | 5940 |
| Cayman2015 | 11826 | Kartogenin | 10 mg | 1330 |
| Cayman2015 | 11826 | Kartogenin | 25 mg | 2982 |
| Cayman2015 | 11826 | Kartogenin | 5 mg | 700 |
| Cayman2015 | 11832 | Corilagin | 1 mg | 350 |
| Cayman2015 | 11832 | Corilagin | 10 mg | 2800 |
| Cayman2015 | 11832 | Corilagin | 25 mg | 5250 |
| Cayman2015 | 11832 | Corilagin | 5 mg | 1582 |
| Cayman2015 | 11838 | Embelin | 10 mg | 770 |
| Cayman2015 | 11838 | Embelin | 100 mg | 6160 |
| Cayman2015 | 11838 | Embelin | 50 mg | 3472 |
| Cayman2015 | 11845 | β-Glycyrrhetinic Acid | 1 g | 350 |
| Cayman2015 | 11845 | β-Glycyrrhetinic Acid | 10 g | 1232 |
| Cayman2015 | 11845 | β-Glycyrrhetinic Acid | 5 g | 672 |
| Cayman2015 | 11846 | Gallic Acid | 10 g | 350 |
| Cayman2015 | 11846 | Gallic Acid | 100 g | 882 |
| Cayman2015 | 11846 | Gallic Acid | 50 g | 616 |
| Cayman2015 | 11852 | Kaempferol | 100 mg | 1918 |
| Cayman2015 | 11852 | Kaempferol | 25 mg | 532 |
| Cayman2015 | 11852 | Kaempferol | 50 mg | 1008 |
| Cayman2015 | 11859 | Prostaglandin Transporter (C-Term) Blocking Peptide | 200 μg | 1498 |
| Cayman2015 | 11860 | Prostaglandin Transporter (C-Term) Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 11861 | Brefeldin A | 10 mg | 700 |
| Cayman2015 | 11861 | Brefeldin A | 25 mg | 1330 |
| Cayman2015 | 11861 | Brefeldin A | 5 mg | 490 |
| Cayman2015 | 11862 | 4-MTA (hydrochloride) | 1 mg | 392 |
| Cayman2015 | 11862 | 4-MTA (hydrochloride) | 10 mg | 1246 |
| Cayman2015 | 11862 | 4-MTA (hydrochloride) | 5 mg | 672 |
| Cayman2015 | 11864 | 4-hydroxy DMT | 10 mg | 1484 |
| Cayman2015 | 11864 | 4-hydroxy DMT | 25 mg | 3528 |
| Cayman2015 | 11864 | 4-hydroxy DMT | 5 mg | 784 |
| Cayman2015 | 11865 | 5-methoxy DiPT | 10 mg | 952 |
| Cayman2015 | 11865 | 5-methoxy DiPT | 25 mg | 2310 |
| Cayman2015 | 11865 | 5-methoxy DiPT | 5 mg | 616 |
| Cayman2015 | 11866 | Prion Protein Monoclonal Antibody (Clone SHA31) | 1 ea | 4130 |
| Cayman2015 | 11871 | FK506 Binding Protein-12 (human recombinant) | 100 μg | 2625 |
| Cayman2015 | 11871 | FK506 Binding Protein-12 (human recombinant) | 200 μg | 4200 |
| Cayman2015 | 11871 | FK506 Binding Protein-12 (human recombinant) | 50 μg | 1470 |
| Cayman2015 | 11877 | AB-005 azepane isomer | 1 mg | 910 |
| Cayman2015 | 11877 | AB-005 azepane isomer | 10 mg | 7280 |
| Cayman2015 | 11877 | AB-005 azepane isomer | 5 mg | 4102 |
| Cayman2015 | 11878 | Salicylcurcumin | 1 mg | 910 |
| Cayman2015 | 11878 | Salicylcurcumin | 10 mg | 7280 |
| Cayman2015 | 11878 | Salicylcurcumin | 5 mg | 4102 |
| Cayman2015 | 11879 | 2-HBA | 10 mg | 1386 |
| Cayman2015 | 11879 | 2-HBA | 5 mg | 728 |
| Cayman2015 | 11879 | 2-HBA | 50 mg | 5824 |
| Cayman2015 | 11880 | Ferulic Acid ethyl ester | 1 g | 686 |
| Cayman2015 | 11880 | Ferulic Acid ethyl ester | 10 g | 5488 |
| Cayman2015 | 11880 | Ferulic Acid ethyl ester | 5 g | 3094 |
| Cayman2015 | 11881 | 2-Trifluoromethyl-2'-methoxychalcone | 10 mg | 1204 |
| Cayman2015 | 11881 | 2-Trifluoromethyl-2'-methoxychalcone | 100 mg | 8820 |
| Cayman2015 | 11881 | 2-Trifluoromethyl-2'-methoxychalcone | 5 mg | 630 |
| Cayman2015 | 11881 | 2-Trifluoromethyl-2'-methoxychalcone | 50 mg | 5040 |
| Cayman2015 | 11882 | Sofalcone | 100 mg | 546 |
| Cayman2015 | 11882 | Sofalcone | 250 mg | 1302 |
| Cayman2015 | 11882 | Sofalcone | 500 mg | 2464 |
| Cayman2015 | 11883 | CDDO methyl ester | 1 mg | 336 |
| Cayman2015 | 11883 | CDDO methyl ester | 10 mg | 2352 |
| Cayman2015 | 11883 | CDDO methyl ester | 5 mg | 1344 |
| Cayman2015 | 11883 | CDDO methyl ester | 50 mg | 4032 |
| Cayman2015 | 11884 | Rosiglitazone Maleate | 1 g | 3052 |
| Cayman2015 | 11884 | Rosiglitazone Maleate | 100 mg | 1050 |
| Cayman2015 | 11884 | Rosiglitazone Maleate | 500 mg | 2044 |
| Cayman2015 | 11888 | 2C-D (hydrochloride) | 10 mg | 952 |
| Cayman2015 | 11888 | 2C-D (hydrochloride) | 5 mg | 616 |
| Cayman2015 | 11888 | 2C-D (hydrochloride) | 50 mg | 3696 |
| Cayman2015 | 11889 | 2C-H (hydrochloride) | 10 mg | 952 |
| Cayman2015 | 11889 | 2C-H (hydrochloride) | 5 mg | 616 |
| Cayman2015 | 11889 | 2C-H (hydrochloride) | 50 mg | 3696 |
| Cayman2015 | 11890 | 2C-N | 10 mg | 952 |
| Cayman2015 | 11890 | 2C-N | 5 mg | 616 |
| Cayman2015 | 11890 | 2C-N | 50 mg | 3696 |
| Cayman2015 | 11891 | 2C-T-2 (hydrochloride) | 10 mg | 952 |
| Cayman2015 | 11891 | 2C-T-2 (hydrochloride) | 5 mg | 616 |
| Cayman2015 | 11891 | 2C-T-2 (hydrochloride) | 50 mg | 3696 |
| Cayman2015 | 11892 | 2C-T-4 (hydrochloride) | 10 mg | 952 |
| Cayman2015 | 11892 | 2C-T-4 (hydrochloride) | 5 mg | 616 |
| Cayman2015 | 11892 | 2C-T-4 (hydrochloride) | 50 mg | 3696 |
| Cayman2015 | 11896 | Pyripyropene A | 1 mg | 4800 |
| Cayman2015 | 11896 | Pyripyropene A | 250 μg | 1335 |
| Cayman2015 | 11898 | Atpenin A5 | 1 mg | 4710 |
| Cayman2015 | 11898 | Atpenin A5 | 250 μg | 1470 |
| Cayman2015 | 11899 | Hymeglusin | 1 mg | 3075 |
| Cayman2015 | 11899 | Hymeglusin | 2.5 mg | 6480 |
| Cayman2015 | 11899 | Hymeglusin | 500 μg | 1620 |
| Cayman2015 | 11900 | A-769662 | 10 mg | 2198 |
| Cayman2015 | 11900 | A-769662 | 5 mg | 1372 |
| Cayman2015 | 11900 | A-769662 | 50 mg | 6174 |
| Cayman2015 | 11902 | Stevioside (hydrate) | 10 mg | 840 |
| Cayman2015 | 11902 | Stevioside (hydrate) | 25 mg | 1965 |
| Cayman2015 | 11902 | Stevioside (hydrate) | 5 mg | 525 |
| Cayman2015 | 11902 | Stevioside (hydrate) | 50 mg | 3420 |
| Cayman2015 | 11908 | GQ-16 | 10 mg | 672 |
| Cayman2015 | 11908 | GQ-16 | 100 mg | 4900 |
| Cayman2015 | 11908 | GQ-16 | 5 mg | 350 |
| Cayman2015 | 11908 | GQ-16 | 50 mg | 2800 |
| Cayman2015 | 11910 | 19(R)-hydroxy Prostaglandin B2 | 100 μg | 1302 |
| Cayman2015 | 11910 | 19(R)-hydroxy Prostaglandin B2 | 50 μg | 686 |
| Cayman2015 | 11910 | 19(R)-hydroxy Prostaglandin B2 | 500 μg | 5488 |
| Cayman2015 | 11911 | Salsalate | 100 g | 1764 |
| Cayman2015 | 11911 | Salsalate | 25 g | 490 |
| Cayman2015 | 11911 | Salsalate | 50 g | 938 |
| Cayman2015 | 11912 | AP-18 | 10 mg | 952 |
| Cayman2015 | 11912 | AP-18 | 25 mg | 2212 |
| Cayman2015 | 11912 | AP-18 | 5 mg | 630 |
| Cayman2015 | 11912 | AP-18 | 50 mg | 3780 |
| Cayman2015 | 11913 | (S)-Mephenytoin | 1 mg | 364 |
| Cayman2015 | 11913 | (S)-Mephenytoin | 10 mg | 1638 |
| Cayman2015 | 11913 | (S)-Mephenytoin | 25 mg | 3640 |
| Cayman2015 | 11913 | (S)-Mephenytoin | 5 mg | 910 |
| Cayman2015 | 11914 | SAG | 1 mg | 1232 |
| Cayman2015 | 11914 | SAG | 10 mg | 9856 |
| Cayman2015 | 11914 | SAG | 5 mg | 5544 |
| Cayman2015 | 11915 | Benzedrone (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 11915 | Benzedrone (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 11915 | Benzedrone (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 11916 | EAM2201 | 10 mg | 1960 |
| Cayman2015 | 11916 | EAM2201 | 25 mg | 4172 |
| Cayman2015 | 11916 | EAM2201 | 50 mg | 7350 |
| Cayman2015 | 11917 | BAZ2B bromodomain (human recombinant) | 100 μg | 3990 |
| Cayman2015 | 11917 | BAZ2B bromodomain (human recombinant) | 25 μg | 1330 |
| Cayman2015 | 11917 | BAZ2B bromodomain (human recombinant) | 50 μg | 2394 |
| Cayman2015 | 11918 | BPTF bromodomain (human recombinant) | 100 μg | 3990 |
| Cayman2015 | 11918 | BPTF bromodomain (human recombinant) | 25 μg | 1330 |
| Cayman2015 | 11918 | BPTF bromodomain (human recombinant) | 50 μg | 2394 |
| Cayman2015 | 11919 | ORC1 BAH domain (human recombinant) | 100 μg | 5236 |
| Cayman2015 | 11919 | ORC1 BAH domain (human recombinant) | 25 μg | 1750 |
| Cayman2015 | 11919 | ORC1 BAH domain (human recombinant) | 50 μg | 2772 |
| Cayman2015 | 11920 | PCAF bromodomain (human recombinant) | 100 μg | 3990 |
| Cayman2015 | 11920 | PCAF bromodomain (human recombinant) | 25 μg | 1330 |
| Cayman2015 | 11920 | PCAF bromodomain (human recombinant) | 50 μg | 2394 |
| Cayman2015 | 11922 | TAF1 bromodomain 1 (human recombinant) | 100 μg | 3990 |
| Cayman2015 | 11922 | TAF1 bromodomain 1 (human recombinant) | 25 μg | 1330 |
| Cayman2015 | 11922 | TAF1 bromodomain 1 (human recombinant) | 50 μg | 2394 |
| Cayman2015 | 11923 | HC-030031 | 10 mg | 686 |
| Cayman2015 | 11923 | HC-030031 | 5 mg | 406 |
| Cayman2015 | 11923 | HC-030031 | 50 mg | 2030 |
| Cayman2015 | 11928 | UR-144 Degradant | 1 mg | 1330 |
| Cayman2015 | 11928 | UR-144 Degradant | 10 mg | 6650 |
| Cayman2015 | 11928 | UR-144 Degradant | 5 mg | 3654 |
| Cayman2015 | 11931 | GSK 4112 | 10 mg | 1302 |
| Cayman2015 | 11931 | GSK 4112 | 25 mg | 3094 |
| Cayman2015 | 11931 | GSK 4112 | 5 mg | 686 |
| Cayman2015 | 11931 | GSK 4112 | 50 mg | 5488 |
| Cayman2015 | 11932 | Ionomycin (calcium salt) | 1 mg | 238 |
| Cayman2015 | 11932 | Ionomycin (calcium salt) | 10 mg | 1680 |
| Cayman2015 | 11932 | Ionomycin (calcium salt) | 5 mg | 938 |
| Cayman2015 | 11937 | Olanzapine | 100 mg | 938 |
| Cayman2015 | 11937 | Olanzapine | 25 mg | 350 |
| Cayman2015 | 11937 | Olanzapine | 50 mg | 532 |
| Cayman2015 | 11943 | Activated SureLight? Allophycocyanin (APC) | 1 ea | 900 |
| Cayman2015 | 11944 | Activated SureLight? R-Phycoerythrin (RPE) | 1 ea | 1110 |
| Cayman2015 | 11946 | 25D-NBOMe (hydrochloride) | 1 mg | 350 |
| Cayman2015 | 11946 | 25D-NBOMe (hydrochloride) | 10 mg | 1330 |
| Cayman2015 | 11946 | 25D-NBOMe (hydrochloride) | 5 mg | 966 |
| Cayman2015 | 11946 | 25D-NBOMe (hydrochloride) | 50 mg | 3850 |
| Cayman2015 | 11947 | 25I-NBMD (hydrochloride) | 1 mg | 784 |
| Cayman2015 | 11947 | 25I-NBMD (hydrochloride) | 10 mg | 6272 |
| Cayman2015 | 11947 | 25I-NBMD (hydrochloride) | 5 mg | 3528 |
| Cayman2015 | 11950 | Mescaline (hydrochloride) | 10 mg | 868 |
| Cayman2015 | 11950 | Mescaline (hydrochloride) | 5 mg | 546 |
| Cayman2015 | 11950 | Mescaline (hydrochloride) | 50 mg | 3822 |
| Cayman2015 | 11951 | UR-144 N-(5-chloropentyl) analog | 1 mg | 910 |
| Cayman2015 | 11951 | UR-144 N-(5-chloropentyl) analog | 10 mg | 7280 |
| Cayman2015 | 11951 | UR-144 N-(5-chloropentyl) analog | 5 mg | 4102 |
| Cayman2015 | 11952 | Irbesartan | 10 mg | 490 |
| Cayman2015 | 11952 | Irbesartan | 100 mg | 3920 |
| Cayman2015 | 11952 | Irbesartan | 50 mg | 2212 |
| Cayman2015 | 11957 | JWH 307 5'-isomer | 1 mg | 686 |
| Cayman2015 | 11957 | JWH 307 5'-isomer | 10 mg | 5488 |
| Cayman2015 | 11957 | JWH 307 5'-isomer | 5 mg | 3094 |
| Cayman2015 | 11959 | AMD 3465 (hydrobromide) | 10 mg | 2072 |
| Cayman2015 | 11959 | AMD 3465 (hydrobromide) | 25 mg | 4648 |
| Cayman2015 | 11959 | AMD 3465 (hydrobromide) | 5 mg | 1092 |
| Cayman2015 | 11960 | FC 131 | 1 mg | 1386 |
| Cayman2015 | 11960 | FC 131 | 10 mg | 11088 |
| Cayman2015 | 11960 | FC 131 | 5 mg | 6244 |
| Cayman2015 | 11962 | THJ 018 | 1 mg | 910 |
| Cayman2015 | 11962 | THJ 018 | 10 mg | 7280 |
| Cayman2015 | 11962 | THJ 018 | 5 mg | 4102 |
| Cayman2015 | 11963 | INCB 3284 (dimesylate) | 1 mg | 392 |
| Cayman2015 | 11963 | INCB 3284 (dimesylate) | 10 mg | 1316 |
| Cayman2015 | 11963 | INCB 3284 (dimesylate) | 5 mg | 1064 |
| Cayman2015 | 11963 | INCB 3284 (dimesylate) | 50 mg | 6160 |
| Cayman2015 | 11966 | cis-2-Decenoic Acid | 1 mg | 280 |
| Cayman2015 | 11966 | cis-2-Decenoic Acid | 10 mg | 1344 |
| Cayman2015 | 11966 | cis-2-Decenoic Acid | 25 mg | 2520 |
| Cayman2015 | 11966 | cis-2-Decenoic Acid | 5 mg | 896 |
| Cayman2015 | 11967 | Dorsomorphin | 10 mg | 1736 |
| Cayman2015 | 11967 | Dorsomorphin | 5 mg | 910 |
| Cayman2015 | 11967 | Dorsomorphin | 50 mg | 5460 |
| Cayman2015 | 11968 | 25I-NBOMe imine analog | 1 mg | 784 |
| Cayman2015 | 11968 | 25I-NBOMe imine analog | 10 mg | 6272 |
| Cayman2015 | 11968 | 25I-NBOMe imine analog | 5 mg | 3528 |
| Cayman2015 | 11969 | (+)-Etomoxir (sodium salt) | 10 mg | 1792 |
| Cayman2015 | 11969 | (+)-Etomoxir (sodium salt) | 25 mg | 4172 |
| Cayman2015 | 11969 | (+)-Etomoxir (sodium salt) | 5 mg | 1190 |
| Cayman2015 | 11969 | (+)-Etomoxir (sodium salt) | 50 mg | 7140 |
| Cayman2015 | 11970 | Octyl-α-ketoglutarate | 1 mg | 532 |
| Cayman2015 | 11970 | Octyl-α-ketoglutarate | 10 mg | 4256 |
| Cayman2015 | 11970 | Octyl-α-ketoglutarate | 5 mg | 2394 |
| Cayman2015 | 11971 | JWH 412 | 1 mg | 910 |
| Cayman2015 | 11971 | JWH 412 | 10 mg | 7280 |
| Cayman2015 | 11971 | JWH 412 | 5 mg | 4102 |
| Cayman2015 | 11972 | SR 2211 | 1 mg | 546 |
| Cayman2015 | 11972 | SR 2211 | 10 mg | 3556 |
| Cayman2015 | 11972 | SR 2211 | 5 mg | 1918 |
| Cayman2015 | 11973 | Triptolide | 1 mg | 336 |
| Cayman2015 | 11973 | Triptolide | 10 mg | 2016 |
| Cayman2015 | 11973 | Triptolide | 5 mg | 1344 |
| Cayman2015 | 11974 | TC 14012 | 1 mg | 1386 |
| Cayman2015 | 11974 | TC 14012 | 10 mg | 11088 |
| Cayman2015 | 11974 | TC 14012 | 5 mg | 6244 |
| Cayman2015 | 11975 | Fingolimod | 10 mg | 1176 |
| Cayman2015 | 11975 | Fingolimod | 25 mg | 2772 |
| Cayman2015 | 11975 | Fingolimod | 5 mg | 616 |
| Cayman2015 | 11975 | Fingolimod | 50 mg | 4928 |
| Cayman2015 | 11976 | Apocynin | 1 g | 448 |
| Cayman2015 | 11976 | Apocynin | 10 g | 3584 |
| Cayman2015 | 11976 | Apocynin | 5 g | 2016 |
| Cayman2015 | 11977 | RCS-4 M9 metabolite | 1 mg | 1330 |
| Cayman2015 | 11977 | RCS-4 M9 metabolite | 10 mg | 4900 |
| Cayman2015 | 11977 | RCS-4 M9 metabolite | 5 mg | 3150 |
| Cayman2015 | 11978 | RCS-4 M10 metabolite | 1 mg | 1330 |
| Cayman2015 | 11978 | RCS-4 M10 metabolite | 10 mg | 4900 |
| Cayman2015 | 11978 | RCS-4 M10 metabolite | 5 mg | 3150 |
| Cayman2015 | 11979 | RCS-4 M11 metabolite | 1 mg | 1330 |
| Cayman2015 | 11979 | RCS-4 M11 metabolite | 10 mg | 4900 |
| Cayman2015 | 11979 | RCS-4 M11 metabolite | 5 mg | 3150 |
| Cayman2015 | 11981 | Pramipexole (hydrochloride) | 10 mg | 560 |
| Cayman2015 | 11981 | Pramipexole (hydrochloride) | 100 mg | 1610 |
| Cayman2015 | 11981 | Pramipexole (hydrochloride) | 5 mg | 350 |
| Cayman2015 | 11981 | Pramipexole (hydrochloride) | 50 mg | 1050 |
| Cayman2015 | 11984 | Sumanirole Maleate | 1 mg | 336 |
| Cayman2015 | 11984 | Sumanirole Maleate | 10 mg | 2016 |
| Cayman2015 | 11984 | Sumanirole Maleate | 5 mg | 1344 |
| Cayman2015 | 11986 | Biphenylindanone A | 10 mg | 2100 |
| Cayman2015 | 11986 | Biphenylindanone A | 25 mg | 4914 |
| Cayman2015 | 11986 | Biphenylindanone A | 5 mg | 1190 |
| Cayman2015 | 11987 | Anastrozole | 10 mg | 630 |
| Cayman2015 | 11987 | Anastrozole | 100 mg | 2086 |
| Cayman2015 | 11987 | Anastrozole | 50 mg | 1386 |
| Cayman2015 | 11988 | Cinnabarinic Acid | 10 mg | 1330 |
| Cayman2015 | 11988 | Cinnabarinic Acid | 50 mg | 5992 |
| Cayman2015 | 11989 | NPS 2390 | 10 mg | 1918 |
| Cayman2015 | 11989 | NPS 2390 | 25 mg | 4536 |
| Cayman2015 | 11989 | NPS 2390 | 5 mg | 1008 |
| Cayman2015 | 11990 | Prostaglandin B3 | 100 μg | 3360 |
| Cayman2015 | 11990 | Prostaglandin B3 | 25 μg | 1106 |
| Cayman2015 | 11990 | Prostaglandin B3 | 50 μg | 1820 |
| Cayman2015 | 11991 | Ro 01-6128 | 1 mg | 350 |
| Cayman2015 | 11991 | Ro 01-6128 | 10 mg | 1176 |
| Cayman2015 | 11991 | Ro 01-6128 | 5 mg | 784 |
| Cayman2015 | 11992 | Ro 67-4853 | 1 mg | 350 |
| Cayman2015 | 11992 | Ro 67-4853 | 10 mg | 1050 |
| Cayman2015 | 11992 | Ro 67-4853 | 5 mg | 672 |
| Cayman2015 | 11995 | VU0360223 | 1 mg | 350 |
| Cayman2015 | 11995 | VU0360223 | 10 mg | 1470 |
| Cayman2015 | 11995 | VU0360223 | 5 mg | 1050 |
| Cayman2015 | 11995 | VU0360223 | 50 mg | 5950 |
| Cayman2015 | 11998 | JNJ-5207852 | 10 mg | 1918 |
| Cayman2015 | 11998 | JNJ-5207852 | 5 mg | 1008 |
| Cayman2015 | 11998 | JNJ-5207852 | 50 mg | 8064 |
| Cayman2015 | 11999 | Olopatadine (hydrochloride) | 10 mg | 406 |
| Cayman2015 | 11999 | Olopatadine (hydrochloride) | 100 mg | 2436 |
| Cayman2015 | 11999 | Olopatadine (hydrochloride) | 25 mg | 910 |
| Cayman2015 | 11999 | Olopatadine (hydrochloride) | 50 mg | 1624 |
| Cayman2015 | 12000 | Prostaglandin D1 | 1 mg | 714 |
| Cayman2015 | 12000 | Prostaglandin D1 | 10 mg | 5712 |
| Cayman2015 | 12000 | Prostaglandin D1 | 5 mg | 3220 |
| Cayman2015 | 12001 | 3-Methylbuphedrone (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 12001 | 3-Methylbuphedrone (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 12001 | 3-Methylbuphedrone (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 12002 | Prostaglandin D1 Alcohol | 1 mg | 714 |
| Cayman2015 | 12002 | Prostaglandin D1 Alcohol | 10 mg | 5712 |
| Cayman2015 | 12002 | Prostaglandin D1 Alcohol | 5 mg | 3220 |
| Cayman2015 | 12003 | UR-144 N-(5-bromopentyl) analog | 1 mg | 910 |
| Cayman2015 | 12003 | UR-144 N-(5-bromopentyl) analog | 10 mg | 7280 |
| Cayman2015 | 12003 | UR-144 N-(5-bromopentyl) analog | 5 mg | 4102 |
| Cayman2015 | 12004 | 3,4-Methylenedioxy Pyrovalerone metabolite 2 (hydrochloride) | 1 mg | 1330 |
| Cayman2015 | 12004 | 3,4-Methylenedioxy Pyrovalerone metabolite 2 (hydrochloride) | 10 mg | 4900 |
| Cayman2015 | 12004 | 3,4-Methylenedioxy Pyrovalerone metabolite 2 (hydrochloride) | 5 mg | 3150 |
| Cayman2015 | 12005 | Lisdexamfetamine (hydrochloride) | 10 mg | 1484 |
| Cayman2015 | 12005 | Lisdexamfetamine (hydrochloride) | 25 mg | 3528 |
| Cayman2015 | 12005 | Lisdexamfetamine (hydrochloride) | 5 mg | 784 |
| Cayman2015 | 12006 | Rottlerin | 10 mg | 686 |
| Cayman2015 | 12006 | Rottlerin | 50 mg | 3094 |
| Cayman2015 | 12008 | Atropine | 1 g | 420 |
| Cayman2015 | 12008 | Atropine | 500 mg | 266 |
| Cayman2015 | 12010 | Prostaglandin D2 | 1 mg | 504 |
| Cayman2015 | 12010 | Prostaglandin D2 | 10 mg | 4032 |
| Cayman2015 | 12010 | Prostaglandin D2 | 5 mg | 2268 |
| Cayman2015 | 12010 | Prostaglandin D2 | 50 mg | 17640 |
| Cayman2015 | 12011 | 8-CPT-Cyclic AMP (sodium salt) | 10 mg | 630 |
| Cayman2015 | 12011 | 8-CPT-Cyclic AMP (sodium salt) | 25 mg | 1176 |
| Cayman2015 | 12011 | 8-CPT-Cyclic AMP (sodium salt) | 50 mg | 2212 |
| Cayman2015 | 120111 | BLT1 Receptor Monoclonal Antibody (Clone 7B1) | 1 ea | 3206 |
| Cayman2015 | 120112 | BLT1 Receptor Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 120114 | BLT1 Receptor Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 12012 | Prostaglandin D2 Ethanolamide | 1 mg | 938 |
| Cayman2015 | 12012 | Prostaglandin D2 Ethanolamide | 10 mg | 8442 |
| Cayman2015 | 12012 | Prostaglandin D2 Ethanolamide | 5 mg | 4452 |
| Cayman2015 | 120124 | BLT2 Receptor Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 12013 | Dihydroethidium | 10 mg | 574 |
| Cayman2015 | 12013 | Dihydroethidium | 25 mg | 1288 |
| Cayman2015 | 12013 | Dihydroethidium | 5 mg | 322 |
| Cayman2015 | 12014 | Haloperidol | 100 mg | 350 |
| Cayman2015 | 12014 | Haloperidol | 500 mg | 882 |
| Cayman2015 | 12015 | Prostaglandin D2-1-glyceryl ester | 1 mg | 1008 |
| Cayman2015 | 12015 | Prostaglandin D2-1-glyceryl ester | 10 mg | 8064 |
| Cayman2015 | 12015 | Prostaglandin D2-1-glyceryl ester | 5 mg | 4536 |
| Cayman2015 | 12018 | PF-8380 | 1 mg | 532 |
| Cayman2015 | 12018 | PF-8380 | 10 mg | 1932 |
| Cayman2015 | 12018 | PF-8380 | 25 mg | 4816 |
| Cayman2015 | 12018 | PF-8380 | 5 mg | 1484 |
| Cayman2015 | 12020 | JWH 387 | 1 mg | 910 |
| Cayman2015 | 12020 | JWH 387 | 10 mg | 7280 |
| Cayman2015 | 12020 | JWH 387 | 5 mg | 4102 |
| Cayman2015 | 12021 | SUMO Monoclonal Antibody | 500 μg | 2786 |
| Cayman2015 | 12022 | (-)-WIN 55,212-3 (mesylate) | 10 mg | 882 |
| Cayman2015 | 12022 | (-)-WIN 55,212-3 (mesylate) | 25 mg | 2086 |
| Cayman2015 | 12022 | (-)-WIN 55,212-3 (mesylate) | 5 mg | 462 |
| Cayman2015 | 12022 | (-)-WIN 55,212-3 (mesylate) | 50 mg | 3696 |
| Cayman2015 | 12027 | OC000459 | 10 mg | 1316 |
| Cayman2015 | 12027 | OC000459 | 25 mg | 2702 |
| Cayman2015 | 12027 | OC000459 | 5 mg | 770 |
| Cayman2015 | 12028 | Oxyresveratrol | 100 mg | 2002 |
| Cayman2015 | 12028 | Oxyresveratrol | 50 mg | 1050 |
| Cayman2015 | 12028 | Oxyresveratrol | 500 mg | 8400 |
| Cayman2015 | 12029 | Rosuvastatin | 10 mg | 1106 |
| Cayman2015 | 12029 | Rosuvastatin | 100 mg | 6160 |
| Cayman2015 | 12029 | Rosuvastatin | 5 mg | 616 |
| Cayman2015 | 12029 | Rosuvastatin | 50 mg | 3696 |
| Cayman2015 | 12030 | Bosutinib | 10 mg | 742 |
| Cayman2015 | 12030 | Bosutinib | 100 mg | 4900 |
| Cayman2015 | 12030 | Bosutinib | 5 mg | 490 |
| Cayman2015 | 12030 | Bosutinib | 50 mg | 2940 |
| Cayman2015 | 12031 | BIM5078 | 10 mg | 1302 |
| Cayman2015 | 12031 | BIM5078 | 25 mg | 3094 |
| Cayman2015 | 12031 | BIM5078 | 5 mg | 686 |
| Cayman2015 | 12031 | BIM5078 | 50 mg | 5488 |
| Cayman2015 | 12032 | BI6015 | 10 mg | 1302 |
| Cayman2015 | 12032 | BI6015 | 5 mg | 686 |
| Cayman2015 | 12032 | BI6015 | 50 mg | 5488 |
| Cayman2015 | 12033 | Daminozide | 10 g | 406 |
| Cayman2015 | 12033 | Daminozide | 25 g | 952 |
| Cayman2015 | 12033 | Daminozide | 5 g | 252 |
| Cayman2015 | 12036 | AH 7921 | 1 mg | 686 |
| Cayman2015 | 12036 | AH 7921 | 10 mg | 5488 |
| Cayman2015 | 12036 | AH 7921 | 5 mg | 3094 |
| Cayman2015 | 12037 | MCOPPB (hydrochloride) | 1 mg | 350 |
| Cayman2015 | 12037 | MCOPPB (hydrochloride) | 10 mg | 2450 |
| Cayman2015 | 12037 | MCOPPB (hydrochloride) | 5 mg | 1372 |
| Cayman2015 | 12038 | 4-chloro-2,5-DMA (hydrochloride) | 1 mg | 686 |
| Cayman2015 | 12038 | 4-chloro-2,5-DMA (hydrochloride) | 10 mg | 2030 |
| Cayman2015 | 12038 | 4-chloro-2,5-DMA (hydrochloride) | 5 mg | 1330 |
| Cayman2015 | 12041 | 4-Methoxyamphetamine (hydrochloride) | 10 mg | 938 |
| Cayman2015 | 12041 | 4-Methoxyamphetamine (hydrochloride) | 5 mg | 490 |
| Cayman2015 | 12041 | 4-Methoxyamphetamine (hydrochloride) | 50 mg | 3920 |
| Cayman2015 | 12042 | 5-IT | 1 mg | 686 |
| Cayman2015 | 12042 | 5-IT | 10 mg | 5488 |
| Cayman2015 | 12042 | 5-IT | 5 mg | 3094 |
| Cayman2015 | 12046 | CID-2745687 | 10 mg | 1582 |
| Cayman2015 | 12046 | CID-2745687 | 25 mg | 3682 |
| Cayman2015 | 12046 | CID-2745687 | 5 mg | 1050 |
我们公司zui大优势是强大的采购，
1：基本什么都能进口，血清，抗体，耗材，还有部分限制进口的，
2： 货品全，现经营过700多个品牌，基本所有生物试剂耗材都可以进口，特别是冷偏的产品那就更有优势，
3：提供加急服务，一般1-2周到货，超过时限加急费全免
4：价格公道，绝大部分价格有优势，当然不能保证100%产品都是,因为意味着没有服务.
5：良好的信誉，大部分客户我们提供货到付款服务，客户包括清华，北大 交大 复旦，中山等100多所大学，ROCHE，阿斯利康，国药 ，fisher等500多家公司
6：我们还是santa,Advanced Biotechnologies Inc;Athens Research & Technology, bangs, BBInternational, crystalchem, dianova, FD Neurotechnologies, Inc. FormuMax Scientific, Inc; Genebridege; Glycotope Biotechnology GmbH; iduron; Innovative Research of America； Ludger ； neuroprobe; omicronbio; Polysciences; prospecbi; QA-BIO；quickzyme；RESEARCH DIETS, INC；sterlitech；sysy；TriLink BioTechnologies, Inc；worthington-biochem;zyagen;......几十家国外公司授权代理
7：我们还从事invitrogen，qiagen; abcam ;sigma;neb; roche;merck; rnd; BD; GE; pierce; BioLegend....等*批发
